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ABSTRACT 
 
Introduction 
People living with HIV and AIDS (PLWHA) receiving antiretroviral therapy (ART) increases their life 
expectancy. Receiving ART coupled with physical inactivity results in increase in prevalence of 
hyperlipidaemia, obesity and overweight, type 2 diabetes mellitus, lipodystrophy, decrease in mineral 
bone density and hypertension among others. Resistance exercise (RE) interventions address chronic 
disease risks affecting PLWHA receiving ART.  
Aim   
The study investigated the effect of RE on body composition, chronic disease risks and strength scores 
in PLWHA receiving ART.  
  
Methods 
The study followed an experimental, pre-and-post-test design. The sample constituted 128 PLWHA, of 
black African ethnic groups, aged between 18-45 years and receiving ART. The participants were 
recruited from Glenview and Mabvuku suburbs in Harare. The participants from Glenview were 
randomly allocated to an experimental group i.e. the EXP group (n=64) performing REs three days per 
week and those from Mabvuku to a control group i.e. the CON group (n=64) for 12 weeks following a 
pre-test session. Body composition (waist-to-hip ratio, body mass index, percentage body fat, fat mass, 
lean body mass), chronic disease risks (fasting blood glucose, fasting total blood cholesterol, blood 
pressure) and strength (1RM tests) scores were pre-and-post-test measured in all participants observing 
standard protocols. Chi-square, Fisher’s test, linear regression, Binomial test, Spearman’s and 
Pearson’s correlations were conducted. SPSS statistical package version 22 was used and significance 
set at p<0.05.   
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Results   
Post-test body composition scores remained high in the CON group (n=64), but improved significantly 
(p<.0005) in the EXP group (n=64). Significant differences (p<.0005) were noted in post-test chronic 
disease risks between the EXP group (n=64) and the CON group (n=64). Post-test fasting blood 
glucose and fasting total blood cholesterol scores in the CON group (n=64) were significantly higher 
(p<.0005) than in the EXP group (n=64). A 100% of the CON group (n=64) participants remained 
with pre-hypertension at post-test, while 66% of the EXP group (n=64) with hypertension 2 improved 
to hypertension 1.  
Strength scores in the EXP group (n=64) participants significantly increased (p<.0005) for bench 
press, squat, bicep curl and leg curls than in the CON group (n=64). There were no effects of gender 
in respect of fasting blood glucose and total fasting blood cholesterol scores in both groups at post-test.   
Conclusion  
The results showed that the 12 week RE intervention programme improved body composition, chronic 
disease risk and strength scores in PLWHA receiving ART. Resistance exercise is safe and beneficial 
for PLWHA in resource-constrained settings. Policy makers may utilise this information to include RE 
programmes for PLWHA as a healthy lifestyle intervention in Zimbabwe. 
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CHAPTER ONE: INTRODUCTION 
 
1.1. BACKGROUND    
 
The American College of Sports Medicine (ACSM) validate resistance exercise (RE) as an important 
health benefit for people living with HIV/AIDS (PLWHA), in mitigating chronic disease risks and 
improving strength scores  (ACSM, 2014 p294; Souza et al., 2011; Yarasheski et al., 2001).  The 
identifiable chronic disease risk factors in PLWHA are modifiable through lifestyle changes, 
(Compston, 2015; Junior et al., 2010; McComsey et al., 2010; Stanley and Grinspoon, 2012).  Studies 
show that PLWHA can safely perform REs without aggravating their clinical status  (Quiles and Ortiz, 
2017).  Exercise training reduces chronic disease risks in PLWHA by improving body composition 
patterns (Malita et al., 2005).   
The benefits of exclusive RE seem as if they vary from those of other exercise modalities. However it 
is important to note that RE alone increases lean body mass, muscle strength, sum of skinfolds, limb 
girths and mitigate muscle wasting more than quality of life in PLWHA (Leach et al., 2015, Grace, 
2016, Neto et al., 2013).  Although RE are not widely used they are safe and an effective non-
pharmacological therapy for PLWHA (Grace et al., 2016, Gomes-Neto et al., 2015, Lopez, 2015). 
Furthermore, RE improves glucose tolerance, percentage body fat, psychological status, insulin 
sensitivity and lipid profiles in PLWHA (Grace et al., 2016). The REs performed are many and include 
resistance bands, dumb bell free weights, body weights, cables, machines, kettle bells, medicine balls 
and plyometrics among others (Grace et al., 2016, Sandler, 2010, p.22).   Therefore when conducting 
RE for PLWHA they have to be conducted under supervision.  It has been shown that RE improve 
bone mineral density and essentially reduce body weight in PLWHA (Neto et al., 2013). The lean body 
mass improves more in PLWHA especially males experiencing wasting in relation to notable 
improvements in day to day bodily functioning (Quiles and Ortiz, 2017).  In PLWHA such as women, 
RE have an equally beneficial effect for it also improves muscles strength and lean muscle mass 
(Quiles and Ortiz, 2017). When the RE is progressively prescribed women can experience reductions 
in fat mass while muscle mass and quality of life scores improve (Quiles and Ortiz, 2017). Importantly 
RE can effectively improve blood lipids, glucose (chronic disease risks) and bone metabolism in 
PLWHA (Quiles and Ortiz, 2017 and O’Brien et al., 2017). However, exclusive RE researches are few 
although presenting evident benefits for PLWHA. 
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1.2. AIM OF THE STUDY  
The aim of the study was to investigate the effect of a resistance exercise intervention 
programme on body composition, chronic disease risks and strength of PLWHA receiving 
ART in Zimbabwe.   
 
1.3. OBJECTIVES  
1.3.1. To investigate body composition scores post 12 week RE exercise intervention programme.   
1.3.2. To investigate chronic disease risk factors in PLWHA at pre and post test.  
1.3.3. To investigate the strength levels at pre and post test.  
 
1.4. HYPOTHESIS 
1.4.1. There is a relationship between increased weight, fat mass, lean body mass and 12-week RE 
intervention programme.  
1.4.2. A 12-week RE intervention programme improves strength scores in PLWHA receiving ART.  
1.4.3. A 12-week RE intervention programme reduces the risk of chronic disease in PLWHA.  
 
1.5. DELIMITATIONS OF THE STUDY 
The study only included participants without opportunistic infections, not participating in a pre-
existing exercise programme. The pre-menopausal female subjects were none pregnant or lactating, or 
had had regular menstrual cycles for the past year. Only those medically diagnosed were recruited in 
this study.   The study was delimited by excluding individuals with Acquired Immune Deficiency 
Syndrome; musculoskeletal disorders; seriously ill and bed-ridden. HIV-negative individuals or those 
with any history of leg injury, back pain; congestive heart failure; angina, cardiovascular and 
peripheral vascular diseases were excluded. Individuals who had experienced a cold or fever at least 
one month leading up to the protocol or with flu symptoms and of non-black African ethnicity did not 
participate in this study. Further, individuals receiving medications affecting central or peripheral 
circulation, on nonsteroidal anti-inflammatory agents or serotonin reuptake inhibitors and with any 
other health circumstances that could be exacerbated by lifting weights were left out. 
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1.6. SIGNIFICANCE OF THE STUDY 
Zimbabwe has limited data on the effect of REs for PLWHA receiving ART. In undertaking 
this study, it is perceived that it may lead to further investigation on the effects of REs as an 
intervention to improve health and lifestyles of PLWHA receiving ART in Zimbabwe. The 
study is important in forming the basis for coming up with exercise programmes for HIV 
patients in Zimbabwe. This is perceived to contribute towards encouraging PLWHA to live 
healthier while ageing with the disease by engaging in REs. The study is wholly believed to 
add to the body of knowledge in the care and support for PLWHA in the country. 
 
1.7. DEFINITION OF TERMS 
a) Atherosclerosis.  
Refers to a disease in which plaque builds up inside the arteries. 
b) Cholesterol. 
Is a type of fat in the blood carried by a type of protein known as lipoprotein.  
c) Chronic disease. 
Also known as non-communicable disease that emerges after long exposure to an unhealthy 
lifestyle physical inactivity, tobacco use, consuming high fat diets, sugars, salts). 
d) Comorbidity. 
Is the presence of one or more additional diseases or condition together with a primary disorder 
or disease. 
e) Dyslipidaemia. 
Is an elevated total or low-density lipoprotein cholesterol levels or low levels of high-density 
lipoprotein. 
f) Glucose tolerance. 
Is a pre-diabetic state of hyperglycaemia associated with insulin resistance. 
g) Health-related quality of life. 
Is a multidimensional concept that includes domains related to physical, mental, emotional and 
social functioning. 
h) Hyperglycaemia. 
Is an excess of glucose in the blood stream often associated with diabetes mellitus. 
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i) Hyperlipidemia.  
Are elevated lipid fat levels in the blood. 
j) Hypertension.  
Is an abnormal state of high blood pressure. 
k) Intervention.  
Is an action to improve a medical disorder or act of intervening. 
l) Lipodystrophy. 
Is a disorder of the adipose tissue characterized by selective loss of body fat. 
m) Maximum oxygen consumption.  
Is the amount of oxygen the body can use during a specific period of intense exercise dependent 
on body weight and strength of lungs. 
n) Multi-morbidity. 
Is the presence of two or more chronic medical conditions in an individual. 
o) One repetition maximum (1RM).  
Is the greatest weight an individual can lift with one repetition or contraction. 
p) Osteoporosis. 
Is a medical condition in which the bones become brittle and fragile from loss of tissue. 
q) Poly-neuropathy.  
A general degeneration of peripheral nerves that spread towards the centre of the body. 
r) Progressive resistance exercise.  
Is a method of strength training that involves the utilisation of resistance observing the principle 
of overload. 
s) Protease inhibitors. 
Is a class of antivirus drugs that’s that are widely used to treat HIV/AIDS and hepatitis.   
t) Resistance exercise.  
Are exercises that require muscle contraction against a force or weight.  
u) Resistance exercise.  
Is any of the exercises that forces the skeletal muscles to contract. 
v) Sarcopenia.  
The loss of skeletal muscle mass and strength. 
w) Triglycerides.  
 Are the main constituents of natural fats and oils. 
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The outline of this thesis is as follows:  
Chapter Two provides a review of related literature regarding body composition and chronic disease 
risk responses of RE interventions in PLWHA.   
Chapter Three: Article 1 is a systematic review study intended for submission to a journal for 
publication.  
Chapter Four: Article 2 is the original research manuscript to be submitted to a journal for publication 
(in the accepted format for submission of a Masters dissertation at the University of Kwa-Zulu Natal) 
and; 
Chapter Five provides the conclusions of the study and recommendations for future research.  
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CHAPTER TWO: REVIEW OF LITERATURE 
 
 
2.1. INTRODUCTION  
The Human Immunodeficiency Virus (HIV) has become a persistent health challenge and many 
families are left either infected or affected (WHO, 2016). The concerns are that HIV still has no cure, 
in spite of ongoing efforts (Lederman at al., 2016). The preferred treatment available to people living 
with HIV/AIDS (PLWHA) is antiretroviral therapy (ART) (AIDSinfo, 2016).  
Antiretroviral therapy increases life expectancy of PLWHA (WHO, 2016).  However, the incidence of 
chronic disease in PLWHA is also increasing (Guaraldi et al., 2015). To a greater extent studies 
provide relevant information on the valuable effects of exercises in lessening the effects of chronic 
disease risks in PLWHA (Roubenoff and  Wilson, 2001; Srikanthan and Karlamangla, 2014). 
Resistance exercise (RE) offer the possibility of averting the chronic disease risks in PLWHA 
(Mkandla et al., 2016; Phillips et al., 2006; Souza et al., 2011; Hamid and Rajah, 2015; Yarasheski et 
al., 2001).  
2.2. SIDE EFFECTS OF ART AND THE ROLE OF EXERCISE IN PLWHA 
Antiretroviral therapy is not a cure for HIV, but it should be taken conscientiously for life to preserve 
immune function  (Ministry of Health and Child Welfare, 2013). The chronic disease risks affecting 
PLWHA are classified as early onset, late onset and unintended (Lundgren and Mocroft, 2006).  The 
effects of ART in PLWHA are evident through alteration in body fat, mineral bone density, blood 
glucose, blood pressure and body composition leading to increased incidences of chronic disease risks.   
2.2.1. SIDE EFFECTS OF ART ON TOTAL CHOLESTROL AND THE ROLE OF 
EXERCISE IN PLWHA  
Fasting total blood cholesterol and triglyceride levels are used to identify individuals at risk of chronic 
diseases. The optimal targets for fasting blood cholesterol are 4.1mmol/L or 160mg/dL; and 
5.1mmol/L or 200mg/dL for those at high-risk (ACSM, 2014, p. 46).When considering total serum 
cholesterol, a value of <5.1mmol/L or <200mg/dL is desirable, while borderline high ranges from 5.1 
to 6.1mmol/L or 200 to 239mg/dL; and anything >6.21mmol/L or >240mg/dL is very high (ACSM, 
2014, p 46).  
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Hyperlipidaemia (high level of blood lipids) and fat redistribution (lipodystrophy), are caused by 
Zidovudine, Norvir, Sustiva and Stavudine ART drugs, and  are the most common chronic disease 
risks in PLWHA (AIDSinfo, 2016; Teklay et al., 2013). Didanosine, an ART drug also causes fat 
redistribution (Hubbard, 2007). In India, high mean total blood cholesterol levels were evident among 
HIV-infected males following a shorter period on ART (Zephy, Lakshmi and Ashraff, 2015). 
Zidovudine, Lamivudine and Nevirapine (first line of treatment) were the ART drugs the PLWHA 
were receiving (Zephy et al., 2015).  
Fat accumulation in PLWHA receiving ART are associated with mitochondrial toxicity occurring 
following combinations of thymidine-containing nucleoside reverse transcriptase inhibitors, plus a 
protease inhibitor (PI) (Hubbard, 2007; Neto et al., 2013).  In Brazil, studies show that dyslipidaemia 
and triglycerides with levels >150 mg/dl were evident among PLWHA, after only three years of 
receiving ART (Neto et al., 2013). Dyslipidaemia (abnormally elevated cholesterol or blood lipids) 
was closely associated with lopinavir use although more participants in their study were receiving 
lamivudine–zidovudine (Neto et al., 2013).  
In Zimbabwe, some study found that major adverse drug reactions in PLWHA were peripheral 
neuropathy and lipodystrophy (Nemaura et al., 2013). In Spain, chronic disease risk prevalence was 
high and gradually increased with age among PLWHA (Jerico et al., 2005). Many patients taking 
Stavudine (d4T) and lopinavir/ritonavir presented with chronic disease risks, adjusted for age and body 
mass index (Jerico et al., 2005). The same findings were evident in a Cameroonian study involving 
patients receiving ART for more than 3.5 years (Nsagha et al., 2015). The results were independently 
related to total blood cholesterol scores ≥ 200 mg/dl or raised low density lipoprotein-cholesterol 
values (Nsagha et al., 2015). This shows that PLWHA receiving PI drugs may have alterations in their 
body fats (Malapati et al., 2014).    
Although statins are a more effective treatment for increased blood cholesterol levels, there is need to 
raise awareness on its risks (ACSM, 2014, p.295). This shows that lifestyle modifications involving 
RE regimens may also be adopted in managing dyslipidaemia among PLWHA without the need for 
more medications to address the risk (ACSM, 2014, p.286). The benefit of REs in addressing 
dyslipidaemia in PLWHA is discussed in subsequent sections. 
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2.2.2. SIDE EFFECTS OF ART ON BONE MINERAL DENSITY AND THE ROLE OF 
EXERCISE ON PLWHA   
Tenofovir Alafenamide is a novel drug of the antiviral acyclic nucleoside phosphonate tenofovir type, 
which has enhanced properties compared to tenofovir disoproxil fumarate (Ray et al., 2016). The 
generally well-tolerated, potent tenofovir disoproxil fumarate therapy causes reductions in bone 
mineral density in PLWHA (Grund et al., 2009; Ray et al., 2016). A decreased bone mineral density is 
a chronic disease risk that increases the incidence of osteopenia in PLWHA (Ray et al., 2016). Bone 
mineral density losses may reach 2 to 6% in the hip and backbone during the first 2 years of ART 
(Compston, 2015; Stein et al., 2008). 
The stimulation of osteoclast creation and inhibition of osteoblast function by some PI, zidovudine and 
reverse-transcriptase inhibitor causes a reduction in bone mineral density (Womack et al., 2011). A 
reduction in bone mineral density cause increased fracture risks in PLWHA (Battalora, Young and 
Overton, 2014; Yin et al., 2012). The condition can progress to bone demineralisation in individuals 
following an average of two and half years receiving ART (Bonjoch et al., 2010). The associated 
factors include age, sex, low body mass index and time on PI or tenofovir current use of PI (Bonjoch et 
al., 2010; Compston, 2015; Ray et al., 2016; Womack et al., 2011). 
There is limited information on the reduction in bone mineral density in black African PLWHA 
(Compston, 2015). However, one study conducted in Nigeria noted a significant prevalence of 
osteopenia (47%)  and osteoporosis (32%) among PLWHA (Alonge et al., 2013).  Authors have shown 
that exercises reduce the risk of osteoporotic fractures, enhance bone mass and reduce rate of bone 
mineral loss (ACSM, 2014, p.316). Resistance exercise increase muscle and bone strength which 
limits the risks of falling while improving balance (ACSM, 2014, p.316). Furthermore, if PLWHA 
undertake RE programmes they directly slow down bone mineral density loses in the backbone and hip 
(ACSM, 2014, p.316). 
2.2.3. THE SIDE EFFECTS OF ART ON FASTING BLOOD GLUCOSE AND THE 
ROLE OF EXERCISE IN PLWHA 
Monitoring of fasting blood glucose provides a risk indicator of cardiovascular disease progression in 
clinical and general populations (ACSM, 2014, p.278). The desired fasting blood glucose scores are 
<110mg/dL or <6.1mmol/L  (ACSM, 2010, p.279). The diagnostic criteria for normal fasting blood 
glucose levels are shown in the table below:   
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Table i: Plasma blood glucose classification criteria  
Normal Prediabetes Diabetes Mellitus 
Fasting blood glucose 
<100mg/dL or 
5.55mmol/L 
Impaired Fasting glucose 
100-125mg/dL or 5.55 to 
6.94mmol/L 
Symptomatic with causal glucose 
≥200mg/dL or 11.10mmol/L 
 Impaired glucose tolerance 
140-199mg/dL or 7.77-
11.04mmol/L during an oral 
glucose tolerance test (OGTT) 
Fasting plasma glucose 
≥126-200mg/dL or 6.99-
11.10mmol/L during OGTT. 
 
Source: Adapted from (ACSM, 2014, p.279) 
The incidence of insulin resistance, impaired glucose tolerance and type 2 diabetes in PLWHA 
receiving ART has increased (Wiwanitkit, 2007). There are more PLWHA frequently diagnosed with 
high fasting blood glucose scores following commencement of ART (Wiwanitkit, 2007). Type 2 
diabetes was observed in PLWHA receiving ART for three years with smoking further aggravating the 
condition (Neto et al., 2013).  In Nigeria, PLWHA receiving Lamivudine, Nevirapine, Combivir, 
Combipack and Efavirenz (first-line ART drugs) recorded a 6% prevalence of type 2 diabetes 
(Chukwuanukwu et al., 2013).  In the same study, those receiving truvada (comprising tenofovir and 
emtricitabine) and Aluvida (a PI comprising lopinavir and ritonavir) (second-line ART drugs) recorded 
a 10% prevalence of impaired glucose tolerance after three months of receiving the drugs 
(Chukwuanukwu et al., 2013). None of the participants had a history of diabetes in their families, or 
diabetes risk factors (Chukwuanukwu et al., 2013).  
In Rwanda, Dusingize et al. (2013) found that HIV-infected females 42-43years had minimal 
differences in fasting blood glucose scores in relation to the none HIV-infected. However, the HIV-
negative women had higher, fasting glucose scores (Dusingize et al., 2013). Antiretroviral drug 
ritonavir (Norvir), received in combination with another PI, increases the risk of diabetes or 
hyperglycaemia (Stein et al., 2008). Increased age in both males and females receiving ART increases 
the chances of developing type 2 diabetes (Domo and Jalyson, 2015; Stein et al., 2008).   
The literature stresses that ART causes high fasting blood glucose scores in PLWHA (Wiwanitkit, 
2007; Chukwuanukwu et al., 2013;Dusingize et al., 2013; Domo and Jalyson, 2015; Stein et al., 2008). 
Those with type 2 diabetes or pre-diabetes require glycaemic control through diet and exercise among 
other lifestyle management methods (ACSM, 2014, p.290).  Importantly REs have been shown to 
improve the body’s ability to utilise blood sugar, reducing the incidence of type 2 diabetes (ACSM, 
2014, p.291).   
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2.2.4. SIDE EFFECTS OF ART ON BLOOD PRESSURE AND THE ROLE OF 
EXERCISE IN PLWHA 
High blood pressure scores are related to the risk of cardiovascular events (ACSM, 2014, p.299). The 
following table shows the new classification of blood pressure, each with corresponding expectations 
on lifestyle modifications according to American College of Cardiology (ACC) and American Heart 
Association (AHA). 
Table ii: The new blood pressure classification according to ACC and AHA 
BP Category Systolic BP Diastolic BP Treatment or Follow-up 
Normal <120 mm Hg <80 mm Hg  Evaluate yearly; encourage healthy lifestyle changes 
to maintain normal BP 
Elevated 120-129 mm Hg <80 mm Hg  Recommend healthy lifestyle changes and reassess 
in 3-6 months 
Hypertension
: Stage 1 
130-139 mm Hg 80-89 mm 
Hg 
 Assess the 10-year risk for heart disease and stroke 
using the atherosclerotic cardiovascular disease 
(ASCVD) risk calculator 
 If risk is less than 10%, start with healthy lifestyle 
recommendations and reassess in 3-6 months 
 If risk is greater than 10% or the patient has known 
clinical cardiovascular disease (CVD), diabetes 
mellitus, or chronic kidney disease, recommend 
lifestyle changes and BP-lowering medication (1 
medication); reassess in 1 month for effectiveness of 
medication therapy If goal is met after 1 month, 
reassess in 3-6 months 
 If goal is not met after 1 month, consider different 
medication or titration 
 Continue monthly follow-up until control is 
achieved 
Hypertension
: Stage 2 
≥140 mm Hg ≥90 mm Hg  Recommend healthy lifestyle changes and BP-
lowering medication (2 medications of different 
classes); reassess in 1 month for effectiveness  
 If goal is met after 1 month, reassess in 3-6 months 
 If goal is not met after 1 month, consider different 
medications or titration 
 Continue monthly follow-up until control is 
achieved  
Source: Adapted from (ACC/AHA, 2017) 
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It has been shown that age, male gender and family history are associated with hypertension (Junior et 
al, 2010). Furthermore, a body mass index  > 25kg/m2, a large waist circumference, fasting total blood 
cholesterol >200mg/dl, with >100 mg/dl blood glucose levels, >150mg/dl triglyceride, duration on 
ART and CD4 count >200 cells/mm3 in PLWHA are associated with hypertension (Crane et al., 2006; 
Junior et al., 2010; Palacios et al., 2006). Blood pressure can increase in PLWHA within 48 weeks of 
initiating ART and it is important to consider early detection of hypertension for healthy lifestyles 
management purpose (Palacios et al., 2006). Another study observed that there was an increase in the 
incidence of high blood pressure and new diagnoses of hypertension in PLWHA receiving ART over a 
10-year period (Crane et al., 2006). Participants receiving lopinavir/ritonavir had the highest risks of 
developing high blood pressure compared to efavirenz-based regimens (Crane et al., 2006).       
However, in Western Kenya, it was shown that more mortality rates were noticed in PLWHA with low 
blood pressure over a five year period (Bloomfield et al., 2014).  There were increased mortality rates 
among the males with low systolic blood pressure, than those with normal systolic blood pressure 
(Bloomfield et al., 2014). The study did not mention type of ART drugs the PLWHA were receiving. 
Very low CD4 cell counts and prolonged periods on ART are associated with chronic hypertension; 
while delaying the start of ART until a state of advanced immunosuppression is reached might add or 
fuel those chronic disease risks associated with receiving ART (Manner et al., 2013). The prolonged 
use of ART was shown to be significantly associated with a higher prevalence of systolic hypertension 
(Seaberg et al., 2005). Studies in Zimbabwe, have also noticed the prevalence of hypertension in 
PLWHA receiving ART in a predominantly rural setting (Mutede et al., 2015).  Receiving ART for ≥ 
two years, >0.85 for waist-to-hip ratio in women, body mass index >25kg/m2, smoking, sedentary 
recreation and high salt intake increased hypertension incidences (Mutede et al., 2015).  
The literature shows that receiving ART causes hypertension in PLWHA though a general consensus 
on causative ART drugs was not clearly established (Junior et al., 2010; Crane et al., 2006; Palacios et 
al., 2006; Bloomfield et al., 2014; Manner et al., 2013; Seaberg et al., 2005; Mutede et al., 2015).  
Individuals with 120-139 mmHg and 80-89 mmHg for systolic and diastolic blood pressure 
respectively are strongly advised to adopt healthy lifestyle changes including weight reduction, 
exercise and a healthy diet (ACSM, 2014, p.296).  Aerobic exercises are highly recommended, 
however, they have to be complemented by moderate- intensity RE (ACSM, 2014, p.297). This shows 
that RE are important interventions in addressing changes in blood pressure scores among PLWHA 
receiving ART. 
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2.2.5. SIDE  EFFECTS OF ART ON BODY COMPOSITION AND  THE ROLE OF 
EXERCISE  
 
The body mass index, also known as the Quetelet index, is the most frequently used standard to define 
excess body weight in clinical and non-clinical populations.  
       The body mass index equation is: Weight (kg) 
                      Height2 (m) 
 
  
Table iii: Body mass index classification according to World Health Organisation 
Classification BMI (kg/m2) Sub-classification BMI (kg/m2) 
Underweight < 18.50 Severe thinness < 16.00 
Moderate thinness 16.00 - 16.99 
Mild thinness 17.00 - 18.49 
Normal range 18.5 - 24.99 Normal 18.5 - 24.99 
Overweight ≥ 25.00 pre-obese 25.00 - 29.99 
Obese 
(≥ 30.00) 
obese class I 30.00 - 34.99 
obese class II 35.00 - 39.99 
obese class II ≥ 40.00 
Source: Adapted from (World Health Organisation, 2016) 
When body mass index scores increase beyond 25 kg/m2 health problems begin to increase (WHO, 
2016). Body mass index score  ≥30.00 kg/m2 increases the incidence of hypertension, cancer, type 2 
diabetes mellitus and dyslipidaemia (ACSM, 2014, p.318). Waist-to-hip-ratio has been proven to 
assess body fat distribution and determining the risk of chronic diseases (ACSM, 2014, p.66). It is 
calculated by measuring the circumference of the waist just above the iliac crest and dividing this 
value by the circumference of the hips (a horizontal extent taken at the greatest boundary of the 
buttocks). The table below shows wait-to-hip classifications; 
Table iv Waist-hip-ratio classification according to World Health Organisation 
Gender  Acceptable  Unacceptable 
 Excellent Good Average High Extreme 
Male < 0.85 0.85 - 0.90 0.90 - 0.95 0.95 - 1.00 > 1.00 
Female < 0.75 0.75 - 0.80 0.80 - 0.85 0.85 - 0.90 > 0.90 
    
Source: Adapted from (World Health Organisation, 2016)  
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Skinfold measurements are an ideal field procedure to determine body composition levels, since the 
amount of subcutaneous fat is proportional to the volume of body fat (ACSM, 2014, p.67). The 
skinfold sites range from 3 to 8, for which equations have been developed to predict body density and 
percentage body fat scores based on age, sex, race, and population type (ACSM, 2014, p.69). The 
following tables show fitness categories in relation to percentage body fat classifications in men and 
women.  
Table v: Fitness categories for percentage body fat of men by age 
 
 
     Adapted from (ACSM, 2014, p.73)  
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Table vi: Fitness categories for percentage body fat of women by age 
 
 
      Adapted from (ACSM, 2014, p.74)  
 
Body mass index, skinfold measurements and waist-hip-ratio offer a valuable indication of general 
health and risk stratification during assessments of clinical and healthy populations (ACSM, 2014, 
p.67). Underweight remains an important condition in PLWHA receiving ART but those newly 
diagnosed with HIV-infection can experience weight gain even though some experience no change 
(Denue et al., 2013). The PLWHA can become overweight and obese due to ART (Denue et al., 2013).    
In a salient report, it has been shown that the prevalence of central obesity is associated with greater 
consumption of lipids, although carbohydrates ingested had a negative correlation with central obesity 
(Jaime et al., 2006).  Increases in body mass index can be associated with minor increases in CD4 cell 
counts (Jones et al., 2003).  About  40-50% of PLWHA exhibit an abnormality in body composition 
when they start to receive ART (Grinspoon and Carr, 2005). The major factors associated with 
overweight and obesity include: being female, older age, receiving ART for five years, living an over-
indulgent lifestyle, hypertension, and WHO HIV stage 2 (Guehi et al., 2016).  
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Erlandson et al. (2016) however, in a fifteen year observational study, compared body composition 
between HIV-infected and uninfected individuals.  They found out that body mass index gains were 
slower among PLWHA with 40 years or less and plateaued after the age of 60 in both groups 
(Erlandson et al., 2016). Furthermore, ethnic Blacks and Hispanics appeared were associated more 
with greater body mass indexes (Erlandson et al., 2016).    
Sharma et al. (2014) showed that after receiving ART medication, 40% of women became overweight, 
47% obese and 71% of overweight women stayed obese while 27% became unhealthily heavy. Each 
year of reverse-transcriptase inhibitor use reduced the chances  of reaching a higher body mass index 
score by 3%; while each year of PI or non-nucleoside reverse transcriptase inhibitors use increased by 
6% the chance of reaching a higher body mass index score (Sharma et al., 2014). 
In a study group of women on ART in Sub-Saharan Africa (SSA), increases in the prevalence of 
obesity were observed over a ten year period (McCormick et al., 2014). However, in contrast to 
another study it showed that a longer duration on ART may not  be a predictor of obesity (Denue et 
al.,2013). Studies in Zimbabwe, revealed the prevalence of under-nutrition and over-nutrition 
(overweight and obesity) among PLWHA enrolled in ART clinics and the factors were associated with 
increased ill health and mortality (Takarinda et al., 2017). It was found out that females, aged 
≥45years, wealthier and with CD4 counts >350 cells/mL were more likely to be overweight or obese 
(Takarinda et al., 2017). The researchers referred to this trend as reflecting a change in the pattern of 
HIV infection to a chronic manageable condition (Takarinda et al., 2017).  
In summary, it appears that increased  body composition scores increases the risk of chronic diseases 
in PLWHA (Cade et al., 2013; Singh et al., 2013). It is important to note that  there remain concerns 
about the effects of newer ARTs on chronic disease risks in PLWHA (Srinivasa and Grinspoon, 2014).  
Overweight and obese PLWHA are encouraged to take part in consistent physical activity, exercise 
and weight loss management programmes (ACSM, 2014, p.298).  It was shown that there are few 
well-designed studies involving supervised exercises to prevent weight regain in PLWHA and 
therefore RE are safely recommended in addressing the condition (ACSM, 2014, p.298).   
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2.2.6. CHRONIC DISEASES AND THE ROLE OF EXERCISE IN PLWHA    
Antiretroviral therapy has clinically transformed the lives of PLWHA, reducing their morbidity and 
mortality rates (Werberich et al., 2013).  It is a concern that higher rates of chronic disease have been 
noted in PLWHA (Friis-Møller et al., 2007).  Grochocinski (2011) asserted that there are increased 
incidences of myocardial infarction (heart attack) with cumulative year on year use of PI in PLWHA. 
The consumption of high fat diets by PLWHA has been shown to increase the chances of blocking 
arterial walls causing  a reduction in the amount of blood supply and oxygen to the heart 
(Grochocinski, 2011). The figure below therefore shows a healthy heart artery compared to a 
blocked artery. 
 
Source: https://healthcare.utah.edu/cardiovascular/conditions/coronary-artery-disease.php 
 
Peripheral vascular disease affects vessels in the legs and cerebrovascular disease affects blood vessels 
in the brain which also leads to stroke  (Grochocinski, 2011). Authors opine that PI increase the levels 
of cholesterol, triglycerides and blood glucose in the blood, thereby increasing the chances of 
developing cardiovascular disease (Currier et al., 2008; Friis-Møller et al., 2007). Studies have shown 
that higher rates of cardiovascular disease are increasingly being reported in the PLWHA receiving 
ART (Grochocinski, 2011; Martinez et al., 2007; Sharma et al., 2014).   
 
 
* 
Figure 1: Healthy heart artery compared to a blocked artery. 
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There are concerns that fewer PLWHA exercise, and studies have shown that 65% of those receiving 
ART for at least five years had a sedentary lifestyle (Romancini et al., 2012).  Further, they identified a 
firm relationship amongst physical activity levels and advanced levels of high density lipoprotein-
cholesterol (Romancini et al., 2012).  The agreed recommendations for PLWHA include specific 
physical activities, taking sufficient intake of fruit and vegetables to address cardiovascular disease. 
(Romancini et al., 2012; World Health Organisation, 2015).  The Figure below shows the deaths 
accredited to nineteen prominent risk causes by country income status according to  (WHO, 2015). 
 
 
Global Health Risks Mortality and Burden of Disease Attributable to Selected Major Risks (WHO, 2009) 
Figure 2: Deaths accredited to nineteen prominent risk factors by country income status 
Studies have shown that mortalities among PLWHA are increasingly a result of chronic diseases or 
non-communicable diseases (Barbaro and Barbarini, 2011; Bloomfield et al., 2014; Currier et al., 
2008; Friis-Møller et al., 2007). In Zimbabwe, one study estimated that the prevalence of 
comorbidities (presence of other diseases occurring together with a primary disease) among PLWHA 
of male and female gender were at 15 and 5%, respectively and females recorded higher rates than 
males (Magodoro et al., 2016).  The commonly observed individual chronic risks were hypertension, 
asthma, type 2 diabetes mellitus, cancer and congestive cardiac failure (Magodoro et al., 2016).  It was 
also confirmed that the incidences of chronic diseases had increased over time due to urbanisation and 
the high HIV-infection rate in Zimbabwe (Zhou, Oktedalen, Chisango and Stray-Pedersen, 2016). The 
study identified HIV and chronic diseases as a potential recipe for disaster (Zhou et al., 2016). 
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The chronic diseases in PLWHA are presented in the form of enlarged central adiposity, peripheral 
lipoatrophy, peripheral insulin resistance, diabetes, dyslipidaemia and hypertriglyceridemia, 
overweight, obesity, osteoporosis and osteopenia, among others (Akl et al., 2017; Alonge et al., 2013; 
Crane et al., 2006; Erlandson et al., 2016; Grinspoon and Carr, 2005; Jaime et al., 2006; Junior et al., 
2010; Malita et al., 2005; Neto et al., 2013; Zephy et al., 2015).  
Although many of these adverse effects are treated, mostly by pharmacological means, it is less than 
ideal to continue relying on additional medications to address this epidemiological situation in the 
PLWHA receiving ART (Ciccolo et al., 2004).  Patients with cardiovascular disease are encouraged to 
exercise for it is safe but should be adjusted according to the risk of cardiac-related event, 
musculoskeletal limitations, baseline exercise capacity and angina threshold (ACSM, 2014, p.236). 
Resistance exercise are an ideal intervention for cardiac conditions in the PLWHA (ACSM, 2014, 
p.252).  
2.3. OVERVIEW OF INTERVENTIONS ADDRESSING ART SIDE EFFECTS IN PLWHA 
Stanley and Grinspoon. (2012), state that long term treatment for body composition changes and 
cardio metabolic anomalies in PLWHA includes lifestyle modifications, the use of lipid-lowering 
proxies, insulin sensitisers and cures to reverse endocrine anomalies, including growth hormone-
releasing hormone. The pharmacological redress for treating lipoatrophy is to shift PLWHA off 
thymidine analogues onto non-thymidine equivalents on condition that it does not jeopardise control of 
the individual’s HIV-infection (Hubbard, 2007).   
Murphy and McKay (2013) assert that, once a diagnosis of diabetes in PLWHA receiving ART is 
made, routine screening for the complications linked with diabetes should take place and plans should 
be made to improve glycaemic control. The study showed that such efforts are dependent on the 
healthcare systems and need a multidisciplinary approach in addressing the prevalence of diabetes in 
PLWHA (Murphy and McKay,  2013).  
Junior et al. (2010) determined that efforts should be directed toward controlling modifiable chronic 
disease risks in PLWHA. Other researchers suggest giving lifestyle advice where appropriate, 
particularly with respect to tobacco use, alcohol abuse, exercise and dietary interventions (Compston, 
2015; McComsey et al., 2010). Treatment with alendronate and vitamin D also appears to be effective 
(McComsey et al., 2010).    
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Hubbard (2007) recommended exercise because it can decrease abdominal fat than associated surgical 
interventions (liposuction of dorsocervical fat pads) which can offer temporary relief, since the fat 
accumulation tends to recur. In South Africa, Ogutibeju et al. (2007) went on to research the use of 
nutritional supplements to address body weight and body mass index in PLWHA. Significant results 
were evident and about 70% of participants had body mass indexes within the normal range after 
nutritional supplementation for three months (Ogutibeju et al., 2007).  
In Zimbabwe,  Mudzviti et al. (2012) examined the impact of herbal drug use on the adverse side 
effects of ART in PLWHA receiving first line treatment.  The local herbs, Musakavakadzi and 
Peltoforum Africanum were taken together with ART  and significantly reduced the incidence of 
chronic disease risks in the PLWHA  (Mudzviti et al., 2012).  Similarly, Jaime et al. (2006) supported 
the use of nutritional interventions after research suggested  that they are beneficial for preventing 
central obesity among PLWHA receiving ART.  
Treatment for glucose abnormalities (a chronic disease risk) in PLWHA is the same as in none HIV-
infected individuals, with the use of insulin sensitising agents and/or sulfonylureas (Grinspoon and 
Carr, 2005). Body weight should be timeously checked and healthy lifestyle supervision encouraged 
such as dietary measures and regular exercise to limit concentrated sugar (Hubbard, 2007). The 
treatments for lipodystrophy, include changes in diet, engaging in specifically designed exercise 
regimens which influence muscle building and reduce fat accumulation (AIDSinfo, 2016). Exercise 
improves overall health and boosts a sense of well-being among the HIV-infected according to the 
Canadian AIDS Treatment Information Exchange guide  (Lands, 2015).  A strong body is better 
equipped to fight HIV and chronic disease risks, such as heart disease, diabetes and osteoporosis 
(Lands, 2015). 
Furthermore, Lands (2015) stipulated that besides aerobic exercises, as recommended in AIDSinfo 
(2016), RE such as weight training, are particularly beneficial because they are the most efficient way 
to build healthy muscles. Monroe (2009) similarly advises diet, exercise, glucose monitoring, 
medications and smoking cessation as good self-care practices for PLWHA receiving ART.  Stanley 
and Grinspoon (2012) recommend that more research is needed to develop collective strategies to 
improve body composition and eradicate chronic disease risks in PLWHA. In the midst of appraised 
interventions, exercise is a natural solution that appeals reasonably more as the next best option in 
addressing chronic disease risks among PLWHA.   
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Scholars concur that physical exercise is a natural intervention highly beneficial to PLWHA in 
alleviating identified chronic disease risks (Roubenoff and Wilson, 2001; Srikanthan and Karlamangla, 
2014). In such instances the need for more medication to address chronic disease risks may be reduced 
or be strongly complemented with exercise. The overburdened, drug-dependent bodies of PLWHA 
stand to benefit from exercise interventions (Stanley and Grinspoon, 2012). 
2.4. EXERCISE INTERVENTIONS FOR PLWHA 
According to Malita et al. (2005),  exercise training in particular helps in altering body composition 
patterns among PLWHA receiving ART. The use of RE and aerobic exercise has associated positive 
effects on insulin resistance, total and central body fat in PLWHA receiving appropriate ART (Hunter 
et al., 2010; Malita et al., 2005).  Smith et al. (2001) points out that increased consideration has been 
directed towards exercise since it is a safe beneficial lifestyle addition in treatment of PLWHA. 
Ciccolo et al. (2004) consistently list exercise as one of the most recommended self-care therapies 
because it does not considerably increase circulating HIV-viral load or reduce CD4 counts.  The study 
further stated that exercise improves the psychological condition of mood in PLWHA receiving ART 
(Ciccolo et al., 2004).  
Zimbabwe generally lacks data on the use of exercises for PLWHA. Health-promoting behaviour and 
lifestyle changes involving exercise makes a difference in settings involving HIV, poverty and 
oppression (Myburgh, 2008).   Bopp et al (2003) agrees that prolonged HIV-infection is linked with 
degeneration of muscles, tiredness, compromised functional capacity to work, depression, and declined 
quality of life, leading to frailty and mortality. It is noted that exercise can have a positive effect on 
many aspects of physical and mental health of PLWHA (Bopp et al., 2003). There is evidence that 
resistance and aerobic exercises offer physical and metabolic health benefits for PLWHA through 
developing aerobic capabilities, cardiorespiratory strength, muscular endurance and general wellbeing; 
while reducing the percentage body fat and metabolic consequences (ACSM, 2014, p.294). 
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2.5. ASSOCIATION OF THE EFFECTIVENESS OF RESISTANCE EXERCISE AND 
AEROBIC EXERCISE FOR PLWHA RECEIVING ART  
Resistance exercise training offers the opportunity of improving strength in PLWHA. There seem to be 
inconclusive evidence on the most effective exercise modality that can be prescribed to PLWHA. The 
exercise prescription varies between exclusive RE, exclusive aerobic exercise and or combined 
exercise.  In studying literature Hamid and Rajah (2015) assessed the effects of RE sessions on self-
reported health-related quality of life, body composition and muscle strength among PLWHA. In their 
study participants, 14 were randomly allocated to an experimental group (the EXP group) exercising 
using elastic bands and 15 were assigned to a RE programme without elastic bands control group (the 
CON group). The participants in both groups completed exercise programmes for 12 weeks (Hamid 
and Rajah, 2015).  The self-reported health-related quality of life, body composition and isometric 
shoulder lift strength were measured at baseline and at week 12.  
In total, ten men (four experimental and six controls) dropped out of the programme. Participants in 
the CON group  showed significant improvements in psychological health. Although no significant 
changes in all body composition factors were found in either group over time, but strength improved 
(Hamid and Rajah, 2015). The authors concluded that RE significantly improve shoulder lift strength 
and show positive effects on self-reported health-related quality of life scores among PLWHA (Hamid 
and Rajah, 2015).  
Yarasheski et al. (2001) investigated the effects of 64 sessions of RE on 18 asymptomatic HIV-
infected males without lipodystrophy, receiving ART. The variables examined were body composition 
(measured using dual energy x-ray absorptiometry), thigh muscle area (using axial proton-magnetic 
resonance imaging) and plasma lipids.  Yarasheski et al. (2001) found that the lean body mass 
increased while  trunk adipose mass and fasting triglycerides decreased significantly (Yarasheski et al., 
2001).  Blood cholesterol scores and fasting insulin levels did not change. The decreases in triglyceride 
levels were greatest in participants with peak baseline triglyceride levels. They also noted that 
increases in fat-free mass were associated with declines in fasting triglycerides (Yarasheski et al., 
2001).  This shows that RE programmes are effective lifestyle interventions in reducing wasting 
among HIV-infected men receiving ART; increasing muscle strength and clearing serum triglycerides 
(Yarasheski et al., 2001). 
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Souza et al. (2011) conducted a RE programme with eleven PLWHA. In their study they also had a 
CON group that was non-HIV-infected. All the participants were older than 60. This was a pre-post-
test study. The participants trained twice a week, with supervision, for one year. In their reported 
results, the PLWHA had a smaller body mass index. The strength scores of PLWHA increased more 
than in the control group independent of gender, age or pre-test fitness level (Souza et al., 2011).  
In a review study, Phillips et al. (2006) observed that PLWHA often experience a loss of lean muscle 
mass. The HIV-related wasting was seen to be correlated to in increased disease advancement and 
increased morbidity (Phillips et al., 2006; Wasserman et al., 2014).  Dietary supplementation, cytokine 
reduction, hormonal treatment and RE training was identified as possible cures for this condition. 
Resistance exercise, which is more easily accessible to this population than other treatments, holds 
promise in counteracting the process of HIV wasting, as it has been successfully used to improve body 
compositions in healthy and clinical populations (Phillips et al., 2006).  
In a systematic review conducted by Leach et al. (2015) resistance training alone increased body mass, 
sum of skinfolds and limb girths in PLWHA. It was shown that exclusive aerobic training improved 
body mass index, weight,  waist-hip ratio and summation of skinfolds (Leach et al., 2015). The 
researchers found that combined resistance and aerobic training both addressed body mass and sum of 
skinfolds (Leach et al., 2015). In this review it showed that the benefits of exclusive resistance training 
may differ from those obtained from aerobic training alone and that full benefits of exercise are 
attained mainly through combined training. Leach et al. (2015) however points out that these findings 
need to be carefully deduced since there are few studies involving exclusive resistance training. The 
researchers recommended that there is need for future studies to be conducted which pay particular 
attention to sample size, women, follow-up as well as comprehensive statistical analysis (Leach et al., 
2015). In some of the resistance training studies they reviewed it showed that frequency was three 
times a week with progression but exercise intensity and supervision was not specified hence no 
standard protocol were followed (Leach et al., 2015). Therefore, the training period ranged from 6 to16 
weeks with volume set from 60 to 90% of 1RM undertaking 1 to 3 sets of 15 to 10 repetitions across 
the reviewed studies (Leach et al., 2015).  Leach et al. (2015) concluded that body composition 
improves following safe application of exercises for they appear beneficial to PLWHA.   
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Grace et al. (2015) in a review study focused on exercise for PLWHA and showed that RE alone can 
increase muscle mass, leg or arm girths, strength and mitigate muscle wasting.   In the reviewed 
studies improvements were also noted in glucose tolerance, percentage body fat, psychological status, 
insulin sensitivity and lipid profile (Grace et al., 2015). The identified resistance training exercises 
include resistance bands, weights, body weights, cables and plyometrics among others (Grace et al., 
2015). The aerobic exercise training studies were also noted to have improved strength scores in 
PLWHA (Grace et al., 2015). This finding though is not specified on the type of strength referred to. 
The generally agreed frequency of exercise in the reviewed studies was three times a week although 
some recorded positive outcomes two times a week (Grace et al., 2015). In the review the aerobic 
exercise training intensity had a range of 50-90% of HRmax while for the resistance exercise was also 
50–90% of 1RM over 45 minutes and 30–90 minutes respectively (Grace et al., 2015). In addition to a 
previous review conducted by Leach et al. (2015) it showed that Grace et al. (2016) agrees to the fact 
that combined aerobic and RE appears to be more effective than one component (aerobic or 
resistance). This could have been agreed to since in the review study the combined aerobic and 
resistance training exercises was noted to have improved functional ability, quality of life, decrease in 
fat percentage, abdominal fat,  increase in body mass index,  muscle mass, viral load, cell counts as 
well as improvement in lipid profile and glucose tolerance (Grace et al., 2015).  
 
Grace et al. (2015) confirmed that resistance exercise is a safe non-pharmacological therapy and 
effective in PLWHA. However, Lopez et al. (2015) contented that although exercise interventions 
have renowned appeal they have not been comprehensively used or globally accepted as a valuable 
option for PLWHA.  In line with the notion of agreeing to the fact that combined aerobic and 
resistance exercise have a more benefit; Gomes-Neto et al. (2015) conducted a meta-analysis study to 
find its effects on exercise capacity, strength and quality of life in PLWHA. The findings from the 
studies reviewed showed that the aerobic component had an intensity range of 50-80% of HRmax, 2-3 
times a week lasting for 30-90 minutes over a 6-24 weeks, while the resistance element was set at a 
range of 60-80% of 4-12RM assuming the same frequency and time as the aerobic component 
(Gomes-Neto et al., 2015).   It showed that more of these studies were conducted under supervision 
than those without supervision  (Gomes-Neto et al., 2015).  The results showed that there were 
improvements in maximum oxygen consumption, muscle strength (up to 25.06kg for knee extensors 
and 4.44kg for elbow flexors), health-related quality of life, improving the ability to undertake daily 
activities compared to control group  (Gomes-Neto et al., 2015).    
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The researchers admitted that they did not compare aerobic or resistance exercise alone to combined 
aerobic and resistance exercise for they were still not sure of the most ideal exercise modality among 
the three  (Gomes-Neto et al., 2015). It was recommended that further resistance exercise researches 
be conducted so as to highlight it as the next best natural health-care management option for PLWHA  
(Gomes-Neto et al., 2015).  In conclusion Gomes-Neto et al. (2015)advised that the exercise 
instruction should match the medical characteristics of PLWHA in determining the most appropriate 
FITT (frequency, intensity, time and type) dosage in achieving peak maximum oxygen consumption 
and quality of life outcomes (Gomes-Neto et al., 2015).      
A latest systematic review and meta-analysis study showed that only eight studies out of 20 focused on 
exclusive resistance exercise and 12 of the studies had included aerobic and resistance exercise 
combined over duration of 6-52 weeks (O’Brien et al., 2017). The results showed that improvements 
were noted in maximum oxygen consumption, exercise time, strength, body composition and weight 
compared to control group but greater improvements in weight and body composition were in studies 
involving resistance exercise alone than in aerobic exercise component (O’Brien et al., 2017).  The 
health-related quality of life improved compared to control group although no much changes were 
noted in CD4 count and viral load (O’Brien et al., 2017). The study affirmed that it is safe to perform 
any of the three exercise modalities for three times per week over six weeks leading to improvement in 
maximum oxygen consumption, body composition, strength and weight in PLWHA (O’Brien et al., 
2017). In this review and analysis it was noted that no studies were found that researched on the effect 
of exclusive resistance exercise on PLWHA in developing nations (O’Brien et al., 2017). Although in 
West Africa and SSA there has been some emergence of similar studies (O’Brien et al., 2017).  In 
Zimbabwe Mkandla et al. (2016) undertook the only one exclusive resistance exercise study conducted 
two times a week over 12 weeks and noted improvements in quality of life among PLWHA related 
distal symmetrical poly-neuropathy compared to the CON group.  This underscores the role of 
resistance exercise studies further than the confines of developed nations (O’Brien et al., 2017). The 
reaffirmation is that exclusive resistance exercise is safe and valuable for PLWHA (O’Brien et al., 
2017). 
Gomes-Neto et al. (2013) in a systematic review study found that resistance exercise alone improved 
muscle strength and body composition more than quality of life in PLWHA while aerobic exercise 
improved maximum oxygen consumption and body composition. Longer durations at moderate 
intensities involving combined resistance and aerobic exercise were found to be essential in improving 
assessed variables (Gomes-Neto et al., 2013).  
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The studies reviewed varied in the sample sizes as well as the inclusion of male and female 
participants. The exclusive resistance exercise studies had a final sample of 20 to 50 participants with a 
duration range of 6-16 weeks of which 40% of the studies only applied 12 weeks (Gomes-Neto et al., 
2013). The other studies did not report about the study duration altogether.  The resistance exercise 
targeted major muscle groups involving the use of weight stations, machines and free weights based on 
each participant’s 50-90% of 1RM (Gomes-Neto et al., 2013). The outcome of exclusive RE included 
increased muscle strength, lean body mass, mid-thigh girth, done mineral density and decrease in body 
weight besides a minimal effect on quality of life (Gomes-Neto et al., 2013).  
 
The exclusive aerobic exercise studies had a final sample range of 18 to 109 participants with most of 
the studies recruiting both men and women over 6 to 24 weeks although 60% of studies lasted for 12 
weeks.  The majority of the studies used combined exercise programmes or cycle ergometer at an 
intensity adjusted at 50-80% of HRmax (Gomes-Neto et al., 2013). The related body composition 
outcomes and maximum oxygen consumption improved while reductions in body weight, total body 
fat and the waist-to-hip ratio scores were recorded (Gomes-Neto et al., 2013). Contrary to exclusive 
resistance or aerobic exercise outcomes, combined aerobic and resistance exercise further improved 
thigh muscle volume, effect on quality of life and reduced thigh muscle adiposity, percentage body fat 
as well as exercise duration (Gomes-Neto et al., 2013).  
 
The decrease in strength may be in part associated with decreases in lean body mass according to 
disease progression (Quiles and Ortiz, 2017). RE improves protein synthesis there by increasing 
muscle mass, strength and muscle mass in PLWHA. Quiles and Ortiz (2017) allude to a study they 
reviewed involving male participants with muscle wasting and performed RE 3 times per week, 
completing 3 sets of each exercise at 75-80% of 1RM over 8 weeks. These men were compared to 
those without wasting. The results showed that strength and lean body improved more in men with 
muscle wasting (60% and 5.3%)  than those without (44% and 2.3%) respectively (Quiles and Ortiz, 
2017).  
Quiles and Ortiz (2017) cited another study that compared the effects of exclusive RE, RE together 
with testosterone and RE with a placebo on HIV diagnosed men over 16 weeks.  The exclusive RE  
was performed 3 times per week using light, medium and heavy training days tolerating intensities 
ranging from 70-90% of 1RM (Quiles and Ortiz, 2017).  Similarly lean body mass and strength scores 
improved in exclusive RE at 2 kg and 22–23% (Quiles and Ortiz, 2017).  
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Improvements were also noted in RE plus testosterone giving evidence that exclusive RE is more or 
less equally effective (Quiles and Ortiz, 2017). In men who had experienced muscle wasting it showed 
that lean body mass increases were related to marginal improvements in day to day activities (Quiles 
and Ortiz, 2017).   In a study with a different gender involving a sample of all women diagnosed with 
HIV over 16-week s was also referred to by (Quiles and Ortiz, 2017).  The exclusive RE programme 
was home-based training 3 times per week at a range of 60-80% of 1RM progressively (Quiles and 
Ortiz, 2017).  The improvements in strength (at the knee, ankle, shoulder and elbow muscles) and lean 
muscle mass were noted (Quiles and Ortiz, 2017).  Another study with all women diagnosed with HIV 
and performing RE 3 times a week over 14 weeks was conducted in a hospital setting (Quiles and 
Ortiz, 2017).  The exercise routine was performed in a circuit format with a multi-station machine at 
50-70% of 1RM progressively and the women had improved fat mass (by 2.5kg), lean body mass (by 
0.6kg) and health-related quality of life in vitality as well as health perceptions (Quiles and Ortiz, 
2017).   
Quiles and Ortiz (2017) further cited a study conducted by Garcia et al. (2014) in which a 20 week 
combined aerobic (30 minutes at 60–75% of the maximal oxygen uptake)  and circuit resistance 
training exercise ( 3 days a week using 12-15 repetitions per exercise three days per week) was 
undertaken on PLWHA. The findings showed an improvement in lean body mass of 1.8kg and 
muscular strength (Quiles and Ortiz, 2017).  The study concluded that RE seem effective when 
conducted exclusively or in a circuit or in combination with an aerobic component (Quiles and Ortiz, 
2017).  Cardiovascular diseases can increase in PLWHA receiving ART if lipids and glucose disorders 
are not managed (Quiles and Ortiz, 2017).  Importantly some studies reviewed showed that exclusive 
RE can efficiently improve blood lipid, glucose and bone metabolism and muscular strength in 16 
weeks, at 50 to 80% of 1RM in PLWHA (Quiles and Ortiz, 2017).  In Quiles and Ortiz (2017) they 
referred to a reviewed study and found out that fasting blood glucose decreased following a RE 
programme conducted 3 times a week at 80% of the 1RM over a 24-week period with PLWHA. It was 
also noted that improvements in blood lipid concentrations may change following a12 week RE 
programme for PLWHA     
 
Quiles and Ortiz (2017) again  reviewed that RE conducted 3 times a week at 70 and 80% of the 1RM  
over 12 weeks on PLWHA with lipodystrophy improves bone mineral density in the backbone (by 
3.28%), femoral neck (by 8.45%), and radius (by 5.41%) .  RE should be prioritized since there is 
strong evidence to suggest that some ART drugs cause a decrease in mineral bone density leading to 
functional impairments and osteoporotic fractures (Quiles and Ortiz, 2017).   
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A major knowledge gap was that there were no studies identified by Quiles and Ortiz (2017)that had 
been conducted to compare different RE volumes and intensities in PLWHA at the time of review in 
determining the most effective dose. The studies have shown that with HIV-infection, loss of muscle 
affects strength and the only anabolic treatment to improve lean body mass and strength is RE training. 
This supports the idea that maintaining a desirable adipose-lean tissue ratio restores body weight and 
muscle mass to normal or desirable body composition levels (Anderson, 2006). Therefore, RE 
improves health-related quality of life, body composition scores, strength and physical functioning, 
(Hamid and Rajah, 2015; Mkandla et al., 2016; Roubenoff and Wilson, 2001; Souza et al., 2011; 
Walker et al., 2013; Yarasheski et al., 2001).  Resistance exercise has great potential to be a 
sustainable substitute to pharmacological cures for preserving and improving muscle mass and 
strength in PLWHA (Dudgeon et.al., 2006). 
Scholars confirms that there is less data on the effect of RE in PLWHA (ACSM, 2014, p.293). It  is 
recommended that RE programmes for PLWHA should be supervised and be performed two to three 
days a week; at an intensity of 8-10 repetitions, at about 60% of 1RM and completing two to three sets 
of 10-12 exercises in 30 seconds (ACSM, 2014, p.294). It is important to note that RE may be varied 
depending on the interest and health status of the PLWHA (ACSM, 2014, p.295).  
The literature shows that RE are beneficial for PLWHA. The studies give evidence that RE 
has potential to address issues of total blood cholesterol, blood glucose, blood pressure, body 
composition and strength in PLWHA. There is limited data in the use of RE for PLWHA and 
hence more need for such studies be held in Africa.  
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3.1. ABSTRACT  
Human Immunodeficiency Virus (HIV) related mortality rates are a cause of concern the world over. 
Prompt initiation of antiretroviral therapy (ART) is advisable once diagnosed HIV-positive. The 
advent intake of ART has increased life expectancy for people living with HIV and AIDS 
(PLWHA).   The PLWHA now live longer to the extent of acquiring lifestyle/non-communicable 
conditions. The PLWHA receiving ART may then experience a reduction in general strength which 
limits bodily functioning, alterations to composition scores and reduced activity levels. Physical 
exercise intervention strategies are largely being used to alleviate the negative effect of ART on 
PLWHA.  There is limited data on use of resistance exercise (RE) and aerobic exercise interventions 
for PLWHA. This article systematically reviews resistance exercise (RE) and aerobic exercise 
intervention strategies and how they affect body composition, chronic disease risks and strength 
scores in PLWHA receiving ART.  
KEY WORDS: HIV, ART, body composition, resistance exercise, aerobic exercise 
3.2. INTRODUCTION 
The prevalence of HIV rates remain extraordinarily high (UNIAIDS, 2015). Treatment regimens of 
ART reduce HIV associated mortality (Walker et al., 2013). The PLWHA receiving ART suffer 
from chronic disease risks at almost the same rate as the general population presenting multiple 
burdens (Barbaro and Barbarini, 2011; Bhatia et al., 2011; Greenland et al., 2003; Mgunya, 2012; 
Post, 2012; Syed and Sani, 2014; Shields et al., 2012; Singh et al., 2013; Stein, 2010; Yusuf et al., 
2001) . Non-communicable ailments are now the leading cause of non HIV-related deaths in 
PLWHA  (Hadigan et al., 2003; Post, 2012). The chronic disease risks in PLWHA receiving ART 
include, but not limited to bone fractures, hypertension, diabetes mellitus,  a high total blood 
cholesterol leading to premature deaths in some circumstances (Mgunya, 2012).  
The PLWHA experience wasting syndrome, decreases in caloric intake along with a loss of lean 
body mass (Anderson, 2006). It is affirmed that a decrease in physical activity and nutritional intake 
causes wasting syndrome (Anderson, 2006).  PLWHA receiving ART may further experience 
activity limitations and participation restrictions/disabilities involving routine obligations like 
shopping, cooking and housework (Mlambo, 2011).   
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An increased risk for developing cardiovascular events associated with lipodystrophy syndrome 
emerges once PLWHA initiate ART, (Barbaro and Barbarini, 2011). Lipodystrophy is mainly 
caused by the specific action of antiretroviral drugs on the metabolic system especially protease 
inhibitors (Pi) (Barbaro and Barbarini, 2011).  HIV-associated lipodystrophy syndrome and related 
cardiovascular risks have increasingly become clinical entities in developed and developing 
countries alike (Barbaro and Barbarini, 2011).  Significantly, ART is associated with increased 
levels of triglycerides, body mass index and type 2 diabetes (Mgunya, 2012).  There is a direct 
increase in chronic disease risk factors with duration on treatment generally from two years onwards 
(Dolan  et al., 2005; Mgunya, 2012; Shields et al., 2012; Singh et al., 2013). Research in America 
revealed that 10% of  PLWHA had recently been detected with cardiovascular disease (Syed and 
Sani, 2014).  The prevalence of cardiomyopathy being the most common HIV-related presentation 
followed by pericardial disease and hypertension (Syed and Sani, 2014; . Studies have examined the 
effect of RE interventions in mitigating chronic disease risks (Bhatia et al., 2011). It shows that RE 
based interventions offer significant health benefits to PLWHA receiving ART though in some cases 
show varying outcomes of the same variables under study (Bhatia et al., 2011). The studies include 
RE interventions in combination with nutritional or pharmacological or aerobic exercise components 
while others involve exclusive RE without a co-intervention (Yarasheski et al., 2001). 
Chronic disease risk, anthropomorphic and metabolic complications associated with PLWHA 
receiving ART have become possible prime targets for RE interventions, (Ciccolo et al., 2004).  
Studies on RE prescription largely conform to a dose equivalent to a frequency of between two to 
three days per week, performing eight to ten repetitions, targeting 10-12 muscle groups, undertaking 
two to three sets and at 60-80% of individual’s 1RM according to ACSM  (2014, p.294).  Resistance 
exercise studies involving nutritional, pharmacological, aerobic exercise and solely RE interventions 
purportedly point out improvements in body mass index, fat mass, lean mass, thigh muscle 
circumference, total body water, decreases in visceral adiposity, resting energy, improved strength, 
fitness and quality of life (Yarasheski et al., 2001).  However, study results among researchers vary 
regarding effects of RE on fasting blood glucose, insulin, cholesterol and CD4+ counts (Agin et al., 
2001).  The aim of this systematic review was to examine whether RE and aerobic exercise 
interventions on PLWHA are effective in reducing the effects of chronic disease risks, body 
composition and strength scores. 
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3.3. METHODOLOGY  
3.3.1. LITERATURE REVIEW AND STUDY SELECTION  
 
The method to retrieve articles was through searching web based databases included PUBMED,   
Googlescholar, MEDLINE and Cochrane Database Register of Controlled Trials to retrieve published 
research literature on subject matter under review. Key search words that were not limited to, “HIV”, 
“ART”, “Body Composition”, “Strength”, “Chronic Disease Risk”, “Resistance Exercise” , “ Aerobic 
exercise” and “Physical Activity” in order to retrieve relevant articles. The search was conducted in 
December 2016. The sought literature constituted of articles and abstracts covering the period January 
2006 to December 2016. Manual handsearching of reference lists and table of contents of relevant 
journal articles were carried out to incorporate applicable studies that could have been possibly missed 
for inclusion.  
The process enabled further searching of non-indexed relevant information in other databases. Eligible 
selected articles were individually vetted for inclusion depending on relevance, founded on a pre-
established inclusion and exclusion criteria (below).  Whereupon, indecisiveness concerning inclusion 
matters emanated, consultations with second and third researchers were conducted to decide on 
inclusivity or exclusivity of an article. Study discussions with second and third researchers were also 
held concerning other desired characteristics existing in retrieved publications like study design, 
homogeneity in study samples, availability of data on reliability of RE interventions and variable 
outcome measures. However, the pre-established inclusion criteria remained applicable.  
3.3.2. INCLUSION/EXCLUSION CRITERIA 
Design: The analysis was restricted to manuscripts using human subjects, random controlled trials, pre 
and post-test studies, English language published peer reviewed journals, RE intervention studies and 
RE intervention studies in combination with other co-interventions like nutrition, diet, aerobic exercise 
and pharmacological intervention. Summary of the studies included for review are listed in table 7. A 
total of 43 studies were excluded from analysis due to inconsistencies. This included studies that were 
non-randomised control trials, without pre and post-test, not published in peer reviewed journals, 
having participants < 18 years of age, studies focusing on other exclusive interventions without a RE 
component.   
Participants: Studies with males and females between the ages of 18 – 46 years were included. Studies 
only looking at children <18 years or adults >46 years were excluded regardless of gender.   
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Outcome Measures: Studies were only included if body composition, chronic disease risks and 
strength (1RM) variables were pre-and-post measured. Further, studies including outcome measures 
such as health related quality of life, fitness, VO2 max, limb circumferences, CD4+, CD8+, insulin 
sensitivity, self-efficacy, bone density, resting energy and total body water in addition to the 
aforementioned were also included.  
Studies included were those that used different data collection instruments not limited to dual-energy 
X-ray absorptiometry, skinfolds measurements, CT scanners, Kasch pulse recovery test, electron beam 
tomography, 1RM, homeostatic model assessment and hyperinsulinemic glycemic clamp to establish 
outcome variable measures. Studies that involved different types of RE exclusively or in combination 
with aerobic exercises and or nutrition, or pharmacological interventions were included. The figure 
below shows the processes followed to consider articles for inclusion in the study: 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Schematic representation of the selection process for articles included in the systematic review 
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3.4. RESULTS AND DISCUSSION 
 
3.4.1. STUDY CHARACTERISTICS 
There were seven published studies that meet the inclusion criteria (see table 7 for study details).  The 
number of participants in each study ranged from 20-221. Study participants were either males or 
females between the mean ages of 18-45 years. Four studies recruited both male and female 
participants (Balasubramanyam et al., 2011; Cade et al., 2013; Mendes et al., 2013; Yarasheski et al., 
2011), while three recruited men exclusively (Dudgeon et al., 2010; Fillipas et al., 2006; Troseid et al., 
2014).   
None of the studies exclusively recruited female participants. In the studies that recruited both males 
and females: one study included sedentary participants (Mendes et al., 2013) while the other three 
studies made no mention of the exercise background of participants.  In two of the studies involving 
males only, they mentioned that the subjects had a sedentary lifestyle (Dudgeon et al., 2010; Troseid et 
al., 2014). 
In total, across the seven studies, three included sedentary participants and four did not specifically 
mention exercise backgrounds of recruited participants. In four of the studies they experienced 
participants dropout ranging from 1-30 participants (Balasubramanyam et al., 2011; Cade et al., 2013; 
Fillipas et al., 2006; Mendes et al., 2013), however three studies did not mention about dropouts.  
None of the studies mentioned gender differences in response to resistance exercise interventions. The 
study period extended from a minimum of six weeks to a maximum of nine months across the seven 
studies that met inclusion criteria.  
Studies included were those involving varied RE prescription dosages in combination with co-
interventions and none were exclusive RE. The co-interventions to RE dosages in the seven studies 
included:  
Aerobic at 60-75% of maximum heart rate and resistance at 60-80% of 1RM, performing ten reps, 
with two seconds rest, one to two minutes between sets, two to four minutes between exercises 
(Fillipas et al., 2006);  
Aerobic exercise progressively increased from 50-80% of heart rate reserve and RE three sets of eight 
to ten reps up to 80% of 1-RM (Mendes et al., 2013);  
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Aerobic exercise or endurance training and RE supervised strength exercises (Troseid et al., 2014);  
Aerobic exercise 30min of 60-65% of age related heart rate and RE 30min, one set of 12 reps for nine 
selected upper and lower body muscles at 60% of 1-RM (Dudgeon et al., 2010);  
Diet, nutritional and pharmacological involving pioglitazone 30mg/d for four months, progressive 
aerobic conditioning at 50-85% of heart rate reserve and RE of 90-120min/day, three days a week, 
four upper body and three lower body exercises (Cade et al., 2013);  
Pioglitazone 30mg/d, aerobic exercises 1.5-2hours/day, three days per week at 50-58% heart rate 
reserve, RE 8-12 repetitions on any exercise and diet weight maintenance diet 25% carbohydrates per 
day with protein 12%, carbohydrate 55% and 33% fat calories (Yarasheski et al., 2011);   
Diet low saturated fat, cholesterol not more than 200mmol/l, fiber 20-30g/d, niacin , fenofibrate, 
aerobic exercise three times per week for 75-90 mins, RE three times per week according to ACSM 
guidelines (Balasubramanyam et al., 2011).  
The diverse RE protocols are summarized in Table 7. In these selected studies, four of the studies 
involved control (CON) and experiment (EXP) groups; three of the studies used a range of three to 
five groups, (Balasubramanyam et al., 2011; Dudgeon et al., 2010; Mendes et al., 2013). All studies 
were random controlled trials.  
There were three studies that mentioned the particular types of RE participants performed including 
[squat, bench press, hamstring extension, back pulley, knee flexion and calf on bench], (Mendes et al., 
2013), chest press, leg press (Dudgeon et al., 2010),  pull down, elbow flexion, shoulder raise, knee 
extension, knee flexion, chest press, and abdominal exercises (Fillipas et al., 2006). 
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Various research variables were measured across the seven studies which included: chronic disease 
risks such as blood pressure, blood glucose, total cholesterol, cardiorespiratory fitness, insulin-
mediated glucose uptake, lipopolysaccharide, insulin sensitivity, myocardial insulin sensitivity, quality 
of life, self-efficacy, heart rate, endocrine and liver lipid content, (Balasubramanyam et al., 2011; Cade 
et al., 2013; Dudgeon et al., 2010; Troseid et al., 2014; Mendes et al., 2013; Yarasheski et al., 2011); 
anthropometry, skinfolds, arm muscle area, (Mendes et al., 2013 and  Yarasheski et al., 2011); 
strength, (Mendes et al., 2013); body composition variables such as waist measurement, body mass 
index, body fat distribution, waist and hip circumference, fat and fat-free mass, abdominal 
subcutaneous tissue, visceral adipose tissue, (Balasubramanyam et al., 2011; Cade et al., 2013; Troseid 
et al., 2014; Mendes et al., 2013); CD4+ count, HIV-1 viral load (Balasubramanyam et al., 2011; 
Troseid et al., 2014); adiponectin C-reactive protein, energy expenditure, high-sensitivity C-reactive 
protein ,(Balasubramanyam et al., 2011) ; circulating hormones and cytokines, (Dudgeon et al., 2010) 
and safety parameters, (Yarasheski et al., 2011). The following table shows the studies that were 
included for this review. 
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Table vii:  A Summary of studies included in the review 
REF Participants Protocol Co-
Intervention 
PRE/POST 
TEST 
STUDY 
DESIGN 
Fillipas at al, 2006 40 subjects ,5 drop outs, men EXP group took part in a supervised aerobic and 
resistance exercise programme 2 times/wk, for 6 
months.  Goal 80% of 1RM, 3 sets 8 reps, 2 times a 
week, 
30-60 minutes. The CON group participated in an 
unsupervised walking programme and attended group 
forums monthly.   
Aerobic   Pre and post 
 
Randomized 
control trial,   
 
Dudgeon, et al 2010 HIV-infected men, Exercise-
naïve. 14 in MOD group (44.3 ± 
8.3yrs) and 11 in LOW group 
(42.9 ± 7.5yrs) and 13 in  the 
CON group (44.5 ± 7.3 years) 
African American 
MOD Grp: A moderate-intensity group (MOD)  
completed 30 min of moderate-intensity aerobic training  
60%–65% of age related HR, and 30 min resistance 
training i.e. 1 set of 12 repetitions of 9 selected upper-
body and lower-body resistance exercise with resistance 
set at 60% of the estimated 1-RM.  
LOW Intensity Grp (LOW), completed 60 min treadmill 
walking at 50% of age-predicted maximal HR.  
CON Grp:  Participated in no activity i.e. remained 
seated in the facility for 60 min and participated in no 
physical activity. 
Aerobic exercise Pre and mid post 
and post-test. 
3 Groups 
Randomized 
Control 
Experimental 
Design. 
Yarasheski at al, 2011 44 subjects,39 completed,  HIV-
infected men and women (18–60 
yr old), with insulin resistance/ 
IGT and central adiposity, 
Pioglitazone group 44 years+/- 2,  
Piogliterzone and exercise group  
46 years +/- 2 
 
4 mo of pioglitazone (pio; 30 mg/day) Group or  
Pioglitazone plus exercise training Group 1.5–2 h/day, 3 
days/wk., of supervised, progressive, combined aerobic 
conditioning exercising at 50–85% HR reserve and 
resistance training firstly at one to two sets of each 
exercise while lifting a weight that caused muscle 
fatigue/failure after eight repetitions until they were 
conditioned to12 repetitions on any exercise. On diet for 
a weight-maintaining diet that contained adequate 
amounts of energy and macronutrients: 250 g 
carbohydrate/ day and 12% protein, 55% carbohydrate, 
and 33% fat calories. 
 
 
 
 
 
 
 
Aerobic 
Pioglitazone  
Pre and post Random 
control trial 
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REF Participants Protocol Co-Intervention PRE/POST 
TEST 
STUDY 
DESIGN 
Balasubramanyam et 
al,2011 
Hypertriglyceridemic patients 
21-65 years, 221 subjects 
(mixture of males and females), 
30 withdrew, 87% were males, 
46% Hispanic, 36% white, 17% 
African American 
Usual Care Gr 1 receiving heart healthy diet and fitness 
advice. Usual Care Group 1, Low saturated fat diet and 
exercise Group 2, Diet + Exercise (D/E) + Fenofibrate 
Grp 3, Diet + Exercise (D/E) + Niacin Group 4, D/E + 
Fenofibrate + Niacin Group 5. Groups 2-5 were taught a 
weight maintaining diet 50% calories from CHO, 30% 
from fat, cholesterol not more than 200mg/d, fiber 20-
30g/d, participated in an exercise programme according 
to ACSM guidelines 3 times per week 75-90min 
Aerobic and Resistance exercise over 24 weeks, in 
addition to diet and exercise Fenofibrate was given to 
Grp 3, Niacin to Grp 4, Fenofibrate + Niacin to Grp 5. 
Diet 
Drugs – 
Fenofibrate, 
Niacin  
Aerobic exercises 
Pre, multi-mid 
post and post test 
5 Group, 
Randomized, 
double blind, 
placebo 
controlled 
Mendes et al., 2013 99 PLWHA were randomly 
allocated into 4 groups, 29men 
(39.7 +/- 9.3 years) and 51 
women (38.8 +/-11.6 years). 
Sedentary for at least six months 
prior to the on ART for about 1 
year and indicated no 
contraindications for physical 
exercise. 19 dropped from the 
study. 
24 weeks of RE with aerobic component (REAC). Grp 
1: exercise and lipodystrophy (n = 24; EX + LIP); Group 
2: exercise without lipodystrophy (n = 21; EX + 
NoLIP); Group 3: control and lipodystrophy (n = 27; 
NoEX + LIP); Group 4: control without lipodystrophy 
(n = 27; NoEX + NoLIP).Performed 3times/week in 
non-consecutive days. Warm-up and stretching exercises 
(10 min), aerobic training (15-20 min), and resistance 
training (40 min) before return to calmness (10 min). 
The REAC started after interpretation of 1-RM and 
20mMST results. Resistance Ex 3 sets of 8-10 
repetitions, at 80% of 1-RM i.e. 6 exercises squat, bench 
press, hamstring extension, back pulley, knee flexion, 
calf on bench. Aerobic based on the reserve heart rate on 
treadmill or cycle ergometer, according to individuals’ 
adaptation, with intensity increase range from 50 to 80% 
of HRres monitoring heart rates. 
 
 
 
 
 
 
 
 
 
 
 
 
Aerobic Pre and post Random 
control trial  
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REF Participants Protocol Co-Intervention PRE/POST 
TEST 
STUDY 
DESIGN 
Cade et al., 2013 24 HIV+ adults with peripheral 
metabolic complications like 
peripheral insulin resistance. 
PIO, 25% of the participants 
were women; 42% were African 
American, and 58% were 
Caucasian. 20 subjects 
completed the study. EXS, all 
participants were males; 38% 
were African American, 25% 
were eastern Indians, and 37% 
were Caucasian. Four 
participants dropped out. 
PIO GRP : 4 months of pioglitazone (PIO; 30 mg/d) or 
supervised, 
EXS GRP: Progressive Resistance Exercise training 
(EXS; 90–120 min/d, 3 d/wk) 4 upper and 3 lower body 
exercises at increased individual’s %1RM.  
Combined with progressive endurance or aerobic 
conditioning (HR range of 50% to 85% HR reserve) 
Pioglitazone 
Progressive 
Aerobic Training 
Pre and post test 2-Group, 
Random 
Assignment 
Study 
 
Troseid et al., 2014 
 
20 sedentary middle-aged HIV-
infected men on ART and with 
lipodystrophy. 14, age and VO2 
max matched HIV-seronegative 
healthy men were control group. 
 
 
 
Supervised strength Group  
Endurance training Group 
3 times per week for 16 weeks. 
 
Aerobic/Enduran
ce training 
 
Pre and post test 
 
2 Group, 
Randomly 
Assigned 
39 
 
3.4.2. RESULTS OF RESISTANCE EXERCISE INTERVENTIONS IN PLWHA 
3.4.2.1. EFFECTS OF RE INTERVENTIONS ON BODY COMPOSITION  
Three studies noted improvements in body compositions scores in PLWHA following RE (Troseid et 
al., 2014; Mendes et al., 2013 and  Yarasheski et al., 2011). In one study by  Mendes et al. (2013) they 
established that, body circumferences and waist-to-hip ratio significantly changed after 24 weeks of 
RE and aerobic conditioning.  The sum of seven skinfolds, percentage body fat, total fat, central fat 
and peripheral subcutaneous fat similarly decreased in response to RE and aerobic conditioning. 
Meanwhile, the muscle mass increased in exercised groups  (Mendes et al., 2013).  
Troseid et al. (2014) discovered that, although body mass index (23.4 vs. 24.0 kg/m2) and trunk fat 
mass reduced, the variables did not significantly change following strength training. Yarasheski et al 
.(2011) confirmed noting decreases in total body and limp adipose tissue. 
3.4.2.2. EFFECTS OF RESISTANCE EXERCISE INTERVENTIONS ON CHRONIC 
DISEASE RISK INDICATORS  
In five studies researchers noted improvements in chronic disease risk indicators following RE 
interventions (Yarasheski et al., 2011; Fillipas at al., 2006; Yarasheski at al., 2011; Balasubramanyam 
et al.,2011; Cade et al., 2013; Troseid et al., 2014) . In the study conducted by Troseid et al. (2014) 
there were reductions in triglyceride and lipopolysaccharide levels reduced by 9.6% (−5.0% to 
−14.7%, P = 0.0001) for each unit reduction in triglycerides in the strength training group.  Insulin 
sensitivity after strength training improved while increases in insulin-mediated glucose uptake were 
noted following strength and endurance training (Troseid et al., 2014).   
Balasubramanyam et al. (2011) investigated the effect of fenofibrate, niacin, diet and exercise (aerobic 
and RE) on PLWHA. The researchers established that the intervention reduced triglycerides (-52%), 
increased high density lipoprotein-cholesterol (+12%) and decreased non- high density lipoprotein-
cholesterol (-18.5%) and (-24.5%) total blood cholesterol to high density lipoprotein-cholesterol ratio 
(Balasubramanyam et al., 2011).    
Cade et al. (2013), investigated the effect of progressive resistance exercise combined with progressive 
endurance in the CON group receiving supervised 3mol of pioglitazone. There were minor increases 
noted in fasting blood glucose, insulin, triglycerides, and total and low-density lipoprotein in the 
exercise group. Also, basal myocardial insulin sensitivity non-significantly increased, while 
myocardial fatty acid metabolism and utilization rates increased but not significantly. However, resting 
systolic and diastolic blood pressure was unchanged (Cade et al., 2013).    
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Dudgeon et al. (2010) carried out a study involving a moderate intensity (resistance and aerobic) 
exercising group, low intensity (aerobic) exercise and the CON group (no exercise). Results showed 
that at post-exercise period, the moderate intensity exercising group had 135% increases in growth 
hormone, 34% decrease in cortisol. A 31% increase in interleukin-6 at 30-min post exercise and 23% 
increase in interleukin -6. At 60- min post exercise a 13% decrease in soluble proteins was noted 
(Dudgeon et al., 2010). The low intensity exercising group had a 3.5% decrease in soluble tumor 
necrosis factor receptor 2 at 30-min post exercise compared with baseline and a 49% decrease in 
growth hormone at 60-min post exercise (Dudgeon et al., 2010). The CON group had a decrease in 
growth hormone at 62%  and 61%  at 30-min and 60-min respectively post-exercise compared to pre-
test (Dudgeon et al, 2010).  
 
Yarasheski et al. (2011)  studied the effect of pioglitazone, combined (aerobic exercise and RE) 
exercise and diet in PLWHA. The training group was noted to have improved peripheral insulin 
sensitivity, decreased liver lipid content and fasting low density lipoprotein. However, high density 
lipoprotein-cholesterol concentrations were not changed (Yarasheski et al., 2011). 
 
3.4.2.3. EFFECTS OF RESISTANCE EXERCISE INTERVENTIONS ON STRENGTH IN 
PLWHA 
Mendes et al. (2013) affirmed that strength increased while on the other hand Fillipas et al. (2006) 
confirmed that cardiorespiratory fitness increases in response to RE and aerobic conditioning. 
According to Cade et al. (2013) the whole-body peak oxygen consumption increases, although not 
significantly.  The following table shows results of the effects of RE and aerobic exercise studies in 
PLWHA. 
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Table viii: Results of the effects of RE interventions on PLWHA 
REF Study Variables Results Differences among 
study groups 
 
Fillipas at al. (2006) 
Self-efficacy using General Self-efficacy 
scale, Cardiovascular fitness, using Kasch 
Pulse recovery test, health related quality of 
life using medical outcome study HIV health 
survey.  
EXP group improved their self-efficacy by 6.8 points (95% 
CI 3.9 to 9.7, p<0.001), improved cardiovascular fitness by 
reducing their heart rate by 20.2 bpm (95% CL – 25.8 to 
14.6, P < 0.001). Health related Quality of life improved in 
only two out of 11 dimensions i.e. in EXP group they 
improved overall health by 20.8 points, their cognitive 
functioning by 14 points. 
Improvements in 
cardiovascular fitness, 
Q.OL and cognitive 
functioning in EXP 
group was more than 
in  the CON group 
 
Dudgeon et al. (2010) 
Circulating anabolic and catabolic factors i.e. 
Blood and saliva samples or circulating 
hormones and cytokines 
At the post time point MOD group had an increase of 
135% in growth hormone (GH), 34% decrease in cortisol 
(CORT), 
At min post exercise a 31% increase in interleukin-6 (IL-6) 
at 30-min post exercise and 23% increase in IL-6, At 60- 
min post exercise. a 13% decrease in soluble tumor 
necrosis factor receptor 2 (sTNFrII). Increases in lean 
tissue mass   
The LOW group a 3.5% decrease in sTNFrII at 30-min 
post exercise compared with baseline and a 49% decrease 
in GH at 60-min post exercise 
The CON group had a decrease in GH at 30-min (62%), 
and at 60-min (61%) post exercise compared with baseline.  
GH increase from 
baseline to post was 
greater in the MOD 
group and a decrease 
in CORT from pre to 
post was greater than 
in the other groups. 
Yarasheski at al. (2011) Metabolic, endocrine, anthropomorphic, and 
safety parameters i.e. Insulin sensitivity 
(hyperinsulinemic glycemic clamp), 
metabolic, endocrine, glucose 
(hyperinsulinemic euglycemic clamp) 
anthropomorphic, central adiposity (DEXA), 
visceral adiposity volume, liver lipid content, 
safety parameters. 
 
Improved peripheral Insulin sensitivity, decreased total 
body and limp adipose, decreased liver lipid content, 
fasting LDL and HDL-C concentrations were not changed 
There were differences 
in response to the 
study protocol for 
males and female 
subjects.  
 
Balasubramanyam et 
al. (2011) 
Fasting triglycerides (automated analyzer), 
HDL-C, non HDL-C, plasma glucose 
(glucose oxidase method), insulin sensitivity 
(RIA), CD4 count (flow cytometry), HIV-1 
vital load (quantitative PCR) glycemia, 
adiponectin (RIA), C-reactive protein, energy 
expenditure, hsCRP (latex particle-enhanced 
immunoturbidimetric and BC (BMI), FFA 
(microtiter procedure). 
Fenofibrate improved triglycerides, TC and non-HDL-C. 
Niacin improved HDL-C. D/E + Fenofibrate + Niacin 
reduced triglycerides (-52%), increased HDL-C (+12%) 
and decreased non-HDL-C (-18.5%) and TC to HDL-C 
ratio (-24.5%). Niacin doubled adiponectin levels. 
Combination therapy 
D/E + Fenofibrate + 
Niacin in group 5 was 
the most effective in 
lowering triglycerides, 
lowest ratio of 
cholesterol to HDL-C 
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REF Study Variables Results Differences among 
study groups 
 
Mendes et al. (2013) 
Anthropometric, strength and 
cardiorespiratory fitness i.e. body perimeters 
(non-elastic measuring tape) (Sanny®), on 
neck, thorax, waist, hip, arm forearm, thigh 
and calf perimeters, Waist measurement, 
waist/hip ratio (WHR), body mass and 
stature using mechanical scale attached to 
stadiometer (Filizola®), body mass index 
(BMI), Skinfolds by a scientific adipometer 
brand name Lange® on tricipital (TR), 
bicipital (BI), subscapular, suprailiac (SI), 
chest (C), abdominal(AB), midaxillary 
(MA), thigh (T) and midcalf (MC). Arm 
muscle area, BFD, BF estimation, Strength 
test (1RM)on squat, bench press, hamstrings 
extension, triceps, back pulley, knee flexion 
and barbell curl, Cardiorespiratory fitness 
test  measured by the modified multi-stage 
fitness test. 
Body circumferences and waist-to-hip ratio changed after 
24 weeks of REAC in both exercised groups. The sum of 
seven skinfolds, %BF, body fat mass, total fat, central fat 
and peripheral subcutaneous fat reduced in response to 
REAC. Lean body mass increased in exercised groups, 
regardless of the outcome (LIP or NoLIP). Strength and 
cardiorespiratory fitness increased in both exercised groups 
in response to REAC.  
Reduction in the neck, 
thorax and waist 
perimeters and 
increase in the arm, 
forearm and calf 
perimeters have been 
observed in the EX 
groups. The waist 
perimeter and the 
WHR increased and 
the arm, forearm and 
calf perimeters 
reduced only in the 
NoEX+LIP group after 
the intervention. 
The Σ7 SF, %F and 
FBM increased in the 
NoEX+LIP and 
NoEX+NoLIP groups 
Cade et al. (2013) Basal myocardial insulin sensitivity and 
diastolic function. Fat and fat-free mass 
(DXA), Abdominal subcutaneous (SAT) and 
visceral adipose tissue (AIDS) (1H-magnetic 
resonance imaging), arterialized venous 
blood sampling(tomography), BP and HR, 
echocardiographic examination, Plasma 
glucose concentration (automated glucose 
analyser), Plasma insulin (chemiluminescent 
immunometric method), Peripheral insulin 
resistance (homeostatic model assessment), 
Fasting plasma lipid/lipoproteins. 
In PIO - No significant changes in CD4+ T-cell count or 
plasma viral load, on whole-BF or fat-free mass or visceral 
or subcutaneous adipose tissue. Fasting plasma glucose 
and insulin levels trended lower after PIO, while peripheral 
metabolic parameters were unchanged. Myocardial oxygen 
consumption decreased slightly but not significantly. Basal 
myocardial insulin sensitivity did not change in response to 
PIO.  Myocardial fatty acid oxidation and utilization rates 
increased slightly, but not significantly, resting systolic 
and diastolic function were unchanged. EXS- Whole-body 
peak oxygen consumption increased but not significantly, 
Visceral adipose tissue, fat-free mass, total fat mass, and 
subcutaneous fat content were unchanged, small 
improvements in fasting plasma glucose, insulin, 
triglycerides, and total and low-density lipoprotein. Basal 
myocardial insulin sensitivity non significantly increased. 
Myocardial fatty acid oxidation and utilization rates 
increased but not significantly, resting systolic and 
diastolic function were unchanged 
 
Neither PIO nor EXS 
resulted in a detectable 
improvement in basal 
myocardial insulin 
sensitivity or diastolic 
function. 
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REF Study Variables   Results  Differences among 
study groups 
Troseid et al. (2014) BF composition was measured by dual-
energy x-ray absorptiometry scan, insulin-
mediated glucose uptake was measured by 
euglycemic hyperinsulinemic clamp 
combined with stable isotope infusion, and 
lipopolysaccharide (LPS) was measured with 
the limulus amebocyte lysate assay 
At baseline, the strength and endurance group did not 
differ significantly in CD4+ T-cell count, ART duration 
(10.3 vs. 9.0 years), body mass index (23.4 vs. 24.0 
kg/m2), fasting glucose (5.5 vs. 5.4 mmol/L), triglycerides 
(2.6 vs. 2.3 mmol/L), or trunk fat mass. 
lipopolysaccharide (LPS) levels were not significantly 
changed in the strength training group [6.8% reduction 
(20% reduction to 6.4%increase) both training modalities 
increased insulin-mediated glucose uptake, whereas 
strength training, but not endurance training, reduced 
triglyceride levels and trunk fat mass, reduced trunk fat, 
triglycerides, and improved insulin sensitivity after 
strength training were associated with reduced LPS levels, 
possibly mediated through a reduction in triglycerides. 
 
There were no 
significant 
associations between 
changes in insulin-
mediated glucose 
uptake, trunk fat, and 
LPS levels in 
endurance group. 
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3.4.2.4. ANTIRETROVIRAL THERAPY DURATION AND RESPONSE TO RESISTANCE 
EXERCISE INTERVENTIONS  
Only one study by Mendes et al. (2013) subtly indicated ART duration background of participants in 
relation to RE intervention response. Mendes et al. (2013), considered participants who were on ART for 
at least one year and found that body circumferences, sum of seven skinfolds, percentage body fat, total 
fat, central fat and peripheral subcutaneous fat had reduced following RE and aerobic conditioning. 
Further, lean body mass increased in exercised groups, while strength and cardiorespiratory fitness 
increased in both exercised groups in response to RE and aerobic conditioning. The other studies did not 
indicate any association between participants’ duration on ART and their response to RE interventions. 
Therefore, findings related to RE exclusively are undetermined due to multi interventions. 
3.4.2.5. GENDER EFFECT ON RESPONSE TO RESISTANCE EXERCISE INTERVENTIONS 
In the four studies that had participants of mixed gender, none of the studies indicated any gender 
differences in response to RE interventions. According to a study by Cade et al. (2013), the PIO Group 
had 25% of the participants being females. In further confirming that no gender differences affected 
responses to RE interventions Cade et al. (2013)  established that, neither pioglitazone nor exercising 
group resulted in a noticeable increase in basal myocardial insulin sensitivity or diastolic function 
following an intervention involving RE, aerobic exercise and pioglitazone ingestion. Therefore, the 
studies did not distinct anthropometric, strength, chronic or non-chronic responses in relation to gender or 
compared gender outcome differences among their group participants.   
 
3.5. LIMITATIONS 
An important limitation to the studies included in this review was that none of the studies focused on 
exclusive resistance exercise. All the studies involved RE in combination with either an aerobic, 
nutritional and or pharmacological co-intervention. These studies also involved participants not in African 
contexts or source limited settings like Sub-Saharan Africa (SSA).  All the studies did not mention issues 
of medication adherence and particular type of ART drugs or line of ART that participants were 
receiving.  This was not considered as a study factor relating to PLWHA’s responses to RE interventions. 
The studies included for review did not observe similar prescriptions regarding optimum dose regarding 
the RE mode, intensity, frequency, rest and maximal study durations. The same inconsistency was noted 
in the aerobic exercise modes involved as co-interventions. The HIV-clinical stages of participants were 
not considered as a variable affecting response to RE interventions in PLWHA.  
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The specific types of resistance exercise or aerobic exercises (as co-intervention) were scarcely 
mentioned in some of the studies included in this review. It may also be likely that not all suitable papers 
were retrieved. Excluded or included keywords may have eliminated relevant papers not identified during 
searching of reference lists of retrieved studies.    
 
3.6. CONCLUSIONS AND RECOMMENDATIONS 
Resistance exercise interventions in combination with other components seem to improve body 
composition, chronic disease risk parameters, self-efficacy, bodily functioning, strength and psychologic 
conditions in PLWHA. Studies do not indicate much difference in responses to resistance exercise 
interventions between males and female. There are significant differences between exercising groups and 
none intervention CON groups.   
The study findings assert that a potent remedy for PLWHA can exist in RE training. However, RE 
interventions are being used in combination with other co-interventions. The variations in study 
methodologies calls for unvarying and uniform co-intervention procedures, establishing maximum and 
minimum study duration, identifying specific types of RE or aerobic co-intervention and prescribing 
standard exercise doses in order to produce a clearly set of study criteria. Furthermore, there is generally 
no consensus on the type or types of co-interventions, their duration, design variation and outcome study 
variables.  
It is highly recommended that exclusive RE interventions are safe and largely beneficial to PLWHA 
receiving ART. The exercise training modality may be adjusted to one’s level of ability (individual 1RM 
and symptomatology) and progressively increased. Resistance exercise training then tends to be safe for 
both male and female PLWHA on ART regardless of ethnic background, (Anderson, 2006). Resistance 
exercise intervention studies have been conducted more in developed nations than developing ones.  
A period of 6-12 weeks on a RE or aerobic intervention training programme appears to improve body 
composition and strength of PLWHA is concerned. The RE intervention studies for PLWHA are mostly 
affected by challenges of adherence and drop out. The bottom line being that, exercise prescriptions 
should mirror standard protocols according to the American College of Sports Medicine which states that, 
frequency should be  two to three days per week, eight to ten repetitions, targeting 10-12 muscle groups, 
two to three sets at 60-80% of individual’s 1RM (Pescatello et al., 2014:294).     
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4.1. ABSTRACT 
In Zimbabwe, Human Immunodeficiency Virus (HIV) mortality rates have continued on an upward trend. 
The number of those starting antiretroviral therapy (ART) each year has also increased. Generally, the 
commencement of ART, coupled with nutritional interventions, in PLWHA has increased their life 
expectancy.  In the long term PLWHA are now living longer to the extent that they develop lifestyle 
conditions like hyperlipidaemia, obesity, diabetes mellitus and hypertension, among other chronic disease 
risks. This has led to a reduction in their general physical fitness levels and strength. Resistance exercise 
(RE) can be beneficial to PLWHA in alleviating these chronic disease risks. However, there is little 
information and limited inclusion of RE programmes as healthy lifestyle intervention for PLWHA 
receiving ART in Zimbabwe.   
4.1.1. AIMS   
The purpose of this study was to investigate the effect of a RE intervention programme on body 
composition, chronic disease risks and strength in PLWHA receiving ART.  
4.1.2. METHODOLOGY 
This was a 12 week experimental, pre-test, post-test study measuring somatic and biologic markers in 128 
PLWHA on an outpatient basis. The participants were from Budiriro and Mabvuku communities that 
work with the Zimbabwe National Network for people living with HIV/AIDS (ZNNP+) a local Non-
Governmental organisation in Harare. The participants from Budiriro were randomly allocated to an 
experiment group i.e. the EXP group (n=64) while those in Mabvuku to a control group i.e. the CON 
group (n=64). The EXP group (n=64) had a mean age of 39.16 ± 4.708 years, height 1.69 ± 7.47 m and 
weight 68 ± 15.9 kg participated in a 12 week RE intervention programme attending sessions three days a 
week.  The CON group (n=64) had a mean age of 39.31 ± 4.382 years, height 1.641 ± 8.90 m and weight 
65.9 ± 8.14 kg and did not participate in the RE intervention programme and were prescribed exercise 
after the 12 weeks for ethical reasons only.  Body composition (body mass index, waist hip ratio, 
percentage body fat, fat mass, lean body mass), chronic disease risks (fasting blood glucose, fasting total 
blood cholesterol, blood pressure) and one-repetition maximum (1RM) strength tests were pre-and post-
measured in all participants. The study variables were analysed using ANCOVA to compare each study 
variable between the EXP group (n=64) and the CON group (n=64) allowing for (correcting for) 
variability of other covariates. SPSS statistical package version 22 was used and significance set at 
p≤0.05.  
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4.1.3. RESULTS  
The post-test body composition, fasting blood glucose and fasting total blood cholesterol scores remained 
high in the CON group (n=64) and improved significantly (p<.0005) in the EXP group (n=64). At post-
test, 100% of participants in the CON group (n=64) were still pre-hypertensive while 66% of the EXP 
group (n=64) participants had improved from hypertension stage 2 to hypertension stage 1. Strength 
(1RM) levels in the EXP group (n=64) increased significantly (p<.0005) for the bench press, squat, bicep 
curl and leg curl than in the CON group (n=64).     
4.1.4. CONCLUSION  
Resistance exercise are safe and beneficial for PLWHA in resource constrained settings. Body 
composition, chronic disease risks and strength can be positively addressed using RE in PLWHA.   
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4.1. INTRODUCTION 
Antiretroviral therapy (ART) involves an assortment of drugs to suppress growth of the HIV virus 
(AIDSinfo, 2016). It is strongly recommended that ART be initiated in all adults with HIV regardless of 
the World Health Organisation (WHO) clinical stage and at any CD4 cell count, to reduce the morbidity 
and deaths associated with HIV infection (AIDSinfo, 2016; World Health Organisation, 2015). With 
treatment, the life expectancy of PLWHA receiving ART improves (Ciccolo et al., 2014). However, 
studies show that PLWHA although they now live longer, western diets and sedentary lifestyles are 
predisposing them to chronic disease risks or non-communicable diseases (NCDs) (Grochocinski, 2011). 
Non-communicable diseases have become the leading cause of non–HIV-related deaths among PLWHA 
(Post, 2012). The prevalence of chronic disease risks especially cardiovascular diseases (CVDs) in 
PLWHA is now similar to the uninfected population with developing nations, particularly in Africa, being 
greatly affected (Jerico et al., 2005; Stein, 2010).   
Hyperlipidemia, fat redistribution (lipodystrophy), peripheral neuropathy, decreasing bone mineral 
density, high blood pressure, strokes, overweight and obesity are among a host of chronic disease risks 
affecting PLWHA receiving ART. High blood glucose levels leading to type 2 diabetes mellitus also 
affect PLWHA following ART initiation (Crane et al., 2006; Denue et al., 2013; Grinspoon and Carr, 
2005 ; Grochocinski, 2011; Nemaura et al., 2013;  Neto et al., 2013; Teklay et al., 2013). Each 
antiretroviral drug class causes different chronic disease risks in PLWHA (AIDSinfo, 2016).  The 
chronic disease risks affect both men and women, although females, with a high body mass index, of 
black African ethnicity and older males on treatment for more than ten years are affected more (Akl et al., 
2017; Boccara et al., 2013; Cerrato et al., 2015; Domo and Jalyson, 2015; Guehi et al., 2016; Hubbard, 
2007; Malapati et al., 2014; Palacios et al., 2006; Triant, 2014).   
Pharmacological lipid-lowering agents including hormones (Stanley and Grinspoon, 2012), alendronate 
and vitamin D (McComsey et al., 2010), surgery (Hubbard, 2007), nutritional supplementation (Mudzviti 
et al., 2012)  and insulin sensitising agents (Grinspoon and Carr, 2005 ) all appear to be  effective in 
combating chronic disease risks. Lifestyle interventions involving changes in alcohol consumption, 
tobacco smoking, diet and engaging in exercise are highly recommended for PLWHA receiving ART 
(Compston, 2015; McComsey et.al, 2010).   
Studies show that, RE stimulate muscle building, reduce fat build-up and improve overall health, thereby 
enhancing a sense of well-being in the PLWHA (Gomes Neto et al., 2015; Hamid and Rajah, 2015; 
Hunter et al., 2010; Lands, 2015; Malita et al., 2005; Mutimura et al., 2008; Paes et al., 2014; ACSM, 
2014, p.293; Souza et al., 2011).  
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Resistance exercise are an effective natural means of addressing identifiable chronic disease risks in 
PLWHA (Bonjoch et al., 2010; Malita et al., 2005; Roubenoff and Wilson, 2001; Srikanthan and 
Karlamangla, 2014).  According to Yarasheski et al. (2001) RE improve strength, lean mass, trunk 
adipose mass and thigh muscle circumference scores in PLWHA.  Other studies involving RE noted 
similar findings following their investigations (Hamid and Rajah, 2015; Souza et al., 2011).  In 
Zimbabwe, Mkandla et al. (2016) conducted the only hospital-based study to establish the effect of a RE 
intervention programme on the health-related quality of life in those living with HIV-related distal 
symmetrical poly-neuropathy.  The resistance exercise intervention considerably improved health-related 
quality of life in the PLWHA as compared to the CON group. 
Over half a million people receive ART, and thousands more commence treatment daily in Zimbabwe, 
(UNAIDS, 2015). It was established that, this same population now record increased incidences of 
overweight and obesity (Takarinda et al., 2017), high blood pressure (Mutede et al., 2015).  
 
Zhou et al. (2016) identified this epidemiological development as an increased incidence of chronic 
disease risks among PLWHA receiving ART in Zimbabwe. Mutede et al. (2015) then suggested possible 
lifestyle changes including exercise. However, there is still limited data on the adoption of RE as a 
lifestyle intervention for PLWHA in the country (Quiles and Ortiz, 2017). Therefore, the present study 
aim was to investigate the effect of a RE intervention programme on body composition, chronic disease 
risks and strength in PLWHA receiving ART in Zimbabwe.  
 
4.2. METHODS 
All procedures were each carried out at the two Community Centres in Harare following ethical approval 
from the Medical Research Council of Zimbabwe (MRCZ) and the University of Kwa-Zulu Natal-
Biomedical Research Ethics Committee (BREC); REF: MRCZ/B/948 and BF293/15, respectively 
(Appendix A and B). The clearances from gatekeepers were also obtained from the Ministry of Health 
and Child Care (MoHCC) in Zimbabwe (Appendix C), the National AIDS Council, Harare (Appendix D), 
the ZNNP+ (Appendix E) and the District Community Council (Appendix F).  
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4.2.1. STUDY DESIGN AND PARTICIPANT RECRUITMENT 
This was an experimental, pre-and post-test study.  A total of 128 sedentary male and female PLWHA, 
receiving ART on an outpatient basis, aged between 18 and 45 and of black African ethnicity, from 
Mabvuku and Budiriro in Harare, were screened based on medical doctor’s approval to participate in this 
study. Following initial baseline assessments the participants in Budiriro were randomly allocated as the 
EXP group (n=64) and those in Mabvuku allocated to the CON group (n=64). The EXP group (n=64) was 
taught and trained weight training before being required to perform RE using body and free weight gym 
equipment. The resistance exercise intervention programme targeted intensity ranging from 50% of each 
individual’s 1RM initially and progressively reaching 80% during the final week (for squats, bench 
presses, leg curls and bicep curls). The EXP group (n=64) participants completed two to three sets, of 
eight to ten repetitions, three times per week over 12 weeks. The CON group (n=64) did not partake in 
any exercise programme during the 12 week study period and were prescribed exercise thereafter 
following the same protocol for ethical reasons. The exercise sessions were supervised and monitored by 
four research assistants at Mabvuku and Budiriro community fitness centres.     
4.2.2. PARTCIPANTS CHARACTERISTICS 
The criteria for participants to be recruited into this study included having CD4 counts of ≥350 cells/mm3, 
an absence of opportunistic infection and no pre-existing participation in an exercise programme. Pre-
menopausal female subjects were not pregnant or lactating, had had regular menstrual cycles for the past 
year and had been medically diagnosed as HIV-infected.   The exclusion criteria included individuals with 
Acquired Immune Deficiency Syndrome; musculoskeletal disorders; seriously ill and bed-ridden 
individuals; being HIV negative; any history of leg injury and back pain; congestive heart failure; angina, 
cardiovascular and peripheral vascular diseases. Individuals who had experienced a cold or fever at least 
one month leading up to the protocol, those with flu symptoms or of non-black African ethnicity were 
excluded.  Also excluded were individuals taking medication that affected central or peripheral 
circulation. Those on nonsteroidal anti-inflammatory agents or serotonin reuptake inhibitors; who 
engaged in an existing exercise programme and having any other medical condition that could be 
exacerbated by lifting weights were also excluded. 
Every participant was informed of all investigational procedures, including the risks and benefits 
associated with participation in the study before providing a signed informed consent form, prior to 
participation in the study.  
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4.2.3. EXPERIMENTAL PROTOCOL 
 
4.2.4. SESSION 1: SCREENING  
The study included pre-test initial screening of participants, after which they were randomly allocated to 
the two groups. Participants were each assigned a numerical identification code number to ensure privacy. 
Prior to participation in the study participants were provided with information regarding the study 
(Appendix G) and completed a written informed consent form (Appendix H). The initial visit consisted of 
screening participants using the medical doctor’s note and further considering responses provided on 
completed full health history form and International Physical Activity Readiness Questionnaire (IPAR-Q) 
to ensure that they met the inclusion criteria in consultation with the medical doctor. The participants 
were informed of their qualification for selection and given the next appointment time to visit the 
Community Fitness Centre for consecutive study sessions to conduct pre-test, RE intervention and post-
test procedures.   
4.2.4.1. THE QUESTIONNAIRE 
The nutritional risk assessment questionnaire was developed Medical Nutrition Therapy Associates and is 
intended to identify non-pregnant, non-lactating clients at risk for calories, vitamin, mineral and fiber 
deficiency; excess sodium, fat and sugar intake; problematic weight control behaviours or attitudes. The 
questionnaire was further validated by the Ministry of Health and Child Care in Zimbabwe (MoHCC) 
(Appendix C). The Participants completed the five part questionnaire with reference to their 
demographics, IPAR-Q, exercise adherence, health risk background and nutritional risk (Appendix I). The 
participants were assisted in responding to the self-administered questionnaire and vernacular 
explanations were given in areas they did not understand fully.  
a. Demographic Information 
The demographic information section of the questionnaire sought participants’ gender, age, level of 
education and marital status. 
b. International Physical Activity Readiness Questionnaire (IPAR-Q)  
IPAR-Q is an internationally approved pre-participation health risk appraisal for individuals about to 
begin a physical fitness activity programme, designed by the American Heart Association and American 
College of Sport Medicine (ACSM, 2014, p.23). The IPAR-Q allowed participants to give YES or NO 
responses. This section of the questionnaire also established exercise backgrounds and the weekly 
exercise habits (type and duration) of participants.   
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c. Health Risk  
The health background risk segment of the questionnaire required participants to respond to questions 
regarding their cardiovascular risk factors. It also required participants to provide information on the 
estimated time since each had been diagnosed HIV-positive, and the ART they were receiving, on an 
outpatient basis.  
d. Nutritional Risk  
Participants rated their dietary intake for a week, including breakfast; lunch; dinner; herbal supplements; 
protein powders; eating out at restaurants; and whether they were on a special diets for medical reasons. 
The participants provided information on portion sizes for each food item, and according to ‘servings per 
day, per week, per month or never ate’. This was in reference to five food groups: group one was bread, 
cereal, rice and pasta; group two was fruit and vegetables; group three  included milk, yogurt, and cheese; 
group four was meat, poultry, fish, dry beans, eggs, and nuts; and group five included fats, oils, and 
sweets.  
e. Body image 
The concluding segment of the questionnaire required participants to respond with YES or NO to 
questions about body image, eating disorders and weight management.  
4.2.5. SESSION 2: BASELINE LABORATORY TESTING 
The baseline testing session took place a week before participants took part in the study protocol at the 
community centres in Mabvuku and Budiriro. On arrival participants were familiarised with the 
laboratory testing procedures and the necessary baseline measurements. The measurements were taken 
observing issues of privacy and confidentiality hence each participant was measured by a research 
assistant of the same gender in designated testing rooms for males and for females. Ethical principles 
followed were respect for persons, beneficence (doing good) and justice. Participants were also identified 
by their code numbers for privacy.  Testing rooms were made as comfortable as possible at room 
temperature with chairs, tables and curtains. World Health Organisation guidelines on drawing blood,  
best practices in phlebotomy and clinical health standards were followed and among others included 
safety handling of consumables including lancets, wearing of latex gloves by the testing research team 
members and disposal of used alcohol swabs. The research team also included medical personnel cleared 
by the Medical Research Council of Zimbabwe for this study. The used lancets, cotton balls, gauzes and 
latex gloves were immediately disposed in a plastic sharps bin and send for incineration at the end of each 
session. A first aider was in attendance during sessions.  
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Participants had been asked to fast before arriving, to measure their fasting blood glucose and fasting total 
blood cholesterol. The pre-test session also involved measuring blood pressure, anthropometrics (weight 
and height), waist and hip circumferences and body composition using skinfolds. The visits were all 
scheduled during morning hours in order to control the study variables.   
4.2.5.1. ANTHROPOMETRIC MEASUREMENTS 
Standing height (stature), mass and waist and hip (girths) circumferences were the anthropometric 
variables measured, observing International Society for the Advancement of Kinanthropometry standards  
(ISAK, 2001:7). 
a. Height 
The SECA stadiometer were used to measure height. The participants had their height measured without 
wearing any head gear or footwear. Participants stood with heels, buttocks and upper part of the back 
touching the wall. The head was placed in the Frankfort plane. Participants would take and hold a deep 
breath, while keeping the head in the Frankfort plane, with one research assistant applying firm upward 
lift through the mastoid processes. The recorder placed the head board firmly down on the vertex, 
crushing the participant’s hair as much as possible to take a reading. The recorder further assisted by 
watching that the feet of each participant did not lift off the floor and that the position of the head was 
being maintained in the Frankfort plane. Measurements were taken at the end of a deep inward breath and 
the reading was then taken to the nearest 0.1 cm (ISAK, 2001:7). The participants had repeat 
measurements of their height three times and an average determined as the final height. See the 
anthropometrics recording sheet in (Appendix J). 
b. Weight  
Weight was measured using a SECA electronic scale (SECA Deutschland Medical Scales and Measuring 
Systems, Hamburg, Germany). The measurements were taken on participants while barefooted and with 
minimal clothing. Excess accessories were also removed. The scale was checked to make sure it was 
reading zero. The participants stood on the middle of the scale without support and with the weight 
distributed evenly on both feet. The SECA electronic scale measuring to the nearest 50g was used. The 
participants had repeat measurements of their weight three times and an average determined as the final 
weight (ISAK, 2001:8). 
c. Waist-Hip Circumferences 
A Lufkin W606PM 2m flexible steel tape measure, with automatic retraction, calibrated in centimetres by 
millimetre gradations was used to measure circumferences. 
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4.2.5.1.1. Waist measurement  
Participants assumed a relaxed standing position with the arms folded across the thorax. The waist (girth) 
circumference was measured at the level of the narrowest point between the lower costal (10th rib) border 
and the iliac crest. The participants’ abducted their arms slightly allowing the tape to be passed around the 
abdomen in front and the tape adjudged to the level of the narrowest point. The participants were 
instructed to lower their arms to the relaxed position. The tape was then readjusted as necessary to ensure 
it did not slip or excessively indent the skin. Each participant was allowed to breathe ordinarily and the 
measurement was taken for recording (ISAK, 2001:83). When reading the tape the eyes were at the same 
level as the tape for accuracy to the nearest millimeter. Repeat measures were three per each participant 
and an average calculated for recording. 
4.2.5.1.2. Hip measurement  
The hip (gluteal) girth was measured at the level of the greatest posterior protuberance of the buttocks 
which usually corresponds anteriorly to about the level of the symphysis pubis. The research assistant 
passed the tape around the hips from the side. The tape adjusted to the level of the greatest protuberance 
of the buttocks. The participants assumed a relaxed upright position with the arms folded across the 
thorax. The participants were instructed to place feet together and to relax the gluteal muscles. The tape 
was then readjusted as necessary to ensure it did not slip or excessively indent the skin. Then using the 
cross-hand technique, the tape was held in front and on the sides so that it was held in a horizontal plane 
at the target level.The tape was passed around the hips from the side and a measurement was taken for 
recording (ISAK, 2001:84). When reading the tape the eyes were at the same level as the tape for 
accuracy to the nearest millimeter. Repeat measures were three per each participant and an average 
calculated for recording. 
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4.2.5.2. BODY COMPOSITION MEASUREMENTS 
a. Skinfolds 
A Slim Guide skinfold calliper was used to take the skinfolds. Skinfold measurement is a field procedure 
to determine body composition levels, since the amount of subcutaneous fat is proportional to the amount 
of body fat (ACSM, 2014:67). The measurements were taken with participants wearing minimal clothing. 
Measurements were taken observing International Society for the (ISAK, 2001:63-71). The participants 
assumed a relaxed upright position with arms on the side. The research assistant then identified seven 
skinfold locations and marked the skin with a pen for all skinfold landmarks.  
At the marked skinfold, the research assistant lightly tweaked and lifted the skin until a double fold of 
skin formed, including the underlying subcutaneous adipose tissue, which was held between the thumb 
and index finger of the research assistant’s left hand.   
The near brink of the thumb and finger were in line with the marked site. The nearest edge of the contact 
faces of the calliper was applied about one centimetre away from the edge of the thumb and finger. The 
calliper was held at 90° to the surface of the skinfold site at all times and a measurement was recorded 
two seconds after the full pressure of the calliper was applied. The seven skinfold sites measured on each 
participant were the triceps, chest, abdominal, subscapular, suprailiac, mid-axilla and front thigh (ISAK, 
2001:63-71).  
The skinfold site scores enabled participants’ body compositions to be calculated. Three repeat measures 
were taken and an average recorded. The skinfold measurements were recorded in Appendix J. In all 
participants, Jackson and Pollock’s equation (ACSM, 2014:69)for men and women (seven skinfold sites) 
was used to determine body density, after which percentage body fat was calculated using the Siri 
Equation: 
 
 
% Body Fat = (495 / Body Density) – 450 
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4.2.5.3. CHRONIC DISEASE RISK MEASUREMENTS 
a. Blood Pressure  
Blood pressure was measured using the HI-CARE deluxe stethoscope Rappaport type and HI-CARE 
sphygmomanometer. The rooms set aside at the fitness community centres were used to measure blood 
pressure of participants. The participants were seated with the arm flexed at the elbow at the level of the 
heart. The properly sized cuff was wrapped around the upper arm, while the stethoscope’s bell was 
pressed over the brachial artery just below the cuff’s edge. The cuff was rapidly inflated and then air was 
released from the cuff at a moderate rate (3mm/sec).  The recorder simultaneously listened to the 
heartbeat with the stethoscope and observed the reading on the sphygmomanometer. Both systolic 
pressure and diastolic pressure were recorded (ACSM, 2014:45).  
Blood pressure scores were classified according to the new American Heart Association and American 
College of Cardiology guidelines (AHA/ACC, 2017). The categories of blood pressure were recognised 
as follows: normal <120/80 mmHg; elevated 120-129/80 mmHg; hypertension (stage 1) 130-139/80-89 
mmHg; hypertension (stage 2) ≥140/ ≥90 mmHg. See Appendix K for chronic disease risks recording 
sheet.  
b. Fasting Blood Glucose  
Blood glucose was measured using an Accutrend Plus digital meter, Roche, Mannheim, Germany. Fasting 
blood glucose levels were measured. The research assistant first put on latex gloves after checking the 
functionality of the meter. The meter was then switched on and coded with a coding strip inserted into the 
meter. The participant’s hands were washed and after drying, the preferred fingertip of the participant was 
wiped with an alcohol swab. A test strip was inserted into the blood glucose meter.  
The preferred finger of the participant was pricked and a drop of blood was put on the test strip and then 
the reading was taken after 12 seconds. Test results were displayed on the monitor’s screen after a beep 
and results were recorded. The used test strip was removed to reset the monitor. The pricked fingertip was 
then dressed with a gauze pad or Elastoplast bandage. The cotton swab, test strip and used lancet were 
discarded properly after use. Fasting blood glucose levels were categorised as follows: normal glucose 
tolerance 3.9-5.5 mmol/L; impaired fasting blood glucose (pre-diabetes) 5.6- 6.9 mmol/L; and very high 
blood glucose (type 2 diabetes) >7 mmol/L (ACSM, 2014, p.279). 
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c. Fasting Total Blood Cholesterol  
Fasting total blood cholesterol was measured using an Accutrend Plus digital meter, Roche, Mannheim, 
Germany. The research assistant wore latex gloves. The participant’s initially lanced finger was again 
squeezed gently to draw another drop of blood. A second lancing was done only when necessary. The test 
strip was inserted into the meter and the reading was taken after 180 seconds. Test results were displayed 
on the monitor screen after a beep and results recorded. The used test strips were removed to reset the 
monitor and the pricked fingertip was then dressed with a gauze pad or Elastoplast bandage. Fasting total 
blood cholesterol scores are classified as: desirable <5.1 mmol/L; borderline high, 5.1-6.1 mmol/L and 
very high >6.2 (ACSM, 2014, p.46).   
4.2.6. SESSION 3: BASELINE STRENGTH TESTING 
The baseline strength testing session took place in the gym at the community fitness centres (in Mabvuku 
and Budiriro) two weeks before participants took part in the study protocol and involved determining 
their 1RM.   
4.2.6.1. ONE-REPETITION MAXIMUM (1RM) TEST   
The baseline strength levels of all participants were determined using 1RM tests (for bench press, squat, 
bicep curl and leg curl). All participants were led through a warm up, performing submaximal repetitions 
of the specific exercises according to ACSM  (2014, p.96). The rest observed between each 1RM test 
procedure was 48 hours. The 1RM was determined within four lifts, observing three to five minute rests, 
assisted by a spotter. Normative data for predicting 1RM was used to select weights that were within the 
perceived capacity of each participant (i.e.50-70% 1RM).  Weights of 2.5 to 20 kg were progressively 
added until a complete repetition could no longer be performed. Then, the previous weight lifted 
successfully become the 1RM for that exercise. The lifted 1RM values for each exercise were recorded 
(Appendix L) and test results were used to design the RE intervention programmes for the EXP group 
(n=64) participants.  Therefore, these results gave a clear-cut indication of how much weight each 
participant was able to lift, one repetition across a number of exercises that were included in this study.   
A cool down activity was done at the end of each session participants. Any participant showing great 
discomfort during this procedure were stopped and rested. Again participants were encouraged to remain 
hydrated and avoid the Valsalva manoeuvre (forceful attempted breathing out against a closed airway).  
Once baseline strength had been established, participants took part in a body weight strength conditioning 
programme (circuit) for four days a week before the study began. Two more days were set aside to 
familiarise participants with weight training, equipment, breathing technique, hydration, maintaining a 
high calorie diet, gym etiquette, and health and hygiene rules in gyms.  
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4.2.6.2. BODY WEIGHT STRENGTH CONDITIONING PROGRAMME 
 
Table ix: Body weight strength conditioning programme  
DAY ACTIVITY REPS REST 
BETWEEN 
STATIONS(mins) 
SETS REST AFTER A 
COMPLETE 
SET(mins) 
1 and 2 Warm up : Jogging (200m) 
 
Dynamic Stretches  
Over (10 metres) 
Butt kicks 
High knees 
Pulling down mangoes 
Ankling 
Bounding 
Hopping 
Combinations 
 
Body weight 
Press-ups 
Squats 
Sit ups 
Leg raises 
Calf raises 
Burpees 
 
Cool down 
Static stretches 
Breathing exercises 
4  
 
 
 
3  
 
 
 
 
 
 
 
 
8-10  
 
1  
 
 
 
10  
 
 
 
 
 
 
 
 
2-3  
 
2  
 
 
 
2  
 
 
 
 
 
 
 
 
3  
 
3  
 
 
 
3-4  
 
 
 
 
 
 
 
 
4-5  
 
 
DAY ACTIVITY REPS REST BETWEEN 
STATIONS  
SETS REST AFTER A 
COMPLETE SET 
3 and 4 Warm up: Jogging (200m) 
 
Dynamic Stretches  
Over (10 metres) 
Butt kicks 
High knees 
Pulling down mangoes 
Ankling 
Bounding 
Hopping 
Combinations 
 
Body weight 
Press-ups 
Squats 
Sit ups 
Leg raises 
Calf raises 
Burpees 
 
Cool down 
Static stretches 
Breathing exercises 
4  
 
 
 
6  
 
 
 
 
 
 
 
 
10-12  
 
1  
 
 
 
1  
 
 
 
 
 
 
 
 
2  
 
2  
 
 
 
2  
 
 
 
 
 
 
 
 
3  
 
2  
 
 
 
3  
 
 
 
 
 
 
 
 
4-5  
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4.2.7. SESSION 4: RESISTANCE EXERCISE INTERVENTION PROTOCOL  
In the study, participants took part in a supervised RE intervention programme, following American 
College of Sports Medicine (ACSM) protocols for PLWHA, ACSM (2014, p.294). The RE programme 
was undertaken in the gym at Budiriro community fitness centre. The EXP group (n=64) participants 
performed the RE programme based on each individuals’ pre-test 1RM, obtained during session 3, for 
bench press, squat, bicep curl and leg curl. The RE programme was carried out three days a week 
(Mondays, Wednesdays and Fridays) for 12 weeks.  The exercise sessions involved working biceps, 
triceps, chest, hamstrings, quadriceps and calf major muscles. Participants were encouraged to maintain a 
calorie diet, rehydrated avoiding the Valsalva manoeuvre. The participants were put into five groups and 
each group was monitored and supervised by a research assistant who also worked as a spotter. The 
groups followed a circuit training format to work out at each station. Body weight exercises were 
performed on Wednesdays only during the first four weeks. The free weight and gym equipment exercises 
performed included preacher curls (using barbell with weights on a bicep bench), triceps extensions 
(triceps extension machine), bench presses (using a barbell with weights on a weight bench), leg curls 
(using a leg curl machine), squats (using barbell with weights on a squat rack) and calf raises (using 
barbell with weights).  In each session, the EXP group (n=64) participants embarked on a 10-20 minute 
warm-up involving light jogging, stretches,  light weight exercises; and ended with an eight to ten 
minutes cool-down and overall duration took up to 2 hours per day. Each participant performed five sets 
of exercises in a circuit format. The EXP group (n=64) participants were encouraged to continue training 
since the RE benefits were already noted. The exercise workout recording sheet is in Appendix M. The 
following table illustrates the protocol:  
Table x: Resistance exercise intervention procedure 
  Week Load as  
% of 
individual 
1RM 
No of 
repetitions 
per exercise 
Volume 
(no. of 
sets) 
Rest after 
each set 
of 10 (in 
minutes) 
Time to 
complete 
(in minutes) 
Type of Exercises 
1-2 50 10 3 2 30 free weight 
3-4 60 10 3 2 30 free weight 
5-6 65 10 3 2 30-50 Free weight, gym equipment 
7-8 70 8 2 3 30-50 Free weight, gym equipment 
9-10 75 8 2 3 30-50 Free weight, gym equipment 
11-12 80 8 2 3 30-50 Free weight, gym equipment 
Adapted from (ACSM, 2014, p.294; Tiozzo et.al, 2013). 
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4.2.8. SESSION 5: POST-TEST MEASUREMENTS 
The baseline anthropometric (height and weight) measurements for body composition (body mass index, 
waist hip circumferences, percentage body fat and lean body mass), chronic disease risks (fasting blood 
glucose, fasting total blood cholesterol) and strength (1RM), which had been taken at pre-test (prior to the 
study protocol), were measured once more at the post-test 12 week RE intervention programme, in all the 
participants. The measurements were taken at the same time of the day, in the morning, with fasting blood 
glucose and fasting total blood cholesterol measured after participants had fasted 6-12 hours.  The results 
were then analysed to draw conclusions and present recommendations. 
4.2.9. STATISTICAL ANALYSES 
ANCOVA was used to compare one variable in the CON group (n=64) group and the EXP group (n=64) 
correcting for variability of other covariates. The dependent variable was the post-measure, the covariate 
was the pre-measure and the independent variable was the group. This was calculated to determine 
significant difference in the post scores for the two groups i.e. in the CON group (n=64) and the EXP 
group (n=64) after correcting for the pre-scores.  
Variables on which ANCOVA was used include blood cholesterol, blood glucose, body composition 
(body mass index, percentage body fat, lean body mass, waist-hip-ratio, body weight) and strength. It was 
also used to determine effect of gender on study variables in finding out suitability or note differences in 
response rates on male and female participants following RE.  
Means and standard deviations as descriptive statistics were used with frequencies represented in tables 
and graphs. Descriptive statistics were used to analyse food group intake for it was tested at one time and 
not pre and post. If conditions did not allow the Chi-square test of independence was used to determine 
whether a significant relationship existed between two categorical variables represented in cross 
tabulation.    
Chi-square was used to analyse Blood pressure because it was categorical hence it would allow for 
analysing if there was a relationship between pre- and-post blood pressure classifications. Chi-square was 
also used on cross tabulations of food group intakes to see if there were any relationships between dietary 
intake and group.   
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When conditions were still not met Fisher’s exact test taking into consideration the small sample size. 
Therefore, Fisher’s exact test was also used on cross tabulations of food group intakes to see if there were 
any relationships between dietary intake and group. Linear regression analysis was conducted to estimate 
the coefficients of the linear equation, involving one or more independent variables that best predict the 
value of the dependent variable. Food group intakes and blood pressure were analysed using linear 
association.  
Binomial tests were used to test whether a significant proportion of the respondents selected one of a 
possible number of responses that showed significant effects. Body image was analysed using Binomial 
test to find out if a significant proportion answered 5 or more “YES” responses to indicate an eating 
disorder. This was then extended when data with more than two response options needed to be split into 
two groups.   
Pearson’s and Spearman’s correlation were used to test if scale or ordinal variables were linearly related. 
Pearson’s correlation (a measure of linear association) was used to test for correlation between study 
variables while Spearman’s correlation analysed blood pressure classification since blood pressure was 
ordinal and not continuous.  
Significance was set at p≤0.05 and the SPSS statistical package 22 was used to carry out the analysis. 
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4.3. RESULTS  
4.3.1. DEMOGRAPHIC CHARACTERISTICS 
After screening, the EXP group (n=64) and the CON group (n=64) participants showed the following 
characteristics in Table XI, below. No significant differences (NS) were noted in age, gender, education, 
marital status and physical activity readiness among participants.   
Table xi: Participant’s baseline characteristics in the EXP group (n=64) and the CON group (n=64) 
        (p-value = NS) 
Characteristic EXP (n=64) CON (n=64) Total Av (n = 128) 
Age (years) 39.16 (±4.708) 39.31 (±4.382) 39.24 (±4.545) 
Males (%) 28.1 14.1 21.1 
Females (%) 71.9 85.9 78.9 
Weight (kg) 68.03 (±15.938) 65.97 (±8.142) 67(±12.04) 
Height (cm) 169.95 (±7,479) 164.15 (±8.907) 167.05(±8.19) 
Body mass index (kg/m2) 23.64 (±5.722) 24.62 (±3.583) 24.13(±4.65) 
% Body fat (%) 21.26 (±10.017) 22.62 (±6.636) 21.94(±8.32) 
Fat mass (kg) 15.67 (±10.213) 15.10 (±5.523) 15.385(±7.87) 
Lean body mass  (kg) 52.42 (±8.360) 50.87 (±6.340) 51.65(±7.35) 
Waist circumference (cm) 84.34 (±11.551) 77.90 (±13.586) 81.12(±12.57) 
Hip circumference (cm) 99.00 (±13.946) 94.56 (±16.112) 96.78(±15.09) 
 
Education  
Primary (%) 34.4 37.5 35.9 
Secondary (%) 62.5 54.7 58.6 
Tertiary (%) 3.1 7.8 5.5 
 
Marital Status    
Single (%) 14.1 25.0 19.5 
Married (%) 43.8 42.2 43.0 
Separated/Divorced (%) 34.4 23.4 28.9 
Widowed (%) 7.8 9.4 8.6 
IPAR-Q  
 
  
Needing Clearance (%) 10.9 42.2 26.6 
Ready (%) 89.1 57.8 73.4 
The mean age of all participants was 39.24 ± 4.545 years. In the 128 total participants, 78.9% were 
females, and 21.1% were males. In total, 5.5% of participants had tertiary level education; in comparison 
to the 35.9% who had completed primary school, and the 58.6% with secondary level education.  A 
relatively large percentage of participants were married (43%), while a combined 48.4% were single, 
divorced or separated. Only 8.6% were recorded as widowed.  In the EXP group (n=64), 10.9% and in the 
CON group (n=64) 42.2% required medical clearance prior to the study since all participants had to have 
their strength (1RM) levels measured initially. 
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4.3.2. PARTICIPANTS EXERCISE BACKGROUND CHARACTERISTICS 
The exercise backgrounds of participants showed that they were not taking part in any formal exercise 
programme prior to the study protocol. The Table XII shows the type of exercise, and the time and 
frequency of exercise, which participants were occasionally involved in before they participated in the 
study. 
Table xii: Participants’ exercise backgrounds in the EXP group (n=64) and the CON group (n=64) 
(p-value = NS) 
PARAMETER (%) EXP (n=64) CON (n=64) TOTAL Av (n=128) 
 
Exercise Type 
 
Walking (%) 78.1 81.3 79.7 
Jogging (%) 0.0 0.3 0.15 
No exercise (%) 21.9 12.5 17.2 
 
Time  
More than 1 hr/wk (%) 7.8 15.5 11.7 
1 hr/wk   (%) 50.0 39.1 44.5 
Less than 30 mins/wk (%) 28.1 21.9 25.0 
Nil/wk (%) 14.1 23.4 18.8 
 
Frequency of Exercise  
More than 4 times/wk. (%) 4.7 7.8 6.3 
3-4 times/wk (%) 51.6 43.8 47.7 
1-2 times/wk (%) 29.7 21.9 25.8 
Nil times/wk (%) 14.1 26.6 20.3 
 
Interest in Exercise     
NO (%) 3.1 3.1 3.1 
YES (%) 96.9 96.9 96.9 
 
There were no significant differences between the groups in exercise backgrounds. Across all the 
participants, (79.7%) were involved in walking, far exceeding the 0.15% jogging, and the 17.2% not 
exercising at all. Only 11.7% of all participants spent more than an hour per week exercising. Only 6.3% 
of participants exercised more than four times a week. Although 96.9% of participants expressed interest 
in exercising, they generally fell below the required 30 minutes of exercise on most days, as required 
according to the (ACSM, 2014:293). Not much difference in exercise backgrounds were noted among 
participants.  
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4.3.3. PARTICIPANTS MEDICATION AND HEALTH RISK BACKGROUND  
There were more participants receiving first line ART medication than second line medication on an 
outpatient basis at 77.3% and 22.7%, respectively. There was little difference in the length of time 
(average total mean years) since participants had been diagnosed HIV-positive 5.74 ± 3.751 years. 
Similarly, average total mean years of receiving ART medication among participants was also at 5.21 ± 
3.417 years. The Table XIII shows the medication and health risk backgrounds of participants. 
Table xiii: Medication and health risk backgrounds in the EXP group (n=64) and the CON (n=64) 
            (p-value = NS) 
PARAMETER (%) EXP (n=64) CON (n=64) Average (n=128) 
 
ART line Medication (%) 
   
Line 1 (%) 84.4 70.3 77.3 
Line 2 (%) 15.6 29.7 22.7 
 
Diagnosis (%) 
   
Mean years since diagnosis (years) (%) 5.55 ±3.784 5.92(±3.717) 5.74(±3.751) 
Mean years taking ART (years) (%) 4.91±3.351 5.50(±3.482) 5.21(±3.417) 
 
Smoking Risk (%) 
   
YES (%) 1.6 0.0 0.8 
NO (%) 95.3 96.9 96.1 
At times (%) 3.1 3.1 3.1 
No of cigarettes/week 2.00(±1.000) 1.50(±.408) 1.75(±2.54) 
 
Alcohol Consumption (%) 
   
YES (%) 6.3 3.1 4.7 
NO (%)  92.2 89.1 90.6 
At times (%) 1.6 7.8 4.7 
No of pints/week 2.60(±2.074) 1.17(±0.707) 1.89(±1.31) 
There were no significant differences between the groups in medication and health risk background. No 
statistical differences were noted in smoking and alcohol consumption among the participants. Generally, 
most of the participants neither smoked nor drank alcohol, indicated by the high percentages of ‘NO’ 
responses at 96.1% and 90.6%, respectively. In total, only 3.9% of participants revealed that they smoked 
(on average 1.75 ± 2.54 cigarettes a week while a combined 9.4% of participants confirmed that they 
drank on average 1.89 ± 1.31 beers per week.  
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4.3.4. NUTRITIONAL RISK ASSESSMENT  
 
4.3.4.1. DIETARY INTAKE 
 
There was no significant difference between the two groups in terms of eating breakfast, lunch, dinner, 
eating between/after meals, water consumption, eating at restaurants, eating vegetarian, mineral 
supplementation, herbal supplementation, use of pills or teas to lose weight and use of protein powders to 
increase weight. Graphs were used to analyse responses of participants with each dietary intake and no 
difference (p-value = NS) was noted between the groups. 
 
In total, 58.6%, 57% and 70.3% of participants ate breakfast, lunch and dinner, respectively, on six or 
seven days every week. The average of participants eating between/after meals several times a week was 
44.5%. An average of 44.5% of participants consumed three to five cups of water a day. On average, 
78.9% of participants rarely ate at a restaurant; while 26.6% were vegetarian. Regarding mineral and 
herbal supplementation, an average 96.4% and 91.6% participants, respectively, never took them. None of 
the participants were using pills or teas to lose weight and 95.3% had never used protein powders to put 
on weight nor were on special diets for medical reasons. There was no significant difference between the 
CON group (n=64) and the EXP group (n=64) in all dietary intakes recorded. The Table XIV below 
shows the dietary intake of participants.  
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Table xiv: Dietary intake percentages for the EXP group (n =64) and the CON group (n=64)   
(p-value = NS) EXP (n-64) CON (n=64) Total Av (n=128) 
No. of days eating breakfast/week (%)    
None (%) 0.0 4.7 3 
1-2 Days (%) 15.6 12.5 14.1 
3-5 Days (%) 32.8 17.2 25.0 
6-7 Days (%) 51.6 65.6 58.6 
No. of days eating lunch/week (%)    
None (%) 7.8 3.1 5.5 
1-2 Days (%) 6.3 12.5 9.4 
3-5 Days (%) 28.1 28.1 28.1 
6-7 Days (%) 57.8 56.3 57.0 
No. of days eating dinner/week (%)    
None (%) 1.6 0.0 0.8 
1-2 Days (%) 3.1 4.7 3.9 
3-5 Days (%) 31.3 18.8 25.0 
6-7 Days (%) 64.1 76.6 70.3 
No. of times eating between/after meals (%)    
Daily (%) 3.1 9.4 6.3 
Several times/week (%) 40.6 48.4 44.5 
≤ once/day (%) 25.0 23.4 24.2 
Rarely (%) 31..3 18.8 25.0 
Water consumption/day (%)    
< 1 cup (%) 3.1 6.3 4.7 
1-2 cups (%) 14.1 12.5 13.3 
3-5 cups (%) 46.9 42.5 44.5 
> 5 cups (%) 35.9 39.1 37.5 
No. of time eating at a restaurant/week (%)    
Daily (%) 0 1.6 0.8 
Several times/week (%) 9.4 6.3 7.8 
≤ once/day (%) 10.9 14.1 12.5 
Rarely (%) 79.7 78.1 78.9 
Vegetarian status (%)    
YES (%) 21.9 31.3 26.6 
NO (%) 78.1 68.8 73.4 
Vitamin/mineral supplementation (%)    
Daily (%) 0.0 1.6 0.8 
Weekly (%) 0.0 1.6 0.8 
Rarely (%) 3.1 1.6 2.3 
Never (%) 96.9 95.3 96.1 
Herbal supplementation (%)    
Daily (%) 1.6 3.1 2.3 
Weekly (%) 3.1 3.1 3.1 
Rarely (%) 3.1 3.1 3.1 
Never (%) 92.2 90.6 91.4 
Use of pills or teas to lose weight (%)    
YES (%) 0.0 0.0 0.0 
NO (%) 100 100 100 
Use of protein powders to increase weight (%)    
Daily (%) 3.1 3.1 3.1 
Rarely (%) 1.6 1.6 1.6 
Never (%) 95.3 95.3 95.3 
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4.3.4.2. FOOD GROUPS INTAKES 
There was no significant difference noted among the groups in most of their food group consumptions, 
except for bread, cereal, rice and pasta. A chi-square test of independence was performed on cross 
tabulations to determine any relationships between dietary intake and each group. The Table XV, below, 
shows food group consumption by participants in the EXP group (n=64) and the CON group (n=64):  
Table xv: Food group intake percentages in the EXP group (n =64) and the CON group (n =64) 
                                                                   (p-value =  NS)   
Food Group Intake (in %) EXP 
(n-64) 
CON 
(n=64) 
Total Av (n=128) 
Bread, cereal, rice and pasta intake (%)    
Low intake (%) 93.8 64.1 78.9 
Meets requirements (%) 6.3 31.3 18.8 
Excessive intake (%) 0.0 4.7 2.3 
 
Fruit and vegetable intake (%) 
   
Low intake (%) 89.1 81.3 85.2 
Meets requirements (%) 10.9 18.8 14.8 
 
Milk, yogurt, and cheese intake (%) 
   
Low intake (%) 90.6 93.8 92.2 
Meets requirements (%) 9.4 6.3 7.8 
 
Meat, poultry, fish, dry beans, eggs, and nuts intake (%) 
   
Low intake (%) 45.3 45.3 45.3 
Meets requirements (%) 37.5 35.9 36.7 
Excessive intake (%) 17.2 18.8 18.0 
 
Fat, oils and sweets intake (%)  
   
Meets requirements (%) 57.8 48.4 53.1 
Excessive intake (%) 42.2 51.6 46.9 
Figure 4, below, shows the significant relationship between the groups and consumption of foods from 
group 1 - bread, cereals, rice and pasta. 
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Figure 4: Food group consumptions for the EXP group (n=64) and the CON group (n=64) at pre-test 
 *= Significant difference (p<.0005) pre-test consumption of food from group one (bread, cereal, rice and 
pasta) the EXP group (n=64) and the CON group (n=64) pre-test 12 week RE intervention programme.  
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4.3.4.3. EATING DISORDERS, BODY IMAGE AND WEIGHT MANAGEMENT 
A binomial test was conducted to establish the possible existence of eating disorders among participants, 
from information elicited from their responses for further referral if any. It showed that a significant 84% 
of the CON group (n=64) participants responded ‘YES’ to fewer than six questions out of a possible 
fifteen questions intended to identify eating disorders (p< .0005). Similarly a significant number (89%) of 
the EXP group (n=64) responded ‘YES’ to fewer than six of the fifteen questions intended to identify 
eating disorders (p< .0005).  
4.3.5. BODY COMPOSITION  
 
ANCOVA was applied to compare body composition variables between the CON group (n=64) and the 
EXP group (n=64) taking into account variability of other covariates. Post-test scores represented the 
dependent variable; the covariate was the pre-test scores and the independent variable was the EXP group 
(n=64) and the CON group (n=64). Significant differences in post-test scores for the EXP group (n=64) 
and the CON group (n=64) were determined after correcting for the pre-scores. The correcting of pre-test 
scores was done so that a participant with a high pre-test score could be treated the same as a person with 
low pre-test for it has the effect of bringing everyone to the same baseline. 
There was a significant difference (p< .0005) between the EXP group (n=64) and the CON group (n=64) 
in body composition during post-test although initially there had been no significant differences between 
the participants pre-test 12 week RE intervention programme. The Table XVI, below, shows mean body 
composition values for the EXP group (n=64) and the CON group (n=64) at pre-and post-test.  
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Table xvi: Mean body composition post-test for the EXP group (n =64) and the CON group (n =64)   
                                                            (p< .0005). 
 BODY COMPOSITION VARIABLE EXP(n=64) CON (n=64) 
POST-TEST POST-TEST 
Weight (kg) 67.50(±15.207) 66.00(±8.154) 
Height (cm) 169.95(±7.47) 164.15(±8.907) 
Body mass index (kg/m2) 23.43(±5.475) 24.63(±3.576) 
Percentage body fat (%) 19.82(±9.522) 22.70(±6.368) 
Fat mass (kg) 14.42(±9.528) 14.67(±5.962) 
Lean body mass (kg) 53.07(±8.225) 47.43(±7.829) 
Waist circumference (cm) 82.20(±11.029) 78.32(±13.506) 
Hip circumference (cm) 98.54(±13.570) 93.81(±16.386) 
Waist-hip ratio (ratio) 0.837(±0.080) 0.844(±0.107) 
 
4.3.5.1. WEIGHT  
ANCOVA was used to analyse weight between the EXP group (n=64) and the CON group (n=64) at pre- 
and post- test. The CON group (n=64) weight score was more than that of the EXP group (n=64) once 
corrected for pre weight. The mean weight of the EXP group (n=64) reduced from 68.03 ± 15.938 kg at 
pre-test, to 67.50 ± 15.207 kg post-test more likely due to the 12 week RE intervention. This suggests that 
the RE programme significantly reduced the mean weight score in the EXP group (n=64). The mean 
weight increased in the CON group (n=64) from 65.97 ± 8.142 kg to 66.00 ± 8.154 kg compared to pre-
test. Height did not differ significantly within groups, pre-and post-study.  Figure 5 below shows the 
weight scores for both groups before and after the 12 week RE intervention programme. 
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Figure 5: Weight scores for both the EXP group (n=64) and the CON group (n=64) at pre- and post-test 
*= Significant difference (p<.0005) post-test exercise weight scores of the EXP group (n=64) and the 
CON group (n=64) pre- to post-test 12 week RE intervention programme.    
4.3.5.2. BODY MASS INDEX  
ANCOVA was used to analyse body mass index between the EXP group (n=64) and the CON group 
(n=64) at pre- and post- test. The CON group (n=64) body mass index score was more than that of the 
EXP group (n=64) once corrected for pre body mass index.  There was a significant difference (p<.0005) 
between the EXP group (n=64) and the CON group (n=64) during post-test study. The EXP group (n=64) 
had a mean body mass index of 23.43 ± 5.475 kg/m2, while the CON group (n=64) had 24.63 ± 3.576 
kg/m2. Generally, body mass index scores for the EXP group (n=64) suggesting the 12 week RE 
significantly reduced body mass index in the EXP group (n=64). In the CON group (n=64) body mass 
index increased at post-test. Figure 6 below shows body mass index in the EXP group (n=64) and the 
CON group (n=64) pre-and post-test the 12 week RE intervention programme.     
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Figure 6: Body mass index scores for both the EXP group (n=64) and the CON group (n=64) at pre- and 
post-test 
*= Significant difference (p<.0005) post-test exercise body mass index scores of the EXP group (n=64) 
and the CON group (n=64) pre- to post-test 12 week RE intervention programme.    
 
4.3.5.3.PERCENTAGE BODY FAT   
ANCOVA was used to analyse percentage body fat between the EXP group (n=64) and the CON group 
(n=64) at pre- and post- test. The CON group (n=64) percentage body fat score was more than that of the 
EXP group (n=64) once corrected for pre percentage body fat.    
The percentage body fat decreased in the EXP group (n=64) from 21.26 ± 10.017 % to 19.82±9.522 % 
and increased in the CON group (n=64) from 22.62 ± 6.636 % to 22.70 ± 6.368 % pre-to-post-test 12 
week RE intervention programme. The reduction in percentage body fat suggests that the 12 week RE 
significantly reduced percentage body fat in the EXP group (n=64). Figure 7 shows the significant 
difference (p<.0005) in percentage body fat between the EXP group (n=64) and the CON group (n=64) 
from pre-to-post-test study.    
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Figure 7: Percentage body fat for the EXP group (n=64) and the CON group (n=64) pre- and post-test 
study:  
*= Significantly higher (p<.0005) mean percentage body fat in the CON group (n=64) than in the EXP 
group (n=64) post-test 12 week RE intervention programme.   
 
4.3.5.4.  FAT MASS    
ANCOVA was used to analyse fat mass between the EXP group (n=64) and the CON group (n=64) at 
pre- and post- test. The CON group (n=64) fat mass score was more than that of the EXP group (n=64) 
once corrected for pre percentage body fat.   Fat mass reduced more in the EXP group (n=64), from 15.67 
± 10.213 kg to 14.42 ± 9.528 kg, than in the CON group (n=64), where it reduced from 15.10 ± 5.523 kg 
to 14.67 ± 5.962 kg, pre- to post-test 12 week RE intervention programme. The greater reduction in fat 
mass for the EXP group (n=64) may suggest that the 12 week RE programme significantly reduced fat 
mass in the EXP group (n=64).  Figure 8 shows the significant difference (p<.0005) in fat mass between 
the EXP group (n=64) and the CON group (n=64) from pre-to-post-test study.     
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Figure 8: Fat mass for the EXP group (n=64) and the CON group (n=64) pre- and post-test study 
*= Significantly higher (p<.0005) mean fat mass reduction in the EXP group (n=64) than in the CON 
group (n=64) post-test 12 week RE intervention programme.   
 
4.3.5.5.  LEAN BODY MASS  
ANCOVA was used to analyse lean body mass between the EXP group (n=64) and the CON group 
(n=64) at pre- and post- test. The EXP group (n=64) lean body mass score was more than that of the CON 
group (n=64) once corrected for pre percentage body fat. Lean body mass increased in the EXP group 
(n=64) from 52.42 ± 8.360 kg to 53.07 ± 8.225 kg, suggest that the 12 week RE intervention programme 
significantly increased lean body mass in the EXP group (n=64). In the CON group (n=64) lean body 
mass reduced from 50.87 ± 6.340 kg to 47.43 ± 7.829 kg during the same period. Figure 9 shows the 
significant difference (p<.0005) in lean body mass between the EXP group (n=64) and the CON group 
(n=64) from pre-to-post-test study.    
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Figure 9: Lean body mass in the EXP group (n=64) and the CON group (n=64) pre- and post-test study  
*= Significantly higher (p<.0005) mean lean body mass in the EXP group (n=64) than in the CON group 
(n=64) post-test 12 week RE intervention programme. 
4.3.5.6. WAIST–TO-HIP RATIO    
ANCOVA was used to analyse waist-to-hip ratio between the EXP group (n=64) and the CON group 
(n=64) at pre- and post- test. The CON group (n=64) waist-to-hip ratio score was more than that of the 
EXP group (n=64) once corrected for pre waist-to-hip ratio. Waist-to-hip ratio decreases in the EXP 
group (n=64) from 0.8562 ± 0.891 to 0.8377 ± 0.080, suggesting that the 12 week RE programme 
significantly (p<.0005) decreased waist-to-hip ratio in the EXP group (n=64) than in the CON group 
(n=64) compared to the CON group (n=64), where it increased from 0.831 ± 0.104 to 0.844 ± 0.107 
during post- test. There was a decrease in mean waist and hip circumferences for the EXP group (n=64) 
participants in post-test 12 week RE intervention programme, from 84.34±11.551 cm to 82.20±11.029 cm 
and 99.00 ± 13.946 cm to 98.54 ± 13.570 cm respectively. The CON group (n=64) participants, however, 
experienced an increase in waist circumferences at post-test, from 77.90 ± 13.586 cm to 78.32 ± 13.506 
cm.   
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The hip circumferences for the CON group (n=64) participants decreased from 94.56cm to 93.81cm.  
Figure 10 below shows waist-to-hip ratio classification according to World Health Organisation per 
percentage of participants in the EXP group (n=64) and the CON group (n=64).  
   
Figure 10: Waist-to-hip ratio in the EXP group (n=64) and the CON group (n=64) pre- and post-test  
*= Significantly higher (p<.0005) mean waist-to-hip ratio scores in the EXP group (n=64) than in the 
CON group (n=64) post-test 12 week RE intervention programme.   
 
4.3.6. CHRONIC DISEASE RISKS 
4.3.6.1. TOTAL BLOOD CHOLESTEROL  
ANCOVA was used to analyse total blood cholesterol score between the EXP group (n=64) and the CON 
group (n=64) at pre- and post- test. The CON group (n=64) total blood cholesterol score was more than 
that of the EXP group (n=64) once corrected for pre total blood cholesterol. This allowed participants to 
be compared on an equal basis.  Total blood cholesterol decreases in the EXP group (n=64) from 4.440 ± 
0.526 mmol/l to 4.240 ± 0.488 mmol/l, suggesting that the 12 week RE programme significantly 
(p<.0005) decreased total blood cholesterol in the EXP group (n=64) than in the CON group (n=64) 
which increased from 4.556 ± 0.445 mmol/l to 4.672 ± 0.497 mmol/l.  The Table XVII below shows 
mean total blood cholesterol for the EXP group (n=64) and the CON group (n=64) at pre-and post-test 
(p<.0005).  
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Table xvii : Mean total blood cholesterol pre-post-test in the EXP group (n=64) and the CON group 
(n=64)    
                                                          p<.0005 
PARAMETER EXP(n=64) CON (n=64) 
PRE-TEST POST-TEST PRE-TEST POST-TEST 
Fasting Total Blood Cholesterol 
(Mmol/L) 
4.440(±0.526) 4.240(±0.488) 4.55(±0.445) 4.672(±0.497) 
 
4.3.6.2. FASTING BLOOD GLUCOSE  
ANCOVA was used to analyse fasting blood glucose between the EXP group (n=64) and the CON group 
(n=64) at pre- and post- test. The CON group (n=64) fasting blood glucose score was more than that of 
the EXP group (n=64) once corrected for pre fasting blood glucose. This allowed participants to be 
compared on an equal basis.  Fasting blood glucose decreases in the EXP group (n=64) from 4.440 ± 
0.445 mmol/l to 4.240 ± 0.488 mmol/l, suggesting that the 12 week RE programme significantly 
(p<.0005) decreased fasting blood glucose in EXP group (n=64) than in the CON group (n=64).  The 
Table XVIII below shows mean fasting blood glucose for the EXP group (n=64) and the CON group 
(n=64) at pre-and post-test.  
Table xviii: Mean fasting blood glucose pre-post-test for the EXP group (n=64) and the CON group 
(n=64) 
                                                      p<.0005 
PARAMETER EXP(n=64) CON (n=64) 
PRE-TEST POST-TEST PRE-TEST POST-TEST 
Fasting Blood Glucose (Mmol/L) 3.65(±2.722) 2.49(±1.846) 3.68(±0.711) 3.98(±0.818) 
 
4.3.6.3. BLOOD PRESSURE 
The Chi-square test of independence was used to determine whether a significant relationship existed 
between two categorical variables for diastolic and systolic pressure represented in cross tabulation.   
Blood pressure scores were categorical hence applying chi-square test of independence allowed for 
analysing the relationship between pre-and post-test blood pressure.The EXP group (n=64) mean systolic 
and diastolic blood pressure reduced from 126.7 ± 21.326 mmHg to 121.5 ± 21.395 mmHg and from 
84.53 ± 13.236 mmHg to 82.92 ± 13.264 mmHg respectively, following the 12 week RE intervention 
programme.  
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In comparison, the CON group (n=64) mean systolic blood pressure and diastolic blood pressure 
increased during the same period from 108.2 ± 10.126 mmHg to 110.7 ± 10.594 mmHg and 79.0 ± 6.410 
mmHg to 81.43 ±6.934 mmHg respectively.  In the EXP group (n=64) a significant relationship between 
pre-and post-test scores existed (p<.0005). In this case, a significant 66% of those with hypertension stage 
2 at pre-test were classified as having hypertension stage 1 at post-test. This indicates an improvement in 
blood pressure following the 12 week RE intervention. In comparison to the CON group (n=64), 100% of 
those with pre-hypertension in pre-test still had pre-hypertension at post-test.  
Figure 11 below shows blood pressure classifications of both groups pre-and-post-test study. 
Figure 11: Blood pressure in the EXP group (n=64) and the CON group (n=64) post-test  
*= Significantly higher (p<.0005) percentage of participants with prehypertension in the CON group 
(n=64) than in the EXP group (n=64) post-test 12 week RE intervention programme. 
   
4.3.7. STRENGTH  
Individuals’ 1RM were used to determine strength levels of each participant at pre-and-post-test. There 
were notable changes in mean strength levels between the EXP group (n=64) participants and those in the 
CON group (n=64). The Table XIX shows a summary of mean strength levels of both groups pre-and-
post-test.  
 
Table xix: Mean strength levels pre-post-test for the EXP group (n =64) and the CON group (n =64) 
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                                                    p<.0005 
PARAMETER EXP(n=64) CON (n=64) 
PRE-TEST POST-TEST PRE-TEST POST-TEST 
Bench press (kg) 18.5(±3.99) 22.4(±4.921) 18.8(±7.130) 16.8(±7.348) 
Squats (kg) 34.00(±9.63) 60.00(±9.631) 27.3(±9.130) 24.5(±8.813) 
Bicep curl (kg) 19.71(±6.29) 27.546(±5.933) 19.3(±6.142) 17.4(±5.895) 
Leg curl (kg) 31.26(±9.13) 42.7(±10.025) 26.8(±8.287) 23.2(±8.250) 
 
4.3.7.1. BENCH PRESS  
ANCOVA was used to analyse bench press strength between the EXP group (n=64) and the CON group 
(n=64) at pre- and post- test. The EXP group (n=64) bench press strength score was more than that of the 
CON group (n=64) once corrected for pre bench press strength. There was a significant increase 
(p<.0005) in mean bench press-lifted weight by the EXP group (n=64) participants from 18.5 ± 3.99 kg 
pre-test, to 22.4 ± 4.921 kg post-test indicating an improvement in bench press strength following the 
exercise intervention . In comparison, the CON group (n=64) mean bench press-lifted weight reduced 
from 18.8 ± 7.130 kg at pre-test 12 week RE intervention programme to 16.8 ± 7.348 kg during post-test 
measurement.  Figure 12, below, shows the mean strength difference in the EXP group (n=64) and the 
CON group (n=64) participants.   
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Figure 12: Bench press in the EXP group (n=64) and the CON group (n=64) pre- and post-test study 
*= Significantly higher (p<.0005) mean bench press strength in the EXP group (n=64) than in the CON 
group (n=64) post-test the 12 week RE intervention programme.   
4.3.7.2. SQUAT 
ANCOVA was used to analyse squat strength between the EXP group (n=64) and the CON group (n=64) 
at pre- and post- test. EXP group (n=64) squat strength score was more than that of the CON group 
(n=64) once corrected for pre squat strength. There was a significant increase (p<.0005) in the mean 
squat-lifted weight by the EXP group (n=64) participants from 34.00 ± 9.63 kg at pre-test to 60.00kg ± 
9.631 kg during the post-test. This indicated an improvement in squat strength following the exercise 
intervention in the EXP group (n=64). In contrast, the CON group (n=64) mean squat-lifted weight 
decreased from a pre-test measurement of 27.3 ± 9.130 kg to a post-test measurement of 24.5 ± 8.813 kg. 
Figure 13 shows the differences in the mean squat-lifted weight between the EXP group (n=64) and the 
CON group (n=64) participants, pre- and post-test period.     
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Figure 13: Squat strength in the EXP group (n=64) and the CON group (n=64) pre- and post-test study 
*= Significantly higher (p<.0005) mean squat strength in the EXP group (n=64) than in the CON group 
(n=64) post-test 12 week RE intervention programme.   
4.3.7.3. BICEP CURL 
ANCOVA was used to analyse bicep curl strength between the EXP group (n=64) and the CON group 
(n=64) at pre- and post- test. The EXP group (n=64) bicep curl strength score was more than that of the 
CON group (n=64) once corrected for pre bicep curl strength. There was a significant increase (p<.0005) 
in the mean bicep curl lifted weight by participants in the EXP group (n=64) and increased from 19.71 ± 
6.29 kg at pre-test, to 27.546 ± 5.933 kg post-test. This indicated an improvement in bicep curl strength 
following the exercise intervention in the EXP group (n=64). The CON group (n=64) participants had a 
mean bicep curl lifted-weight of 19.3 ± 6.142 kg at pre-test. At post-test, it decreased to 17.4 ± 5.895 kg. 
Figure 14 shows changes in the mean bicep curl-lifted weight of the EXP group (n=64) and in the CON 
group (n=64) participants from pre- to post-test.   
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Figure 14: Bicep curl strength in the EXP group (n=64) and the CON group (n=64) pre- and post-test 
study 
*= Significantly higher (p<.0005) mean bicep curl strength in the EXP group (n=64) than in the CON 
group (n=64) post-test 12 week RE intervention programme.    
4.3.7.4. LEG CURL 
ANCOVA was used to analyse leg curl strength between the EXP group (n=64) and the CON group 
(n=64) at pre- and post- test. The EXP group (n=64) leg curl strength score was more than that of the 
CON group (n=64) once corrected for pre leg curl strength. There was a significant increase (p<.0005) in 
the leg curl-lifted weight for the EXP group (n=64) participants following the 12 week RE intervention 
programme, from 31.26 ± 9.13 kg to 42.7 ± 10.025 kg, pre- to post-test. This indicated an improvement in 
leg curl strength following the exercise intervention in the EXP group (n=64). In comparison, the CON 
group (n=64) participants’ mean leg curl-lifted weight decreased from 26.8 ± 8.287 kg to 23.2 ± 8.250 kg 
in the pre- to post-test 12 week RE intervention programme. Figure 15 shows the difference in mean leg 
curl weight, pre-and-post-test period.    
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Figure 15: Leg curl strength in the EXP group (n=64) and the CON group (n=64) pre- and post-test study 
*= Significantly higher (p<.0005) mean leg curl strength in the EXP group (n=64) than in the CON group 
(n=64) post-test the 12 week RE intervention programme.    
4.3.8. EFFECT OF GENDER 
ANCOVA was applied in order to be able to test if the post-test scores differ by gender and needed to be 
counterbalanced by including the pre-test scores. Gender was used as the fixed factor to test if gender had 
a significant effect on post-test scores after correcting for the pre-test scores. Gender, instead of group, 
was used as a fixed factor and analysis was repeated for the two groups separately. The results showed 
that there was significant (p-value = NS) effect of gender on fasting blood glucose and fasting total blood 
cholesterol scores at post-test for both groups. There was also no significant difference (p-value = NS) 
between genders in blood pressure scores at pre-to post-test for the CON group (n=64) participants.   
Gender did not have an effect in either group on bench press, squat, leg curl and bicep curl strength at pre- 
and post-test. There was no effect (p-value = NS) of gender on leg curl strength was noted for the CON 
group (n=64) in post-test scores.    
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4.3.9. RELATIONSHIP BETWEEN BODY COMPOSITION, PERIOD ON ART AND 
CHRONIC DISEASE RISK POINTERS  
In analysing the relationship between body composition, ART duration and chronic disease risk 
indicators, Pearson’s correlation was applied to test for associations between them. The blood pressure 
classification variable was ordinal but not continuous and therefore to analyse associations, Spearman’s 
rho was applied. The Tables XX and XXI below show relationships between study variables  
Table xx: Relationships between study variables in the CON group (n=64) 
CON group (n=64) at pre-test 
Association between variables Statistical Relationship Significance 
Length of time taking ART and weight r = -0.033 p = 0.797 
Length of time on ART and lean body mass r = -0.095 p = 0.456 
Body fat and lean body mass r = -0.272 p = 0.029 
Body mass index and percentage body fat r = 0.465 p = 0.001 
Body mass index and lean body mass r = 0.313 p = 0.025 
Weight and percentage body fat r = 0.0282  p = 0.024 
Weight and lean body mass r = 0.742  p = 0.001 
Fasting blood glucose and fasting total blood cholesterol r = 0.698  p = 0.000 
 
Table xxi: Relationships between study variables in EXP group (n=64) 
EXP group (n=64) at post-test 
Linear relationships between variables Statistical Relationship Significance 
Weight and body mass index r = 0.940  p = .000 
Weight and lean body mass  r = 0.724 p = .000 
Body fat and lean body mass r = 0.831   p = .000 
Body mass index and percentage body fat r = 0.803 p = .000 
Body mass index and lean body mass r = 0.689  p = .000 
Blood pressure and weight r = 0.389  p = 0.01 
Blood pressure and body mass index r = 0.355  p = 0.04 
Blood pressure and percentage body fat r = 0.287  p = .022 
Fasting blood glucose and fasting total blood cholesterol r = -0.258  p = .040 
Years taking ART and waist-to-hip r = -0.272  p = .030 
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4.4. DISCUSSION 
This study demonstrates that the 12 week RE intervention programme on PLWHA receiving ART 
improved their strength, chronic disease risks and body composition.  The EXP group (n=64) attained the 
exercise benefits of the 12 week RE intervention programme than the CON group (n=64) participants. 
The CON group (n=64) had a higher chronic disease risk, body composition and low strength scores 
compared to the EXP group (n=64) at post-test 12 week RE intervention programme. In both groups the 
participants had less intake of fruits and vegetables, while the EXP group (n=64) unexpectedly had higher 
intake of bread, cereal, rice and pasta.   There was no effect of gender relating to response effects to the 
12 week RE intervention programme. 
Resistance exercise have been used previously to positively address chronic disease risks, body 
composition and strength scores in PLWHA (Quiles and Ortiz, 2017; Grace et al., 2015; Hand et al, 2009 
; Roubenoff  et al., 2002). These studies involved exclusive RE and or in combination with an aerobic 
component  (Leach et al., 2015).  Body composition has been positively altered following RE intervention 
programmes and strength (Anderson, 2006; Phillips et al., 2006; Yarasheski et al., 2001; Hamid and 
Rajah, 2015; Souza et al., 2011) . In this study there were encouraging responses in strength as it was 
discovered that it improved by ≥40% with chronic disease risks and body composition scores also 
improving following the 12 week RE intervention programme. 
4.4.1. RESISTANCE EXERCISE AND RESPONSES IN STRENGTH  
The study proved that the 12 week RE intervention programme improves strength in PLWHA. This 
finding is comparable to other studies involving exclusive RE or in combination with other interventions 
(Garcia et al., 2014; Hamid and Rajah, 2015; Mendes et al., 2013; Roubenoff and Wilson, 2001; Souza et 
al., 2011).  This confirms the  evidence that RE produces a dose-response effect on participants (ACSM, 
2014, p.9).  The study periods observed by various authors ranged from six months to a year and strength 
increased in all cases. The studies  also related to the effect that the RE doses corresponded to 
participants’ 1RMs and progressively increased loads (ACSM, 2014, p.10). The current study observed 
progressive loading and strength increased from a range of about +4kg to +25kg (for the bench press, 
bicep curl, leg curl and squat). The findings are similar to studies involving exclusive RE for PLWHA in 
other countries, (Hamid and Rajah, 2015; Roubenoff and Wilson, 2001; Souza et al., 2011).  
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The present study relates to an exclusively RE study conducted by Roubenoff and Wilson (2001). Their 
study recruited an ethnically mixed group of 25 participants (with one female participant) and was a 
longitudinal study for 16 weeks. Roubenoff  and Wilson (2001) showed that RE increased strength of 
PLWHA by 30% to 50% using 1RM tests. The use of a 12 week RE intervention programme in the 
present study improved strength of the EXP group (n=64) participants irrespective of gender. In their RE 
programme, Roubenoff and Wilson, (2001)  included double leg presses; leg extensions, seated chest 
presses; and the use of a seated rowing machine and Keiser pneumatic resistance machines. In the current 
study, participants however, performed squats, bench presses, bicep curls, and leg curls using free weights 
according to each individual’s 1RM.   
In the present study, group participants performed three sets of ten repetitions at 80% of individual 1RM 
by the 12th week. In a similar approach, Roubenoff and Wilson (2001) participants performed three sets 
of eight repetitions at 80% of their 1RM in the final training period. 
Although, Roubenoff and Wilson (2001), had no CON group, the present study had the CON group 
(n=64) for comparison purposes.  The current study findings relate to another exclusive RE programme 
for PLWHA by Hamid and Rajah (2015) in India.  These researchers used elastic bands in the EXP group 
and RE without elastic bands in the CON group for 12 weeks.  Although, there were no differences in 
other study variables, the EXP group and the CON group showed significant improvements in peak  
shoulder lift strength (the EXP group, p = 0.001; p = 0.001; the CON group, p = 0.008; p = 0.016)  
(Hamid and Rajah, 2015). In the current study, the CON group (n=64) participants did not take part in the 
12 week RE intervention programme. In comparison, the mean strength levels of the CON group (n=64) 
participants in the current study as determined by their 1RM tests and decreased over the 12 weeks for 
squat (-2.8125kg), bench press (-3.0312kg), bicep curls (-1.9531kg) and leg curls (-3.1719kg).   
In relation to the current study Souza et al. (2011) conducted a RE programme with PLWHA that had the 
EXP group  and  the CON group. The participants trained twice per week, with supervision, for one year. 
In their reported results, the EXP group had their strength scores increased by about 1.52-2.33 times than 
at baseline independent of gender, age or pre-test physical fitness scores. Resistance exercise has also 
proved that they are effective in developing strength when they are conducted in combination with other 
interventions. It is RE that strengthens muscles. In affirmation, Mendes et al. (2013) conducted a 
combined aerobic (at progressively increased range of 50-80% of heart rate reserve) and RE (three sets of 
eight to ten reps up to 80% of 1-RM), programme for 24weeks.   
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Strength and fitness scores in the PLWHA increased significantly (P< 0.0001), (Mendes et al., 2013). 
Garcia et al. (2014), also conducted a combined exercise programme consisting of RE plus aerobic 
training (60 min sessions, three times per week) for 20 weeks. The resistance exercise included the ½ 
squat, bench press, 45° leg press, sit-ups, seated row, leg curl, shoulder press, triceps pulley, biceps curl, 
seated calf raise and abdominal crunches (Garcia et al., 2014). There were marked improvements in 
muscle strength for the 45° leg press, seated row, triceps extension, abdominal muscle endurance and VO2 
max after the 24 week training period. 
Resistance Exercise stimulates muscle growth leading to increased strength and action of growth-
promoting hormones (Evans, 2004). Skeletal muscles become metabolically active due to muscle cell 
growth and its increased ability to make new proteins (Evans, 2004). Scholars have noticed increases in 
strength, weight, lean body mass and functional performance in PLWHA following RE intervention 
programmes though some involved a combination with anabolic steroids (Bhasin et al., 2000; Roubenoff, 
2002; Yarasheski and Roubenoff, 2001; Yarasheski et al, 2001). Therefore, preventing sarcopenia and 
pre-sarcopenia through RE intervention programmes, reduces morbidity and mortalities among PLWHA 
(Bhasin et al., 2000; Marcell, 2003; Waltson, 2012). The present study was not different since participants 
in the EXP group (n=64) increased their strength scores post-test 12 week RE intervention programme.  
This attests that the current study conforms to similar studies in other countries regarding noting increases 
in strength among PLWHA following a resistance training programme. 
4.4.2. BODY COMPOSITION RESPONSES TO RESISTANCE EXERCISE 
It is evident that RE improve lean body mass. Roubenoff and Wilson (2001) found that significant 
increases were recorded in lean body mass (1.75 (+/- 1.94) kg) of PLWHA similar to other studies 
following RE ( Grace et al., 2015; Gomes-Neto et al., 2013 and Quiles and Ortiz, 2017). The present 
study also confirms to noticeable increases in lean body mass following the 12 week RE intervention 
programme in PLWHA. The findings may be compared to Miller.et.al. (2010) study.  They conducted a 
non-randomised resistance and aerobic exercise intervention with 17 participants, for 12 weeks, twice a 
week.  Lean body mass increased compared to baseline scores, with medium changes in trunk adiposity. 
Although there may be parallels to this study, Miller.et.al. (2010) had included both aerobic and RE.  
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Agin  et al. (2001) found that exclusive resistance training increase body cell mass, among other 
parameters. Dudgeon et al. (2006)  similarly noted that RE programmes have the potential to be a possible 
alternate to medicinal treatments in improving lean body mass in PLWHA. Walker et al. (2013) 
concluded that RE programmes provide important health benefits in improving overall body composition 
levels. The current study showed that the 12-week RE intervention programme improved body 
composition in the PLWHA in Zimbabwe.  
The results from the current study noted the incidence of overweight and obesity among PLWHA in both 
the CON group (n=64) and the EXP group (n=64). The increased body mass index scores were recorded 
in the CON group (n=64) and could be as a result of not taking part in the 12 week RE intervention 
programme, while receiving ART. The higher scores in body mass indexes may have been caused by the 
consumption of excessive dietary fat, oils and sweets noted at 51.2% in the CON group (n=64) in current 
study. The EXP group (n=64) had a fairly high intake of dietary fat, oils and sweets recorded at 42.2% in 
the current study.  The present results are similar to those in a study done in Brazil by Jaime et al. (2006), 
who noted a 45.7% prevalence of central obesity among recruited PLWHA. Furthermore, higher body 
mass indexes were related to greater ingestion of lipids  (Jaime et al., 2006). The consumption rate 
showed that, for every intake increase of 10g in lipids, the chance of central obesity increased 1.28 times 
(Jaime et al., 2006). The findings resonate with findings of the current study with reference to the CON 
group (n=64) participants.    
Erlandson et al. (2016) noted that Black and Hispanic ethnicity was associated with greater body mass 
index and high waist circumferences in PLWHA. All the participants in the current study similarly were 
of Black ethnic origin, with a higher percentage being women.  McCormick et al. (2014) concluded in 
their study that women of African origin were most affected, with 49% being obese, and a further 32% 
overweight (body mass index 25–30 kg/m2). They investigated increasing obesity in 50 female PLWHA 
receiving ART in SSA from 2011 to 2012. Singh et al (2013) concluded that increased body mass 
indexes, waist-to-hip ratios and waist circumferences among PLWHA receiving ART are closely 
associated with developing CVD risks. Therefore chances of this occurring in Zimbabwe may not be 
ignored as confirmed by results of the current study. The present results showed that the mean weight for 
the CON group (n=64) participants increased from pre- to post- test since they did not take part in the 12 
week RE intervention programme. Therefore, they may have added more fat mass than lean body mass. 
This in particular relates to a study by Denue et al. (2013) in Nigeria following assessment of body mass 
index scores in PLWHA over 30 months and found that 83.1% had gained weight.  
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Furthermore, Guehi et al. (2016) in Côte d’Ivoire researched on the high prevalence of overweight and 
obesity among PLWHA, pre- and-post 24 months receiving ART.  They found that, among the research 
participants 19.7 % were overweight and 7.2 % were obese at baseline with the factors associated with the 
condition being female and receiving ART for 5 years. The current study relates well, since females 
constituted 85.9% and 71.9% in the CON group (n=64) and the EXP group (n=64), respectively; had an 
average of five years receiving ART.   
The present study has showed that PLWHA reflected a 21.1% of the participants ate at fast food 
restaurants daily or at least more than once a week. The CON group (n=64) participants recorded a higher 
consumption of bread, cereal, rice and pasta, which may have resulted in increased body mass index 
values. Issues of underweight were also evident in the current study since minimum body mass index 
values of 18.30 kg/m2 and 15 kg/m2 in the CON group (n=64) and the EXP group (n=64), respectively. 
Accordingly, Takarinda et.al (2017) alluded to the fact that Zimbabwe faced both under nutrition and 
overweight disorders among PLWHA which were said to be related to increased incidence of chronic 
disease and deaths. The authors also referred to this trend as reflecting a change in the pattern of HIV, 
from being a highly infectious and fatal disease to a chronic manageable condition.  
The research findings of  current study conform to  a study by Engelson et al. (2006). They revealed 
improvements in body mass index and weight scores following RE intervention for PLWHA. Findings in 
the current study indicated that there was prevalence of high waist-to-hip ratios among PLWHA. This 
may be attributed to poor diet, lack of exercise and lack of nutritional knowledge and increases in waist 
circumference scores at post-test in the CON group (n=64).  
The waist-to-hip ratio significantly reduced in the CON group (n=64) following the 12 week RE 
intervention programme. The findings are in support of a study conducted by Dusingize et al. (2013) in 
Rwanda. The authors noted that PLWHA had mean waist-to-hip ratios ranging between 0.88 ± 0.07; 0.89 
± 0.08 and 0.87 ± 0.08 (p = 0.21). The sedentary lifestyles of individuals in the current CON group 
(n=64), are associated with a greater risk of heart disease, according to the (WHO, 2013). The findings 
are in line with a study conducted by (Romancini et al., 2012).  
They investigated the levels of physical activity and metabolic alterations in 65 PLWHA and found out 
that 64.6% were sedentary, with only 35.4% active, after receiving ART for at least five years (Romancini 
et al., 2012) 
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Yarasheski et al. (2001) findings further reveal that whole-body lean mass increased by 2.5% (1.4 kg), in 
those with wasting condition, following 64 sessions of resistance training by 18 asymptomatic HIV-
infected males without lipodystrophy, receiving ART. Similarly, the present 12 week RE intervention 
programme reduced body mass index scores in the EXP group (n=64) participants as well as improved 
weight scores and wait-to-hip ratios in PLWHA. The fat mass scores decreased significantly in the EXP 
group (n=64) (1.25%) following the 12 week RE intervention programme. Furthermore, there was a 
significant improvement in mean percentage body fat, lean body mass suggesting they may have been 
shedding off fat. By contrast, the mean percentage body fat in the CON group (n=64) participants 
increased, lean body mass decreased suggesting they may have been losing muscle and amassing fat. The 
current findings therefore, relate to those of other similar studies (Grace et al., 2015; Gomes-Neto et al., 
2013; Quiles and Ortiz, 2017).    
4.4.3. EFFECT OF RESISTANCE EXERCISE ON CHRONIC DISEASE RISKS 
The findings in the present 12 week RE intervention programme show that they relate to other studies that 
have involved RE for PLWHA receiving ART and noticed improvements in chronic disease scores 
(Garcia et al., 2014; Lindegaard et al., 2008; Mendes, 2011; Souza et al., 2011; Yarasheski et al., 2001).  
The 12 week RE intervention programme reduced fasting blood glucose and fasting total blood 
cholesterol levels in PLWHA. Therefore, the intervention can be said to have improved the body systems 
of PLWHA in using and controlling blood glucose. The ability of the body to utilize and control blood 
glucose reduced the risk of suffering from type 2 diabetes in PLWHA (Colberg, 2010).  
Therefore RE increase uptake of glucose through transfer, carriage through the muscle tissue and 
intracellular fluid during glycolysis process (Boule et al., 2005; Colberg, 2010; Sylow.et al., 2017).  
Participating in a RE intervention programme stimulates the body to shift its source of energy reliance 
from free fatty acids to fat, muscle glycogen and glucose (Sylow et al., 2017). The accompanying chronic 
responses to REs are increase in muscle mass known as hypertrophy which increases the amount of 
glucose transporters influencing blood glucose utilisation and metabolism at rest or during physical 
activities (Sylow et al., 2017).  
This also increase the ability to attain glucose homeostasis among participants (Sylow et al., 2017). The 
current 12 week RE intervention improved the fasting total blood cholesterol in the body contributing to 
the reduction of chronic disease incidence (ACSM, 2014:294).   
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The findings in the present study relate to Souza et al. (2011) following an exclusively progressive RE 
intervention on PLWHA. Souza et al. (2011) found that the RE intervention improved their fasting blood 
glucose levels. Further, it also showed a tendency to reduce blood lipids in PLWHA after a year’s training 
programme whose study period was different from the current study. Although the improvements were 
more pronounced among those not using protease inhibitors (Souza et al., 2011), the present study also 
noted the improvements in fasting total cholesterol on a shorter period of time.   
Yarasheski et al. (2001), also conducted a RE programme with PLWHA. Although fasting serum 
triglyceride concentrations were reduced, fasting total cholesterol, insulin and glucagon concentrations 
were not affected after the exercise training programme. Study designs, participants’ age, number of 
participants, family background and duration of study, medication, exercise dose and diets may influence 
different findings among researchers. The variances in blood lipid findings between Yarasheski et al. 
(2001) study and the present study might be due to variances in the research designs and the fact that the 
present study only focused on fasting total blood cholesterol and not low density lipoprotein-cholesterol 
or high density lipoprotein-cholesterol levels specifically. 
The current study concurs to noting improvements in strength as was discovered by Hamid and Rajah 
(2015) following a RE programme. However the current study further discovered that blood glucose and 
fasting total blood cholesterol improves besides strength as the only variable that can be focused on when 
conducting RE for PLWHA.  Other study finding with similar results as the current 12 week RE 
intervention programme involved an aerobic component (Mutimura et al., 2008; Thoni et al., 2002).   
Lindegaard et al. (2008) conducted a supervised resistance and an endurance training three times a week 
for 16 weeks. The researchers found that RE decreased triglycerides, free fatty acids, and increased high-
density lipoprotein cholesterol. The current study concurred to the study by Lindegaard et al. (2008) 
although this current study managed to obtain similar outcomes in 12 weeks using RE exclusively.  
Mendes (2011) then conducted a 12-week progressive RE programme with an aerobic component on an 
HIV-infected Caucasian woman. Similarly, findings showed that the participant exhibited reductions in 
her total triglycerides (9.9%), total cholesterol (12.0%) and low-density lipoprotein cholesterol (8.6%) 
after the 12 weeks. In similar discoveries the present study although with a larger percentage of women 
participants there was a decrease in total fasting blood cholesterol among males as well following an 
exclusive RE programme.   
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Martinez et al. (2007) and Teklay et al. (2013) reported that smoking and alcohol are risk factors that 
accelerate the adverse hepatic chronic disease risks in PLWHA receiving ART. The current study also 
discovered that there were the same risk factors whose prevalence was beginning to be noted among study 
participants in Zimbabwe. Garcia et al. (2014), following a combined resistance and aerobic exercise 
training programme on PLWHA found that blood glucose remained stable and total cholesterol decreased.  
The parallels may be drawn with the current study since it was discovered that the total fasting blood 
glucose levels decreased following a 12 week PE programme.  However Garcia et al. (2014) involved a 
combined resistance and aerobic exercise program while the current study only involved exclusive RE. 
Further, this study discovered that fasting total blood cholesterol decreased after only using an exclusive 
RE programme compared to a combined aerobic and RE study carried out by (Garcia et al., 2014).  Junior 
et al. (2010) in Pernambuco Brazil, found that the recruited PLWHA had high fasting total blood 
cholesterol (> 200 mmol/l), high blood glucose levels (> 100 mmol/l), and triglyceride values (> 150 
mmol/l) which were associated with hypertension. However, Dolan et al. (2006), following an aerobic 
and resistance training programme with PLWHA found no significant changes in blood pressure.  
The current study then discovered that blood pressure decreased following the 12 week RE intervention 
programme.  Similarly Baechle (2008:111) asserted that, resting blood pressure may decrease slightly or 
not change, at all following resistance training. This study therefore discovered that both systolic and 
diastolic blood pressure decreased by 2% to 4% suggesting the positive effect of the RE programme.   
In current study it was further noted that the decrease in blood pressure were greatest in those individuals 
with initial high blood pressure scores and a number of participants with hypertension stage 2 improved 
to hypertension stage. However, recent studies by O’Brien et al. (2017) and Quiles and Ortiz (2017) did 
not investigate the effect of RE on blood pressure in PLWHA.  
Generally, the current study findings were not different to studies in other countries.   
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4.5. LIMITATIONS 
The sample size of current study was small and the period was short. The use skinfolds as a field 
measurement to obtain body composition is dependent on measurer’s experience and may have 
contributed as a limitation to the study since no advanced tool was used for this variable. 
The findings are not a one size fit all since participants were only recruited from high density community 
of Harare.   Counter activities and other confounding issues made participants and research assistants miss 
or skip some sessions as the economic situation was not very favourable.    
The participants were asked to be in a fasted state prior to measuring fasting total blood cholesterol and 
fasting blood glucose.  However, it was difficult to measure participants’ compliance with such a request. 
Hence participants that would have not heeded the request meant distortions in measured variables.  
4.6. CONCLUSION    
The study established the effect of a 12-week RE programme on body composition in PLWHA in 
Zimbabwe. The findings in this study are comparable to those done in other countries. The RE 
intervention programme had a positive effect on participants. Improvements were noticeable in body mass 
index, waist-to-hip ratios, percent body fat, lean body mass, fat mass, strength, blood pressure, blood 
cholesterol and blood glucose among PLWHA. The PLWHA in Zimbabwe seem to have been exposed to 
urbanisation hence health and dietary lifestyles may imitate those of developed nations. The use of ART 
further exposes PLWHA to chronic disease risks. Resistance exercise for PLWHA in Zimbabwe receiving 
ART is probably the next feasible option to address chronic disease risks.     
 
 
 
 
 
 
  
96 
 
 
CHAPTER FIVE: CONCLUSION AND RECOMMENDATIONS 
 
5.1. CONCLUSION  
The findings of various studies support the role of exercise in benefiting PLWHA receiving ART. The 
findings of these studies show that ART increases life expectancy (Ciccolo et al., 2014). However, 
chronic disease risks (lipodystrophy, high blood pressure, high fasting blood glucose, increased fasting 
total blood cholesterol, high waist-to-hip ratio scores, overweight, obesity, reduced mineral bone density, 
osteopenia) begin to affect PLWHA after they have been receiving ART in the middle to long term. The 
data presented may serve to alert Sub-Saharan African nations, where significant numbers of individuals 
receive ART. Non-communicable diseases in PLWHA raise health bills, unless deliberate measures are 
put in place to lessen their destructive effect. The failure to address such an epidemiological trend will 
undermine current efforts aimed at increasing life expectancy of PLWHA in Africa. The reviewed studies 
show that current expectations are for PLWHA to utilise natural methods, like RE, as a strategy to cope 
with chronic disease risks (Ciccolo et al., 2004). They show that utmost concern needs to be taken in 
managing chronic disease risks in the PLWHA receiving ART. It is believed that this should be done by 
focusing on increasing their life expectancy through the inclusion of exercise intervention programmes 
(Stein, 2010). A number of studies have thus been conducted to examine the effect of exercise on the 
utmost self-reported chronic disease risks in PLWHA receiving ART.  
Therefore, it is increasingly becoming more imperative to come up with RE programme strategies for 
PLWHA to enhance their quality of life and body composition (Ciccolo et al., 2004). The chronic disease 
risks in PLWHA which include changes in body composition, call for non-medicinal interventions to 
limit the burdens on the already drug-dependent body of an HIV-infected individual. Exercise is seen as a 
valuable adjunct therapy to ART in PLWHA.  It positively addresses body composition, chronic disease 
risks and improves strength in PLWHA. Resistance exercise is also ideal for PLWHA.   
There is limited data in Africa, particularly in Zimbabwe, concerning the use of RE to combat chronic 
disease risks in PLWHA receiving ART. It shows that more research is needed in Zimbabwe to examine 
the effect of complementary lifestyle strategy, involving RE, to improve strength and chronic disease 
risks in PLWHA.   
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5.2. RECOMMENDATIONS 
 
It is recommended that further studies on RE for PLWHA be done in Zimbabwe to check on the validity 
and reliability of these interventions. The studies to follow may also include profiling the drives of 
PLWHA to adhere to an exercise as a critical variable for it indicates sustainability of such programs in 
communities. 
 A home based RE programme for PLWHA may also be structured basing on the current study design so 
as further cater for this population in the comfort of their own homes without incurring extra transport and 
nutritional provisions. This would limit challenges faced by the current research team to provide these 
during and after sessions since the 2015-16 economic environments were challenging and relying on a 
college grant whose exchange rate was pegged against a stronger currency.   
The other recommendation is that a similar study may be done using advanced tools to assess body 
composition such as dual energy x-ray absorptiometry since  in this study only the skinfold calliper were 
used. These are field measurements that rely on experience of a qualified Kinathropometrist. 
It is recommended that for studies of this nature in future the research team should come up with a 
resource funding option so as to cater for food and transport reimbursements commensurate with 
prevailing economic conditions.   
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APPENDIX G: INFORMATION SHEET 
THE EFFECT OF RESISTANCE EXERCISE ON HIV-INFECTED PATIENTS 
TAKING ANTIRETROVIRAL THERAPY (ART) IN ZIMBABWE 
 
INFORMATION SHEET FOR PARTICIPANTS 
I hereby greet and welcome you to this study. Victor Mbayo is my name and undertaking a Masters’ 
degree with University of KwaZulu Natal. I am studying on the above stated topic. I thank you for 
showing an interest in this project. Please read this information sheet carefully before deciding whether or 
not to participate.  If you decide to participate we thank you.  If you decide not to take part there will be 
no disadvantage to you of any kind and we thank you for considering this request.   
  
This study involves preliminary screening for selection purposes. If you decide to participate, you will be 
required to fill in a questionnaire to obtain your general information, dietary background and physical 
activity readiness. You will also undergo some preliminary baseline procedures to determine your blood 
sugar, blood lipids (good and bad fats), percentage body fat and body dimensions (like size, shape, mass, 
height, percentage body fat) using a skinfold calliper, tape measure and steel ruler. Once these baseline 
checks are done, following a medical doctor’s approval you will be required to undertake a weight lifting 
procedure to determine the maximum weight that you can lift only once without experiencing fatigue 
while applying maximum effort (i.e. 100% exertion). This is known as your one repetition maximum 
(1RM). You will randomly be allocated to an experiment or control group. Therefore, being allocated to 
an experiment group one will undergo a resistance exercise (supervised weight lifting) programme twice a 
week for 12 weeks at a local gym. Then, if allocated to a control group you will not be involved in the 
supervised weight lifting (resistance) exercise programme during the 12 week period. The random 
assigning to a control or experiment group is necessary to allow everyone a chance to be allocated to any 
of the groups without bias. This also provides a significant opportunity for the study to investigate the 
effect of resistance exercise on individuals taking antiretroviral treatment.  
It is important to note that, those allocated to a control group will benefit greatly from the study although 
they will not take part in the exercise training.  
This is so because the developed program and gym membership cards will be exclusively availed to all 
participants after the study. Therefore, if benefits to resistance training are shown then the control group 
will also be offered the intervention. You will be assigned a numerical identification code rather than 
using your actual name so to safeguard anonymity.     
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What is the Aim of the Project? 
This project is being undertaken as part of the requirements for a postgraduate Master’s degree in Sports 
Science. The main aims of this project are: 
1. The first aim is to investigate associations between body composition, period of taking ART and 
comorbidity risk pointers in PLWHA. 
 
2. The second aim is to investigate the effect of resistance exercise on body composition in PLWHA. 
What Type of Participants are Needed? 
This study involves PLWHA male, female, of 18-45 years, receiving ART, not taking part in any gym 
exercise program and medically approved will participate in a 12 week resistance training program.  
Participants who fall under one or more of the categories listed below will not be able to participate in the 
project because, in the opinion of the researchers and the Ethics Committee of the University, it may lead 
to unfavourable outcomes of the study, or involve an unacceptable risk to them: 
 Not within the age group limit of 18-45years  
 Non-Black Africans 
 Patients or individuals with AIDS  
 Musculoskeletal disorders. 
 Seriously ill and bed redden individuals  
 With CD4 count less than 350 cells/mm3,  
 HIV Negative individuals  
 Any history of leg injury and back pain 
 Those with congestive heart failure, angina, cardiovascular and peripheral vascular diseases.  
 Individuals who experience a cold or feverish illness at least 1 month leading up to the protocol 
and those with flu symptoms. 
 Individuals taking medications that may affect central or peripheral circulation.  
 Those on nonsteroidal anti-inflammatory agents or serotonin reuptake inhibitors.  
 Currently engaged in an existing exercise programme. 
 Any other medical condition that would be exacerbated by lifting weights. 
What will Participants be asked to do? 
Should you agree to participate in this project, you will be asked to fill out forms and be involved in a 
testing protocol. Written informed consent will be obtained from all participants, and the study will be 
approved by the University of KwaZulu-Natal Research Ethics Committee. 
120 
 
Preliminary research study tests will be conducted at the community centre. You will attend four sessions, 
that is; a preliminary screening phase 1, being the first visit lasting no longer than 50 minutes. Phase 2, a 
baseline information-lab test session being the 2nd visit lasting approximately 1 hour 30 minutes each for 
four days (to take blood pressure, glucose, lipids, anthropometric measures and establishing of 1RM 
values. Anthropometric measurements are a technical procedure undertaken to determine one’s body 
dimensions (i.e. size, shape, mass, height, percentage body fat) using a skinfold calliper, tape measure and 
steel ruler among others. One repetition maximum (1RM) is the maximum weight that one can lift only 
once without experiencing fatigue while applying maximum effort (i.e. 100% exertion). All participants 
will be availed with gym membership cards to be able to access the gym. Control group members shall 
retain gym membership cards after the 1RM procedure only be given back after the study. 
 
Phase 3, which will be the 3rd visit, consists of a 12 week resistance exercise intervention on a frequency 
of 2 days.wk-1 commencing with a one and a half weeks conditioning session. At this stage, participants 
in the experiment group will perform strength exercises on each of the two days. Participants will get an 
opportunity to strengthen the biceps, triceps, chest, calf, hamstrings and quadriceps muscles. It will be 
achieved through performing the following exercises: body weight exercises, preacher curls, triceps 
extensions, bench press, leg curls, squats and calf raises. Initially experiment group subjects will work out 
at 50% of individual 1RM performing 3 sets of 10 repetitions observing 2 minutes rest during the first 
two weeks. The percentage of 1RM will be progressively increased to 60% and 65% observing the same 
number of repetitions and time of rest from week 3 to 6th week. This will be followed by progressively 
increasing the load from 70% to 75% and 80% of individual subjects’ 1RM performing 2 sets of 8 
repetitions observing 3 minutes rest from the 7th  to 12th week.  
 
This will be done in a circuit training format. Workouts will be done with the assistance of a spotter. The 
participants will be expected to maintain a high-calorie diet and rehydrate during the resistance exercise 
sessions. During this phase, participants will go through a 10-20 minute warm up involving light jogging, 
stretches, light weight exercises and 8-10 minutes cool down exercises. Each of the sessions will run for 
30-50 minutes per day. The control group participants will not undergo any exercise training intervention 
during the same period. 
 
Phase 4 will be the 4th visit and shall consist a post-test-activity session. Participants will have their 
baseline-lab tests (anthropometrics, body composition, blood; pressure, glucose and lipid level and1RM 
tests) measured again at 6th and 12th week. The phase is expected to last for approximately 1 hour (+/-).   
 Y N 
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The following tests and evaluations will be performed:  
Preliminary Screening: You will be required to complete the enclosed personal/medical history form. 
The purpose of completing this form is to ensure that you meet the inclusion requirements of the study, 
and that the researcher obtains necessary information about your lifestyle including physical activity. You 
will be required to complete an approved questionnaire by filling in your information regarding 
demographics, nutritional recall, medical history and Physical Activity Readiness.  
 
Pre-testing: You will be required to have baseline lab-tests performed to determine your anthropometric 
value, body composition, blood pressure, blood glucose, blood lipids and 1RM tests. The tests procedure 
will take approximately 1 hour 30minutes (+/-).   
 
(a). Anthropometric measurement procedure  
The procedure will be done observing highest levels of privacy and you will be measured by a research 
team member of the same gender with you. You will have minimal clothing and without shoes when 
these measurements will be taken. A stadiometer and an electronic scale will be used to measure stature 
and mass respectively. 
You will stand with the feet together and the heels, buttocks and upper part of the back touching the scale 
in an anatomical position.  
The measurer will place hands far enough along your jaw for ensuring an upward pressure to be 
transferred through your bony prominence that projects out from both sides of skull behind the ears and 
hinge of jaw. You will take and hold a deep breath keeping the head straight up in a firm and stable 
positon. The recorder will place the head board firmly down on the top of the head (vertex) to crush the 
hair as much as possible. The recorder further assists by watching that your feet will not come off the 
floor. Your height measurement will be taken at the end of the inward breath. To measure your weight, 
you will be required to stands on the central platform of the scale without support ensuring that the weight 
is distributed evenly on both feet. These measurements will be done observing ISAK protocol. 
(b). Body composition procedure 
Your restricted profile will be measuring taking seven (7) skinfold site (triceps, chest, abdominal, 
subscapular, suprailiac, mid-axilla and front thigh) to determine your amount of body fat. You will be 
expected to have minimal clothing when these measurements are being taken. Measurements will be done 
observing International Society for the Advancement of Kinanthropometry protocols using 
anthropometric equipment (skin fold callipers, anthropometric tape, steel ruler, demographic pen, 
retractable metric tape measure). Your skinfold site will be carefully located using the correct anatomical 
landmarks.  
Y N 
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Your skin will be marked using a tipped felt or dermographic pen for all skinfold landmarks. A skinfold 
will be picked up at marked lines. On each site, researcher will lightly grasp / pinch you with the thumb 
and index finger. The site will be lifted so that a double fold of skin plus the underlying subcutaneous 
adipose tissue is raised. A caliper will be applied 1 cm away from the edge of the thumb and finger and 
measurement recorded.        
(c) Blood Pressure Measurement Procedure 
Cuff and monitor will be positioned on flat-solid surface, and your upper arm inserted into the brachial 
cuff. The tubing will be positioned on the middle part of your arm to allow sensors to pick a signal. The 
brachial cuff will be placed on the main artery on the inside part of your arm. The bottom edge of the cuff 
will be about 3 cm from the elbow joint, pulling the end of the cuff to evenly tighten it round your upper 
arm, to fit comfortably. Your elbow will be rested with palm flat on the table. The monitor will be 
switched on to inflate the cuff automatically and you will sit quietly without moving. Your pulse as well 
as blood pressure (diastolic and systolic) readings will be automatically reflected on the monitor after 
some few seconds and recorded. After recording, the cuff will be let loose ensuring that it is deflated and 
reset to measure the next participant.  
 
(d) Blood tests procedure 
You will be allowed to rest for 5 minutes before taking the blood tests to stabilise the body. You will be 
made to sit comfortably on a chair with good back support at a table or desk and you will not eat, drink or 
smoke before or while your blood test is being taken. The feet flat on the floor. Constrictive jewellery and 
clothing will not be expected to be put on if they seem to interference with the procedure. Repeat 
measurements will be done to ensure accuracy.  
 
d. (i) Blood Glucose Measurement Procedure 
In the sitting position you will be expected to offer your preferred fingertip to be lanced with a lancet after 
being swabbed with cotton dampened in alcohol sterilizing solution. Then a drop of blood from the side 
will be drawn. You will be made to touch and hold the end of the test strip inserted into the meter/monitor 
so that the drop of blood gets absorbed into the strip to begin the test. Your test results will be displayed 
on the monitor screen after a beep and results recorded.  
A swab will be used to wipe the finger after the test observing WHO guidelines on drawing blood: best 
practices in phlebotomy and clinical health standards.  
  
 
 
Y N 
Y N 
Y N 
Y N 
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d.(ii) Blood Lipids/ Cholesterol Collection Procedure 
A second prick can only be done for this procedure if necessary. Therefore, the alcohol swabbed and 
initially pricked finger in above (for blood glucose measurement) will then be lightly squeezed once again 
to collect the blood that comes out to be drawn into a capillary tube which should be filled up to the black 
check line. Capillary tube will not touch the finger or be allowed to have bubbles. Blood collection for 
this procedure will be done within 30 seconds. You will be given a cotton swab to hold, press on the 
lanced finger and band it with an Elastoplast. A plunger will be used to apply the entire blood sample into 
the test strip. Your results will be displayed on the monitor after a few minutes and the total cholesterol, 
LDL and HDL level readings recorded. The used capillary tube, cotton swab, test strip, and lancet will be 
disposed properly and machine reset to test another participant. This will be done observing WHO 
guidelines on drawing blood: best practices in phlebotomy and clinical health standards.  
 
(e). 1RM test procedure 
Your current strength levels will be determined using 1RM tests (for bench press, squat, bicep curl and 
leg press 1RM). You will be led through a warm up performing submaximal repetitions of specific 
exercises to be used and the whole procedure done following ACSM Guidelines for Exercise Testing and 
Prescription protocol. The rest to be observed between each 1RM test procedure will be 48hours. The 
1RM will be determined within four lifts observing 3-5 minutes rests with help from a spotter. Normative 
data for predicting 1RM will be used to select weights that are within your perceived capacity (i.e. 50-
70%).  Weights will be progressively added by 2.5-20kg until you can no complete a repetition. 
Therefore, previous weight you would have lifted successfully will become the 1RM for that exercise. 
The lifted 1RM values for each exercise will be recorded and test results used to design your resistance 
exercise program, especially for experiment group members. 
 
(f) Post-test-activity procedure 
You will have your baseline-lab tests anthropometrics (body size, height, percentage body fat, blood; 
pressure, glucose and lipid level and strength tests) measured again at 6 and 12th week to assess progress. 
The results obtained will be analysed to draw conclusions and recommendations.     
 
 
 
 
 
 
Y N 
Y N 
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Possible risks and discomforts: 
Anthropometric Measures: Stature and mass measurements will produce no physical discomfort.  
 
Body composition Measures: The participant will be required to wear minimal clothing and this will 
bring minimal or no discomfort. 
 
Blood Samples: The blood samples will involve lancing the finger with a lancet and therefore there will 
be minimal discomfort.  
 
Blood Pressure Measures: Blood pressure will be taken using electronic monitors and will produce no 
physical discomfort. 
 
1RM test: Lifting of weights bring about some discomfort and fatigue hence rest periods, rehydration 
periods will be observed. 
 
Resistance exercise: Weight training brings about muscle soreness and fatigue hence, exposes you to 
some level of discomfort. This occurs to anyone who starts an exercise after being physically inactive for 
6-7 months or never been physically active. Conversely, this will subside in less than 6 days.  
 
The measurements will be taken observing all issues of privacy and confidentiality hence each participant 
will be measured by a research assistant of the same gender in designated testing rooms for males and for 
females. Ethical principles of respect for persons, beneficence (doing good) and justice will be strictly 
followed for your safety. Your right to self-determination will observed, without exposing you to harm or 
discrimination, in keeping to our agreement respecting cultural differences, preserving your anonymity in 
compliance with procedures and reports of violations. 
 
Blood glucose and cholesterol measures will be taken by a trained research and medical personnel team 
the presence of a first aider who will explain to you the procedure beforehand. Strict safety precautions 
will be followed. Hence the testing team will wear latex gloves during these procedures with appropriate 
clothing and follow guidelines for safe handling of samples and disposal in plastic sharps bins before 
incineration at the end of the whole session. Therefore your lanced finder will be swabbed with an alcohol 
swab. The lanced site will be cleaned using cotton balls and wrapped with an Elastoplast finger bandage. 
The 1RM and exercise session will be done after a trained sport and exercise   specialist would have taken 
you for a warm.  
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When you partake in the session adequate rest periods will be given and a spotter assisting you during 
these procedures. You will also be trained in gym basics prior to the sessions. In cases of experiencing 
delayed onset of muscle soreness, a massage therapist will be in attendance every other rest day as well as 
the medical doctor to attend to you. The opportunities for more rest will be given when you need it. 
Mineral water will be available during these sessions so as showers.  
 
Potential benefits of this study: 
 
Should the study yield significant results, the proposed benefits of the study include opportunities for 
participant to track and have blood pressure, blood sugar and blood lipid levels checked on a regular 
basis. It is also strongly anticipated that you will get an opportunity to have body composition profiling in 
relation to period you have been taking ART. This would in turn allow you to know your anthropometric 
scores in establishing health bench marks for consideration to partake in a physical fitness exercise 
program for your benefit. Also that, those found at risk of suffering from other ailments like diabetes 
mellitus, obesity, high blood pressure and high blood lipid levels after the study will be referred by a 
medical doctor for counselling and be provided with healthy physical lifestyle recommendations for 
adoption while continuing to participate in the study. Once the exercise intervention is found to yield 
significant benefits, all participants will be given the programme and encouraged to sustain it as healthy 
lifestyle practice.  Furthermore, the study may facilitate for a better understanding and appreciation of the 
importance of resistance exercise for HIV-infected members of the population. 
 
Will I Be Reimbursed For Participating In The Study? 
Participants in the study will be provided with a beverage and a snack by the research (at US$0.50/ R7 a 
beverage and US$1.50/R21 for a snack) and reimbursed transport at R15 per visit.The payments will be 
based on Time, Inconvenience and Expenses (TIE) method.  
 
Can Participants Change their Mind and Withdraw from the Project? 
You may withdraw from participation in the project at any time without any disadvantage to yourself of 
any kind. 
What Data or Information will be collected and What Use will be made of it? 
The information will facilitate for evaluation of whether resistance exercise has an impact on the body 
composition profiles of PLWHA. It can assist in establishing whether body composition profiles relate to 
time one has been taking ART. The information obtained will be used to provide awareness into the role 
resistance exercise have on the overall wellbeing of PLWHA.   
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Results of this project may be published but, any data included will in no way be linked to any specific 
participant. Therefore, you are most welcome to request a copy of the results of the project should you 
wish. Although every effort will be made to keep the information confidential, in special circumstances 
BREC and some Zimbabwean Regulatory department may be given access to the confidential 
information. 
 
The data collected will be securely stored in such a way that only those mentioned above will be able to 
gain access to it.  At the end of the project any personal information will be destroyed immediately except 
that, as required by the University's research policy, any raw data on which the results of the project 
depend will be retained in secure storage for five years, after which it will be destroyed. 
What do participants have to avoid prior to testing? 
Participants will be instructed not to eat, drink or smoke before or while blood test will be taken. 
What if Participants have any Further Questions? 
If you have any further questions regarding this study, please feel free to contact: - 
Takshita Sookan 
Discipline of Biokinetics, 
Exercise and Leisure Sciences 
Telephone Number 031 2607987 
This project will be reviewed and approved by the Biomedical Research Ethics Committee of the 
University of KwaZulu-Natal. 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION  
University of KwaZulu-Natal  
Research Office, Westville Campus  
Govan Mbeki Building  
Private Bag X 54001, Durban, 4000  
KwaZulu-Natal, SOUTH AFRICA  
Tel: 27 31 2604769 - Fax: 27 31 2604609  
Email: BREC@ukzn.ac.za 
 
127 
 
APPENDIX H: INFORMED CONSENT 
 
THE EFFECT OF RESISTANCE EXERCISE ON HIV-INFECTED PATIENTS TAKING 
ANTIRETROVIRAL THERAPY (ART) IN ZIMBABWE 
I have read the Information Sheet concerning this project and understand what it is about.  All my 
questions have been answered to my satisfaction.  I understand that I am free to request further 
information at any stage. 
 
Finally, I understand that:  
1. My participation in the project is entirely voluntary.  
2. I am free to withdraw from the project at any time without any disadvantage. 
3. The data will be destroyed at the conclusion of the project but any raw data on which the results of the 
project depend will be retained in secure storage for five years, after which it will be destroyed. 
4. Firstly I am required to fill in a questionnaire. Secondly I understand that there are baseline tests that 
include blood capillary draw, some tests require minimal clothing and that I will be required to lift 
weights. Thirdly I will complete the resistance exercise intervention which may cause some 
discomfort. Hence, I understand that there is a level of discomfort. I may be placed randomly into an 
experiment or control group for a period of 12 weeks.   
5. There is reimbursement of transport in this study. 
6. The results of the project may be published but my anonymity will be preserved. 
7. That I will keep a copy of this consent form and I will receive a report of my results, if requested I am 
entitled to a copy of the study. 
I agree to take part in this project.                                              
.............................................................................  ………………….. 
Signature of participant     Date 
………………………………………………           …………………..         
Witness                                            Date                                                    
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APPENDIX I: QUESTIONNAIRE 
 
 
 
 
Introduction  
Warm greetings to you. I am Victor Mbayo from the University of KwaZulu Natal undertaking a study on 
the effect of resistance exercise on HIV-infected patients taking antiretroviral therapy (ART) in 
Zimbabwe. This questionnaire seeks to obtain valuable information from you and value your honest 
detailed responses. You are kindly requested to fill in or by ticking were relevant. The questionnaire 
should take approximately 20-30 minutes of your time to complete. Your responses are completely 
anonymous and information you provide will be handled with highest degree of confidentiality and 
secrecy. 
A. Demographic Information 
Please tick/ fill in the questionnaire were appropriate. 
1. What is your Gender  Male  or   Female 
 
2. Age Range    18-29  30-41  42-53  54-60 
3. Level of education    
Non-Formal Primary          Secondary   Certificate      Tertiary  
Other_________________________________________________________ 
 
4. Marital Status 
Single   Married Divorced 
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B. General Physical Activity Readiness and Exercise Adherence 
7. Has your doctor ever said that you have a heart condition and that you should only do physical activity 
recommended by a doctor?  YES     NO 
8. Do you feel pain in your chest when you do physical activity? YES   NO 
         YES NO 
9. In the past month, have you had chest pain when you were not doing 
physical activity? 
10. Do you lose your balance because of dizziness or do you ever lose 
consciousness? 
11. Do you have a bone or joint problem (for example, back, knee or hip) 
that could be made worse by a change in your physical activity? 
12. Is your doctor currently prescribing drugs (for example, water pills) for 
your blood pressure or heart condition? 
13. Do you know of any other reason why you should not do physical 
activity? 
 
14. Which form or type of  exercise/ physical activity do you participate in   
Walking     Jogging  Gym Work Outs    I do not exercise   
Any other_______________________________________________________________ 
15. How much time do you spend exercising/ doing physical activity per week 
Less than 30minutes  30minutes- 1Hour      More than 1 Hour  None 
 
16. How often do you exercise/ do physical activity per week:  
1-2times/wk  3-4 times/wk   More than 4times  None  
17. Would you be interested in taking part in some form of exercise for health reasons?  
Yes No 
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C. Health Background 
18. In which year were you diagnosed positive _________ 
19. Which year did you start taking ART ___________ 
20. Which ART medication are you taking ______________________________________ 
D. Risk Assessment 
21. Are you    a Smoker    or Non Smoker    At times 
22. If yes in above how many cigarettes per day on average_________________________ 
23. When did you quit smoking   ______ years/weeks/months ago or Never smoked 
24. Do you take alcohol: Yes  No  At times 
25. If yes in above how often   and how much in quantity___________ 
26. When did you quit taking alcohol_____ years/weeks/months ago or  Never took alcohol  
27. Have you been diagnosed hypertensive (High BP): Yes   No 
     or on hypertensive medication:  Yes  No 
28. Are you diabetic? Yes         No 
E. Nutritional risk assessment 
29. Circle the answer which best describes your usual behaviour 
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DIETARY INTAKE - HABITS  
 
 
 
 
 
 
 
 
 
 
How many days each week do you eat breakfast?  None  1-2 days  3-5 days 6-7 days 
How many days each week do you eat lunch?  None  1-2 days  3-5 days 6-7 days 
How many days each week do you eat dinner?  
 
None  1-2 days  3-5 days 6-7 days 
How often do you eat between meals or after dinner?  Daily  Several 
times /week  
Once/week 
or less  
Rarely  
How much water do you drink each day?  <1 cup  1-2 cups  3-5 cups  >5 cups  
How many times per week do you eat or take out a 
meal from a fast food restaurant?  
Daily  Several 
times/week  
Once/week 
or less  
Rarely  
Are you a vegetarian?  Yes No 
Do you take any vitamin or mineral supplement?  Daily  Weekly  Rarely  Never  
If yes, which brand or type:   
Do you use herbal supplements?  Daily  Weekly  Rarely  Never  
If yes, which one(s)?   
Do you use any pills or teas to lose weight?  Yes No 
Do you use protein powders, creatine or other 
supplements that claim to increase muscles?  
Daily  Weekly  Rarely  Never  
Are you on a special diet for medical reasons?  Yes No 
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FOOD GROUPS: BREAD, CEREAL, RICE, AND PASTA 
Serving Size  Food Item  Servings per 
day  
Servings per 
week  
Eat once a 
month or less  
Never 
eat  
1 slice  Bread      
1/2  Hamburger or hot dog bun      
1/2  English muffing, bagel, pita 
bread  
    
4-6  Crackers      
1-6 inch  Tortilla      
1 small or 1/2 
large  
Muffin, *biscuit      
2 medium  Pancakes      
2 small  Waffle      
1/2 cup  Hot cereal      
3/4 cup  Cold Cereal      
1/2 cup  Rice, cooked      
1/2 cup  Pasta (spaghetti, noodles, 
macaroni, etc.), cooked  
    
TOTAL # OF SERVINGS:      
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FRUITS AND VEGETABLES 
Serving Size  Food Item  Servings per 
day  
Servings per 
week  
Eat once a 
month or less  
Never 
eat  
1 medium  Fresh apple, pear, banana, 
orange, peach, nectarine, 
tomato  
    
½  Grapefruit      
2  Apricots, tangerines      
¼  Cantaloupe      
1 cup  Melon, cut up      
3/4 cup  Berries      
1/2 cup  Pineapple, fresh      
1/2 cup  Canned or frozen fruit      
1/4 cup  Dried fruit (raisins, apricots, 
dates  
    
3/4 cup  100% vegetable juice      
1 cup  Leafy green vegetables      
1/2 cup  Vegetables, raw or cooked      
1 medium  Potato, baked, boiled, or 
mashed  
    
TOTAL # OF SERVINGS:      
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MILK, YOGURT, AND CHEESE 
Serving 
Size  
Food Item  Servings per 
day  
Servings per 
week  
Eat once a 
month or less  
Never 
eat  
1 cup  Unflavored Milk*      
1 cup  Fat free milk      
1 cup  Yogurt      
1-2 ounces  Cheese*      
1 cup  Cottage cheese*      
11⁄2 cup  Frozen yogurt      
11⁄2 cup  Ice cream*      
11⁄2 cup  Pudding,* custard      
8 ounces  Fortified unflavored soy milk      
1 cup  Unflavored Milk*      
TOTAL # OF SERVINGS:      
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MEAT, POULTRY, FISH, DRY BEANS, EGGS, AND NUTS 
Serving 
Size  
Food Item  Servings per 
day  
Servings per 
week  
Eat once a 
month or less  
Never 
eat  
3 ounces  Cooked beef, pork or lamb      
3 ounces  Cooked chicken, turkey or duck      
3 ounces  Fresh or frozen fish, cooked      
3 ounces  Shellfish      
3 ounces  Lunch meats*      
 Hot dogs     
3 ounces  Tuna or other canned fish      
3  Eggs (1 egg = 1 oz. meat)      
9 ounces  Tofu (3 ounces = 1 oz. meat)      
6 Tbsp  Peanut butter*      
11⁄2 cup  Legumes, cooked or canned: 
[lentils, beans (pinto, navy, 
kidney, garbanzo), split peas, 
black-eyed peas]  
    
 Nuts and seeds      
TOTAL # OF SERVINGS:     
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FATS, OILS, AND SWEETS 
Serving 
Size  
Food Item  Servings 
per day  
Servings per 
week  
Eat once a 
month or less  
Never 
eat  
2  Cookies      
1  Brownie      
1  Donut or sweet roll      
1  Granola bar      
1  slice cake or pie      
1⁄2 cup  Pudding, custard, Jello, ice cream, 
sherbet  
    
1  Chocolate bar, M and Ms or candy (1 
pkg)  
    
1 tbsp  Sugar, honey, jam, jelly, syrup      
12 
ounces  
Soda (not diet) (1 can)      
1 cup  Fruit flavored, sugar sweetened drinks 
(lemonade, fruit punch, KoolAid, Hi-C, 
Sunny Delight)  
    
1 tsp  Butter or margarine      
1 Tbsp  Mayo, salad dressing, sour cream      
1 Tbsp  Cream cheese      
1 Tbsp  Vegetable oil      
TOTAL # OF SERVINGS:     
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BODY IMAGE, DISORDERED EATING, AND WEIGHT MANAGEMENT 
Do you worry about gaining weight?  Yes  No  
Are you preoccupied with losing weight?  Yes  No  
Are you on a diet or do you limit your food intake to lose weight?  Yes  No  
Does your mood depend on your weight (e.g., if you gain one pound you are 
depressed, irritable, etc.)  
Yes  No  
Do you feel bad about yourself if you gain weight?  Yes  No  
If you gain one pound, do you worry that you will continue to gain weight?  Yes  No  
Do you think of certain foods as being either “good” or “bad” and feel guilty about 
eating “bad” foods?  
Yes  No  
Do you use foods to comfort yourself?  Yes  No  
Do you ever feel out of control when eating?  Yes  No  
Do you spend a significant amount of time thinking about food and when you will 
eat?  
Yes  No  
Do you vomit or have you thought about vomiting as a way to control your weight?  Yes  No  
Do you try to hide how much you eat?  Yes  No  
Do you use laxatives, water pills, exercise, etc., to prevent weight gain?  Yes  No  
Are you dissatisfied with your body size or shape?  Yes  No  
Do you eat until you feel stuffed?  Yes  No  
Total number of “yes” answers =  
 
 
 
THANK YOU 
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APPENDIX J: ATHROPOMETRIC RECORDING SHEET 
 
 
 
Name/Code: __________________________ Age: ____________________________ 
Contact No: ___________________________  
Gender: Male     or Female  
Date of Test: _________________________________ 
Test number: _________________________________ 
Measurement  Ser Site 1 2 3 Mean/Median 
Basic 1 Weight/Body Mass (kg)     
2 Stature/Height (cm)     
Skin folds 3 Triceps (mm)     
4 Chest (mm)     
5 Abdominal (mm)     
6 Subscapular (mm)     
7 Mid-axilla (mm)     
9 Front Thigh (mm)     
10 Suprailiac (mm)     
Girths 11 Waist (cm)     
12 Hip (cm)     
 
Body Mass Index: = Weight   
           Height2 
 
Sum of 7 mean Skin folds =  
 
Waist-Hip Ratio = Waist 
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          Hip    
APPENDIX K:  CHRONIC DISEASE RISKS RECORDING SHEET 
 
 
  
 
Name/Code: __________________________ Age: ____________________________ 
Contact No: ___________________________  
Gender: Male     or Female  
Date of Test: _________________________________ 
Test number: _________________________________ 
Starting time: _________________________________ 
 Measure or Test Level/Reading Units 
Systolic Blood Pressure   mm Hg 
Diastolic Blood Pressure   mm Hg 
Fasting Total Blood Cholesterol   mmol/L 
Blood Glucose   mmol/L 
 
Finishing time: ______________________________________ 
 
Comments: 
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_______________ 
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APPENDIX L: ONE REPETITION MAXIMUM RECORDING SHEET 
 
 
 
Name/Code:  _______________________ Date: ____________________________ 
Gender: _______________________ Weight: ________ in Kg _________ in lbs 
Age:  _______________________ Mode or type of lift: _________________ 
Estimated 1RM ______________________ in Kg _______________________ in lbs 
Warm Up 
1. _______ reps @ ____________ Kg or ________lbs (at ≈ 50% of estimated 1RM) 
2. _______ reps @ ____________ Kg or ________lbs (at ≈ 60-70% of estimated 1RM) 
1RM Testing (please circle              success or failure with each attempt) 
1st attempt: Success / Failure, lifting ______________ Kg, ________________ in lbs 
2nd attempt: Success / Failure, lifting ______________ Kg, ________________ in lbs 
3rd attempt: Success / Failure, lifting ______________ Kg, ________________ in lbs 
4th attempt: Success / Failure, lifting ______________ Kg, ________________ in lbs 
5th attempt: Success / Failure, lifting ______________ Kg, ________________ in lbs 
6th attempt: Success / Failure, lifting ______________ Kg, ________________ in lbs 
 
Established 1RM per Body weight _________________ =          .            
Percentile rank classification for 1RM in lbs per body weight, in lbs _______, in Kg _______ 
 
Comments: 
___________________________________________________________________________ 
___________________________________________________________________________ 
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APPENDIX M: WORKOUT RETURN FORM 
 
Effect of resistance exercise on HIV-infected patients taking (ART) in Zimbabwe 
Goal: ...................................................................................................................................... 
Identifiable Patient/ Name Code: .................  Date: .................................................... 
Starting time: ...............................................  Finishing time: .................................... 
NB: This work out sheet covers for a period of one week. 
Overall Comments 
..........................................................................................................................................................................
..........................................................................................................................................................................
.......................................................................................................................................................................... 
Checked By: ..................................... Date: .....................................Signature:................................ 
Week Type of Exercise Working %1 RM Volm Weight  Reps  Sets Rest  Remarks 
 
 
Week 
_____ 
 
 
Day 
_____ 
 
 
         
Leg Curl Hams        
         
Bench Press Chest        
         
Bicep Curl Biceps        
         
Squats Quads        
         
 
 
Week 
 
______ 
 
 
Day 
 
______ 
Squats Quads        
         
Chest Press Chest        
         
Preacher Curls Biceps        
         
Leg curls Hams        
         
         
         
 
 
 
Week 
 
______ 
 
Day 
 
_______ 
Lunge Quads        
         
Bicep Curls Biceps        
         
Leg Curls Hams        
         
Bench Press Chest        
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